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ABSTRACT 
Superarmed glycosyl donors in chemical glycosylation 
 
Hemali D. Premathilake 
Doctor of Philosophy  
University of Missouri – St. Louis 
Prof. Alexei V. Demchenko, Advisor 
 
Only recently has the tremendous biological significance and therapeutic potential of 
carbohydrates and conjugates thereof (glycoproteins, glycolipids, proteoglycans, etc.) 
begun to emerge. As the appreciation for the biological roles of carbohydrates a growing 
demand for efficient and scalable methods towards the synthesis of these challenging 
molecules has become even more imperative. This has led to the development of a 
variety of expeditious strategies for oligosaccharide assembly.  Amongst these strategies, 
the so-called armed-disarmed strategy introduced by Fraser-Reid is of particular 
attractiveness as it allows for chemoselective oligosaccharide synthesis. Recently, the 
conformational changes as well as the strategic placement of common protecting groups 
have led to the discovery of new methods for “superarming” of glycosyl donors. 
This doctoral dissertation is dedicated to the exploration of new methods and strategies 
for efficient oligosaccharide assembly. The main focus of this work is centered on the 
detailed study of the superarmed glycosyl donors and broadening their application to the 
chemoselective oligosaccharide assembly.  This study was supplemented by the 
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discovery of new leaving groups and application to the synthesis of biologically 
important oligosaccharides containing residues of sialic acid.  
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CHAPTER 1 
 
Superarmed and superdisarmed building 
blocks in expeditious oligosaccharide 
synthesis 
 
 
 
 
H. D. Premathilake, A. V. Demchenko. Superarmed and superdisarmed building blocks 
in oligosaccharide synthesis. In “Topics in Current Chemistry, Vol. 301. Reactivity 
Tuning in Oligosaccharide Assembly.” B. Fraser-Reid, J. Cristobal Lopez Eds., Springer-
Verlag, Berlin-Heidelberg, 2011, pp. 189-221  
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1.1 Background 
Complex carbohydrates (polysaccharides or complex glycoconjugates in which 
oligosaccharides are connected to peptides, proteins, or fatty acids) are involved in a 
variety of biological processes.
1
  Throughout the past two decades, the main scientific 
effort in the field of glycoscience has remained centered upon those carbohydrates 
associated with diseases that consistently rank among the leading causes of death 
worldwide, such as: cardiovascular disease, cancer, septicemia, bacterial, viral, and 
parasitic infections.  The driving force behind this tremendous scientific and industrial 
effort is the belief that a comprehensive knowledge of the structural, conformational and 
other general properties of these carbohydrates will help scientists to understand the 
pathogenesis of the associated diseases.  Consequently, this could lead to the 
development of new and effective strategies for the prevention, diagnosis, treatment of 
these diseases.  Over the years, glycoscientists have mastered techniques necessary for 
isolating only certain classes of naturally occurring carbohydrates.  Therefore, the 
availability of pure natural isolates cannot satisfy all of the challenges presented by 
modern glycoscience.  As a result, glycoscientists have turned to both chemical and 
enzymatic synthesis as a means for accessing complex carbohydrates.  While enormous 
progress in the areas of synthetic, biological, and analytical chemistry, have made many 
classes of organic compounds readily accessible through broadly applicable methods, 
carbohydrates of even moderate complexity still represent a significant challenge.  A few 
representative examples of such oligosaccharide sequences are shown in Figure 1.1. 
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Figure 1.1.  Representative examples of natural poly- and oligosaccharide 
sequences. 
 
1.1.1 Principles of Chemical O-Glycosylation   
Poly- or oligosaccharide sequences are constructed by connecting monosaccharide units 
via O-glycosidic bonds.  In nature this linkage is formed by a coupling reaction known as 
glycosylation, the course and selectivity of which is controlled by glycosyltransferases.  
In the chemical laboratory, glycosylation typically involves a promoter (or activator)-
assisted nucleophilic displacement, wherein a leaving group (LG = halogen, OH, O-
alkenyl/imidoyl, S-alkyl/aryl/imidoyl, etc.) on the glycosyl donor is displaced by a 
hydroxyl moiety of the glycosyl acceptor (Scheme 1.1a).
2
  Remaining functional groups 
on both the glycosyl donor and acceptor are temporarily masked with protecting groups 
(P, T), which, along with strategies for their installation and removal (protection-
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deprotection), have become essential components of chemical syntheses of 
oligosaccharide molecules.  Although protecting groups were initially applied to reduce 
unwanted side reactions by masking additional sites of reactivity, they can also affect the 
glycosylation in a variety of other ways; in other words,  they “do more than protect.”3  
Since the anomeric center is chiral, particular care has to be taken with regards to the 
stereoselectivity of glycosylation.  Despite the significant progress made in the area of 
glycoside synthesis,
2
 the necessity of forming either a 1,2-cis or a 1,2-trans-glycosidic 
bond with high stereocontrol remains the main reason that chemical O-glycosylation is 
ranked among the most critical challenges of modern synthetic chemistry.  
 
Scheme 1.1.  Outline of chemical glycosylation.  
 
Although mechanistic rationalizations of the glycosylation reaction lack generality and 
consistency, and although studies dedicated to the reaction mechanism are still scarce, 
some conventions have already been well established.
4
  For instance, in the case of ether-
type non-participating substituents, glycosylation proceeds via a flattened oxacarbenium 
ion
5
 (Scheme 1.1b), often leading to anomeric mixtures favoring 1,2-cis glycosides
6, 7
 (for 
D-gluco/galacto series) due to the influence of the anomeric effect.
8, 9
  Thus, variable 
factors such as temperature, pressure, structure, conformation, solvent, promoter, steric 
hindrance, protecting or leaving group are exceedingly important in influencing the 
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stereoselectivity of glycosylation.  Amongst these, neighboring group participation
10
 is 
one of the most prominent effects dictating the stereochemical outcome of the 
glycosylation reaction (protecting groups do more than protect), as it is well established 
that 1,2-trans glycosides can be obtained from 2-acylated glycosyl donors. This 
selectivity arises from the acyloxonium intermediate formed as a result of the anchimeric 
assistance from the neighboring C-2 group (Scheme 1.1c).   
 
1.1.2 Oligosaccharide Synthesis 
The development of new leaving groups and efficient glycosylation methods is largely 
responsible for the progress that has been made in the area of oligosaccharide synthesis.  
When the arsenal of glycosylation techniques was limited to the Fischer (LG=OH)
11
 and 
Koenigs–Knorr (LG = Cl, Br)12, 13 approaches (or their variations),14, 15 oligosaccharide 
assembly was limited to inefficient stepwise linear techniques.  However, as more stable 
glycosyl donors, such as fluorides,
16
 thioglycosides
17
 and O-alkenyl glycosides were 
developed,
18
 the possibility of selective and/or chemoselective activation of one leaving 
group over another emerged.  In linear oligosaccharide synthesis, the disaccharide 
product formed from the single step glycosylation reaction (see Scheme 1.1) is then 
converted into either a second-generation glycosyl acceptor or donor; this is 
accomplished via the liberation a specific hydroxyl group or installation of a suitable 
leaving group, respectively (Scheme 1.2).  These second generation disaccharide building 
blocks are then allowed to react with an appropriate monosaccharide glycosyl donor or 
acceptor, resulting in the formation of a trisaccharide.  The protecting/leaving group 
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manipulation and glycosylation sequence can be then reiterated until an oligosaccharide 
of the desired chain length is obtained.   
 
Scheme 1.2.  Conventional (linear) oligosaccharide synthesis. 
 
It soon became apparent, however, that both the linear and convergent
19-21
 approaches 
were too inefficient, due to the extensive protecting or leaving group manipulations 
between each glycosylation step.  Consequently, the past two decades have witnessed a 
dramatic improvement of the methods and strategies used for oligosaccharide synthesis, 
as scientists have persistently aimed to answer the key question: can oligosaccharides be 
obtained more expeditiously through the elimination of these unnecessary synthetic 
steps?  The first attempts to address this challenge emerged in the mid-1980s and 1990s, 
which resulted in the development of a number of revolutionary approaches.  Many of 
these innovative strategies involve selective activations, wherein different leaving groups 
are sequentially activated minimizing the need for protecting group manipulations 
between glycosylation steps; selective activation,
19, 22
 two-step activation
19, 23-25
 and the 
active-latent concept
26-29
 are just a few classifications of such approaches.  One specific 
example, the orthogonal approach, makes use of two chemically distinct glycosyl donors, 
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wherein one of the leaving groups is selectively activated while the other remains intact, 
and vice versa, offering significant flexibility.
30
  This activation sequence can then be 
reiterated to give straightforward access to larger oligosaccharides. 
Another direction in expeditious oligosaccharide synthesis emerged with the discovery of 
the so-called armed-disarmed approach by Fraser-Reid and co-workers.
31
  This strategy, 
based on the chemoselectivity principle, utilizes only one class of leaving group, thus, 
glycosyl donor reactivity is modulated entirely through the choice of protecting group 
(protecting groups do more than protect).  This effect allows for direct chemoselective 
coupling between an activated (armed) glycosyl donor and a deactivated (disarmed) 
glycosyl acceptor, and the resulting disaccharide can then be used directly in subsequent 
glycosidation.   
With the main focus on the armed-disarmed concept, this chapter discusses the recent 
progress that has been made in the area of chemoselective oligosaccharide synthesis.  The 
classic armed–disarmed approach, developed by Fraser-Reid, has created a solid basis 
for extensive studies and applications, and all strategies discussed in this chapter are 
directly related to (or derived from) this elegant concept.  As recent improvements have 
significantly expanded the scope of the original chemoselective concept, a series of 
building blocks, the reactivity of which extends beyond the traditional armed-disarmed 
definition, have additionally been introduced.  These “superarmed” and “superdisarmed” 
building blocks have helped to expand the scope of the original methodology so that it 
can now be applied to the synthesis of a much broader range of complex oligosaccharide 
sequences, in comparison to that of the classic armed-disarmed concept.  These excellent 
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innovations have already been applied to the synthesis of various oligosaccharides and 
glycoconjugates, and some representative examples are presented herein. 
 
1.2. Armed-disarmed strategy for oligosaccharide synthesis 
 
The chemoselective approach and its variations discussed in this section make use of only 
one class of leaving group for both reaction components, which are either activated 
(armed donor) or deactivated (disarmed acceptor) by the influence of the protecting 
groups (R1, R2, Scheme 1.3).  Usually, the protecting groups in both reaction components 
have to be taken into consideration to allow for direct chemoselective activation of the 
armed glycosyl donor over the disarmed glycosyl acceptor.  As both components bear the 
same type of LG, the key factor for an armed–disarmed activation to take place is finding 
suitable reaction conditions that can efficiently differentiate between the activated and 
deactivated building blocks.  In most cases, the differentiation is achieved by the choice 
of promoter, temperature, or solvent.
32
   
 
Scheme 1.3.  Armed-disarmed strategy outline 
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As aforementioned, the majority of strategies discussed in this subsection allow for 
efficient oligosaccharide assembly without the necessity to perform additional synthetic 
steps between the glycosylation steps.  Accordingly, the disarmed leaving group of the 
resulting disaccharide can be activated directly, although, a more powerful promoter or 
elevated temperatures are typically required. 
 
1.2.1. Classic concept: electron-withdrawing substituents and the synthesis of cis-
trans-patterned oligosaccharides 
Although the effect of protecting groups on reactivity had been noted,
20
 it was Fraser-
Reid who described, in 1988, a new manner by which the differential properties of 
protecting groups could be exploited, termed the “armed-disarmed strategy.”33  It was 
noticed that ester-type protecting groups (OAc, OBz, etc.) strongly reduced, “disarmed”, 
the reactivity of the n-pentenyl glycosyl donor, in comparison to that of its alkylated 
(benzylated, OBn) “armed” counterpart.   
One justification for such an observation is that the increased electron-withdrawing 
ability of ester protecting groups decreases the electron density (nucleophilicity) of the 
anomeric heteroatom, which translates into a diminished ability to interact with the 
electrophilic promoter.  Resultantly, the armed leaving group reacts faster, with the 
disarmed leaving group reacting either much more slowly, or not at all.  In order to 
achieve an efficient differentiation in reactivity, mild promoters have an advantage, as 
they are able to offer a more controlled activation.  For example, iodonium(di-γ-collidine) 
perchlorate (IDCP) was found to be a suitable mild electrophilic activator for O-pentenyl 
glycosyl donor 1.1, and corresponding disaccharide 1.3 was isolated in 62% yield 
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(Scheme 1.4).
33
  As the anomeric configuration of the product is influenced by the 
protective group at O-2, a 1,2-cis-linked disaccharide is preferentially obtained in the first 
step, due to the use of the non-participating, ether-type (O-benzyl) arming substituent.   
 
Scheme 1.4.  Armed (1.1) and disarmed (1.2) O-pentenyl glycosides: 
synthesis of cis-trans-patterned trisaccharide 1.5. 
 
Furthermore, the leaving group of disarmed building blocks (such as 1.2 or 1.3) can also 
be activated, but this would typically require more time, higher temperature, and/or 
stronger promoters.  For instance, the direct glycosidation of disaccharide 3 was readily 
achieved in the presence of a strong promoter system, NIS/TfOH.  This glycosylation 
step was performed with glycosyl acceptor 1.4, resulting in the stereoselective formation 
of a 1,2-trans glycosidic linkage.  As aforementioned, glycosidation of 2-acylated 
glycosyl donors typically proceeds via the formation of the bicyclic acyloxonium 
intermediate, which coordinates the 1,2-cis face of the ring.  As a result of this two-step 
activation sequence, a cis-trans-patterned trisaccharide (1.5) is obtained, wherein the 
monosaccharide units are sequentially connected via a 1,2-cis and 1,2-trans linkage 
(Scheme 1.4).   
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Although this discovery was made using n-pentenyl glycosides, this electronic effect 
ultimately proved to be of a general nature, and as such can be applied to nearly any class 
of glycosyl donor.  This concept was further explored for the chemoselective 
glycosidations of thioglycosides,
34
 selenoglycosides,
35
 fluorides,
36
 phosphoroamidates,
37
 
substituted thioformimidates,
38
 glycals,
39
 and thioimidates.
40, 41
  The usefulness of this 
approach was realized in application toward expeditious oligosaccharide synthesis, as it 
circumvents the need for protecting group manipulations at the anomeric center.
42
   
 
1.2.2. Strategic updates to the original armed-disarmed method 
Synthesis of the cis-cis-patterned oligosaccharides using reprotection of the intermediate 
disaccharide.  To address the major limitation that the armed–disarmed strategy could 
only be applied to the synthesis of oligosaccharides having a cis-trans glycosylation 
pattern, van Boom and co-workers designed a method whereby the synthesis of cis-cis-
linked derivatives could also be achieved.
34
  In the first synthetic step the classic armed-
disarmed activation was performed, however, the resulting disaccharide was then 
reprotected (OBz  OBn) prior to subsequent glycosidation.  A representative example 
of this strategy is shown in Scheme 1.5.   
Armed thioglycoside donor 1.6 was selectively activated over disarmed glycosyl acceptor 
1.7 in the presence of IDCP to provide the disarmed 1,2-cis linked disaccharide (1.8) in 
91% yield.  The latter was then subjected to a two-step debenzoylation-benzylation 
sequence, whereupon the resulting disaccharide donor (1.9) was glycosidated with 
disarmed acceptor 1.7, to afford the cis-cis-linked trisaccharide (1.10) in 72% yield.  The 
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conversion of the second generation glycosyl donor 1.8 into the armed state 1.9, allowed 
for the second coupling step to also be performed with the mild promoter IDCP. 
 
Scheme 1.5.  Synthesis of cis-cis-patterned trisaccharide 1.10, via the 
modified armed–disarmed approach.34 
 
Synthesis of trans-trans patterned oligosaccharides using picolinyl arming participating 
group.  Demchenko et al.
41
 demonstrated that with the use of a O-picolinyl substituent as 
an “arming participating group” at C-2 of the glycosyl donor, a 1,2-trans glycosidic 
linkage can be chemo- and stereo-selectively introduced in the first glycosylation step.  
For example, glycosidation of armed glycosyl donor 1.11 with disarmed acceptor 1.12 in 
the presence of Cu(OTf)2, produced 1,2-trans-linked disaccharide 1.13 in 74% yield 
(Scheme 1.6).  Due to the opposite stereochemical outcome of this glycosylation, in 
comparison to the 1,2-cis linkage formed in the first step of the classic armed–disarmed 
approach, this approach was called the inverse armed–disarmed strategy.  Subsequent 
glycosidation of disarmed disaccharide 1.13 with the standard glycosyl acceptor 1.14 
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could then be achieved in the presence of a more powerful activator AgOTf, and the 
resulting trans-trans-linked trisaccharide 1.15 was obtained in 88% yield.
41
  NMR 
experiments were utilized, showing the presence of the anticipated cyclic compound A as 
the key reaction intermediate (Scheme 1.6).   
 
Scheme 1.6.  Arming participating picolinyl group mediated synthesis of 
trans-trans-patterned trisaccharide 1.15. 
 
1.2.3. Conceptual updates to the original armed-disarmed method 
Deactivation by a remote protecting group capable of powerful electron-withdrawal.  
Madsen et al.
43
 clearly demonstrated that a single electron-withdrawing moiety at the 
remote C-6 position will sufficiently disarm the leaving group of a glycosyl acceptor, in 
comparison to the per-alkylated glycosyl donor.  This effect was especially pronounced 
with the use of a pentafluorobenzoyl (PFBz) ester, capable of a very powerful electron-
withdrawal.
44
  For example, armed benzylated thioglycoside 1.16 could be 
chemoselectively activated over the disarmed 6-O-pentafluorobenzoyl acceptor 1.17 in 
the presence of NIS/TESOTf to provide disaccharide 1.18 (Scheme 1.7).   The latter 
Premathilake, Hemali D., UMSL, p.30 
 
could then be glycosidated with glycosyl acceptor 1.19 the presence of NIS/TESOTf to 
give trisaccharide 1.20 in 61% yield.  It is important to highlight that this approach allows 
for the cis-cis oligosaccharide sequence to be obtained directly, without 
deprotection/reprotection of the intermediate disaccharide, as previously discussed for the 
synthesis reported by van Boom (see Scheme 1.5). 
 
Scheme 1.7.  Disarming the glycosyl acceptor with the remote 6-O-
pentafluorobenzoyl moiety: direct synthesis of cis-cis-patterned 
trisaccharide 1.20.
44
 
 
Crich et al.
45
 also investigated the influence of the electron-withdrawal at the C-6 position 
on the reactivity of glycosyl triflates and stereoselectivity of their glycosidations.  In 
exploring a series of mono-, di-, and tri-fluorinated 6-deoxy rhamnosides, a clear 
correlation between the strength of electron withdrawal at C-6 and stability of the 
anomeric triflates was established.  While common rhamnosyl triflates undergo rapid 
decomposition at temperatures above -60 
o
C, it was shown that their 6,6,6-trifluorinated 
counterparts remained stable at temperatures up to +10 
o
C.  Many related studies have 
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further demonstrated that the arming/disarming effect of the protecting groups may also 
be highly dependent upon their location (see Schemes 1.11 and 1.12 below), geometry, 
and core donor structure.
46, 47
   
Deactivation with cyclic ketals/acetals: torsional and electronic effects.  Fraser-Reid and 
co-workers discovered that the deactivation of glycosyl donors could also be achieved 
through the strategic placement of cyclic acetal/ketal substituents that would lock the 
pyranose ring in the 
4
C1 chair conformation.  This type of deactivating effect was 
attributed to the increased rigidity of the fused ring system, prohibiting the oxacarbenium 
ion intermediate from achieving the requisite planar geometry about the (C-2)-(C-1)-(O-
5)-(C-5) atoms.
48
  As depicted in Scheme 1.8, in a series of O-pentenyl glycosides, 
reactivity was noted to increase from the tricyclic 2,3:4,6-diacetone ketal 1.21 to the 
bicyclic 4,6-benzylidene acetal 1.22 with the traditional armed O-pentenyl glycoside 
(1.1) being the most reactive.  This relative reactivity trend was proven by direct 
chemoselective activation of armed glycosyl donor 1.1 over benzylidene-protected 
glycosyl acceptor 1.23.  As in case of the traditional armed-disarmed approach, IDCP 
was found to be a suitable promoter that allowed for efficient differentiation of the 
reactivity levels between the armed and torsionally disarmed building blocks (1.1 and 
1.23, respectively).  As a result, disaccharide 1.24 was isolated in 52% yield, with no 
observed by-products resulting from the self-condensation of glycosyl acceptor 1.23.  
These results suggested that the disarming could be achieved by acetal/ketal protecting 
groups exclusively. 
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Scheme 1.8.  The disarming of building blocks can be achieved with a 
benzylidene acetal or isopropylidene ketal.
48
 
 
This concept was expanded upon by Ley and co-workers, who clearly demonstrated that 
similar deactivation could be effectively achieved with the use of a variety of cyclic 1,2-
diacetal/diketal systems.
49
  And the example below highlights one such application, in 
which a two-step sequential activation was accomplished using a one-pot synthetic 
strategy.  The one-pot approach allows for two (or more) sequential glycosylation 
reactions to be performed in a single flask (pot) without isolation and purification of the 
intermediate.
50
  Thus, armed glycosyl donor 1.25, of the L-rhamno series, was 
chemoselectively activated over torsionally disarmed rhamnosyl acceptor 1.26 in the 
presence of NIS/TfOH.  The resulting disaccharide (27, not isolated) was then reacted 
directly with rhamnosyl acceptor 1.28, and the final trisaccharide 1.29 was isolated in 
62% yield over the two-step activation sequence.  Clearly, one-pot strategies offer the 
fastest pathway to oligosaccharides, although to ensure successful isolation of the final 
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product, all steps need to proceed with particularly high diastereoselectivity and yield.
50, 
51
  
 
Scheme 1.9.  One-pot synthesis of trisaccharide 1.29 via torsional 
deactivation with cyclohexane 1,2-diacetal (CDA). 
 
It should be noted, that the ester and acetal/ketal groups disarm building blocks following 
different considerations and mechanisms.  Whereas ester disarming effect is purely 
electronic, benzylidene/isopropylidene groups were initially assumed to disarm 
exclusively through torsional strain.  In further mechanistic probing, Bols and co-workers 
proposed that the disarming effect of the 4,6-acetal may also be due to the orientation of 
the electron-withdrawing C-6 substituent.
52
  From a series of model experiments, it was 
found that a basic torsional disarming effect does exist; however, the data suggested that 
the substituent configuration (stereoelectronic effect) also plays a significant role in the 
overall degree of disarming.  For example, the reactivity of torsionally disarmed 
compound 1.32 (with an axially oriented 6-methoxy substituent) falls between that of 
per-methylated armed building block 1.33 and compounds 1.30/1.31 (in which the 
equatorially oriented 6-O-substituents are capable of more a geometrically directed 
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electron-withdrawal, Figure 1.2).  Based on relative rates of hydrolysis (Figure 1.2), it 
was concluded that conformational restriction and stereoelectronics (charge-dipole 
interactions) were almost equally responsible for the observed disarming effect.   
 
Figure 1.2.  The disarming effects of the cyclic ketal/acetal are both 
conformational and electronic. 
 
1.2.4. Going beyond the simple armed and disarmed building block combination 
Many different reactivity levels revealed.   Further progress in the area of chemoselective 
oligosaccharide synthesis emerged with the development of a programmable 
oligosaccharide strategy, which stemmed from the studies pioneered in Fraser-Reid‟s, 
van Boom‟s, Ley‟s, and Wong‟s groups.  Subsequently, attempts to classify, and even 
predict, the outcome of a glycosylation reaction (or a sequence) led to the further 
development of approaches that attempted to quantify the reactivity of building blocks.
46-
48, 53, 54
  For example, Ley at. al. developed a new approach wherein building block 
reactivity could be “tuned.”46  In a series of competitive experiments, wherein two 
glycosyl donors were competing for one standard glycosyl acceptor, a series of relative 
reactivity ratios were established.  Additionally, these ratios were found to correspond to 
various protecting group patterns.  For instance, an important relationship between the 
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position of benzoyl groups and their effect on reactivity surfaced from these studies 
(Scheme 1.10).   
 
Scheme 1.10.  The reactivity of a series of partially benzoylated 
rhamnosides falls between the traditional armed (1.25) and disarmed 
(1.41) building blocks.  
 
Thus, the greatest disarming effect was seen from the 2-benzoyl substituent in compound 
1.37, followed by the 4-benzoyl and 3-benzoyl substituents (in compounds 1.34 and 1.35, 
respectively).  In addition, cyclic ketal 1.36 was found closer in reactivity to the mono-
benzoylated rather than the di-benzoylated series of compounds. Not surprisingly, 
reactivity levels recorded for the mono-benzoylated (1.34-1.35, 1.37), di-benzoylated 
(1.38-1.40) and torsionally disarmed (1.36) glycosyl donors, fell in between the 
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traditional per-benzylated armed rhamnoside 1.25 and its disarmed per-benzoylated 
counterpart 1.41.   
Wong et. al. devised a mathematical approach, assigning relative reactivity values 
(RRVs) to a wide library of building blocks.
47
  The determination of RRVs was made in 
standardized reaction conditions, tolyl thioglycoside donors in the presence of an 
NIS/TfOH promoter system.  The cumulative reactivity data was then compiled into a 
predictive computer program called Optimer.
47
  Various intermediate reactivity levels 
were revealed during these studies, with nearly all compounds clearly situated between 
the armed (1.42) and disarmed (1.48) building blocks (Scheme 1.11).  Similar to Ley‟s 
findings, the acetal-protected building blocks were also positioned between the armed 
and disarmed building blocks, being closer in reactivity to the former.  For example, 4,6-
benzylidene-2,3-dibenzoyl derivative 1.47 was approximately fifty times more reactive 
than its per-benzoylated disarmed counterpart 1.42 (Scheme 1.11).   
Following these studies, a well-rounded technology for one-pot oligosaccharide synthesis 
based on RRVs emerged.  A representative example is depicted in Scheme 1.11, wherein 
armed glycosyl donor 1.48 was chemoselectively activated over glycosyl acceptor 1.52 in 
the presence of NIS/TfOH.  The resulting disaccharide intermediate was then reacted 
with added disarmed glycosyl acceptor 1.43, to form a trisaccharide intermediate that was 
then glycosidated with added glycosyl acceptor 1.53 to provide tetrasaccharide 1.54 in 
39% overall yield.
47
  The reactivity difference between similarly protected sugars of 
different series has also to be taken into consideration. For example, the reactivity ratio 
between per-benzylated tolyl thioglycosides of the 6–deoxy-L-galacto, D-galacto, and D-
gluco series was found to be 27.1/6.4/1 respectively.
47
  Ley‟s studies also showed a 
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similar correlation between the reactivity of building blocks of different series.
49, 55
  
Accumulation of comparison data for reactivity of building blocks of 2-amino-2-
deoxysugars and their neutral counterparts has also began to emerge.
54, 56-60
    
 
Scheme 1.11.  Relative reactivity levels of differently protected 
galactosides.  Synthesis of tetrasaccharide 1.54 via the programmable one-
pot strategy.
47
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1.3. Superdisarmed building blocks 
 
Although most reactivity levels in Fraser-Reid‟s, Ley‟s and Wong‟s studies fall between 
the traditional armed and disarmed building blocks, Wong‟s study revealed a number of 
building blocks that were extended beyond this boundary.  For example, 2-hydroxyl 
galactoside 1.51 was found to be three times more reactive than the traditional armed 
galactoside 1.48 (Scheme 1.11).  Indirectly, this discovery opened up a new avenue for 
studying building blocks that are either more reactive than armed ones (superarmed) or 
less reactive than disarmed ones (superdisarmed); the studies arising from these two 
directions are surveyed below.  In this subchapter, those building blocks possessing a 
lower reactivity than their conventional per-acylated (per-benzoylated) disarmed 
counterparts will be discussed. 
 
1.3.1. Superdisarming by torsional effect.   
As aforementioned, Fraser-Reid,
48
 Ley,
61
 and Bols
52
 found that anomeric deactivation 
can be achieved by the combination of the torsional and electronic effects of cyclic 
acetal/ketal protecting groups.  The combination of two separate effects could lead one to 
believe that such systems would be less reactive than the pure-electronically disarmed, 
acylated building blocks. However, in the majority of cases investigated and surveyed in 
the previous subchapter, the acetal/ketal-protected derivatives were found to be of 
intermediate reactivity, falling between the traditional armed and disarmed building 
blocks (see Schemes 1.10 and 1.11).  It was not until more recent studies by Boons,
62
 that 
it became apparent that thioglycosides protected with the cyclic 2,3-carbonate group 
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could be even less reactive (superdisarmed) than traditional disarmed acylated 
derivatives.  The following example clearly illustrates this finding.  Thus, disarmed per-
benzoylated thioglycoside donor 1.55 was chemoselectively activated over 
superdisarmed glycosyl acceptor 1.56 in the presence of NIS/TMSOTf (Scheme 1.12). 
 
 
Scheme 1.12.  Chemoselective activation of disarmed donors 1.55 or 1.58 
over superdisarmed acceptors 1.56 or 1.59, respectively. 
 
Along similar lines, Demchenko et al. performed the direct chemoselective activation of 
the electronically disarmed SBox glycoside 1.58 over torsionally/electronically disarmed 
(superdisarmed) glycosyl acceptor 1.59.  This direct chemoselective coupling resulted in 
the formation of disaccharide 1.60, proving that even traditional benzylidene systems can 
superdisarm building blocks of the SBox series.  It appears that there is certain 
inconsistency between this result and the comprehensive programmable approach which 
showed benzylidene derivatives to be more reactive than their disarmed counterparts.  
Although a direct investigation of these two findings is not yet available, studies reported 
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by Bols
63
 offer the explanation that the disparity could be simply explained by the 
benzylidene orientation; axial – galactose (Wong et al.) vs. equatorial – glucose 
(Demchenko et al.).  In order to access the electronic effects of various ring substituents, 
Bols et al. designed the following model study which showed equatorial substituents to 
be significantly more electron withdrawing (destabilizing, disarming) than their axial 
counterparts (Figure 1.3).  The values shown are in pH units, and reflect the amount by 
which the pKa of the substituted amine decreases with respect to piperidine.   
 
Figure 1.3.  Effect of axial and equatorial electron-withdrawing 
substituents on basicity of piperidines. 
 
It is believed that this result can help to visualize different relative reactivity found 
amongst 4,6-benzylidene building blocks of different series (gluco vs. galacto in this 
case).  However, a more systematic study of this phenomenon, and perhaps a series of 
side-by-side chemoselective coupling experiments, would be needed to draw a more 
direct conclusion.  
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1.3.2. Superdisarming by electronic effects.   
Demchenko et al. also reported that a mixed protecting group pattern can unexpectedly 
and profoundly affect the glycosyl donor reactivity.
40
  Upon investigating S-benzoxazolyl 
(SBox) glycosides containing an “arming” benzyl group at C-2 and “disarming” acyl 
groups at the remaining hydroxyls, it was expected that reactivity would fall somewhere 
between that of the armed (per-benzylated) and the disarmed (per-benzoylated) glycosyl 
donors; similar to the results found in Ley‟s studies for building blocks of the L-
rhamnose series, as discussed above.  However, the results acquired with the SBox 
glycosides of the D-gluco series revealed that these “mixed-patterned” glycosyl donors 
were the least reactive amongst the building blocks investigated (Table 1.1).
40
   
Thus, the reaction of armed SBox donor 1.61 with glycosyl acceptor 1.63 in the presence 
of copper(II) trifluoromethanesulfonate proceeded smoothly, and product 1.64 was 
isolated in a good yield of 89% (Entry 1, Table 1.1).  Along similar lines, it was 
discovered that disarmed (per-benzoylated) SBox glycoside 1.58 also reacted readily, 
although this glycosylation was marginally slower in comparison to that of the armed 
per-benzylated building block 1.61, never fully going to completion, resulting in a 
slightly lower, 70% yield of the disaccharide 1.65.  Interestingly, when essentially the 
same reaction conditions were applied to the glycosidation of 2-O-benzyl-tri-3,4,6-O-
benzoyl protected SBox glucoside 1.62, no formation of the expected disaccharide 1.66 
was detected.   
As Lemieux‟s halide stability theory,64-66 Fraser-Reid‟s armed-disarmed concept 
rationale,
31, 33
 Ley‟s tuning reactivity studies,46 and Wong‟s programmable 
oligosaccharide synthesis
47
 all predicted 2-O-benzylated glycosyl donor 1.62 to be more 
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reactive than its per-benzoylated counterpart 1.58, these unanticipated results necessitated 
further studies.   
Table 1.1.  Comparative activation of differently protected SBox 
glycosides 1.58, 1.61 and 1.62. 
 
Entry Donor Product Yield α/β ratio 
 
1 
1.61 
 
1.64 
 
89% 
 
5.4/1 
 
2 
1.58 
 
1.65 
 
70% 
 
β only 
 
3 
1.62 
 
1.66 
 
No reaction 
 
-- 
 
 
This finding implies that a combination of electronic effects, beyond the recognized 
inductive effects of the C-2 protecting group, may exist.  The observed reactivity pattern 
was rationalized by the occurrence of the so-called “O-2/O-5 Cooperative Effect.”40  
Thus, in addition to the “arming/disarming” nature of the protecting group at O-2, 
stabilization of the glycosyl cation intermediate must also be taken into consideration.  
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First, this stabilization can be achieved from the lone electron pair on the neighboring 
endocyclic ring oxygen (O-5) like in the armed glycosyl donor A, shown in Figure 1.4.  
However, if electron withdrawing protecting groups are placed near the O-5 ring oxygen 
(C-4 and C-6, like in the disarmed donors B or C), the electron density on O-5 will be 
decreased, effectively suppressing oxacarbenium ion formation.  In this case, the ability 
of the system to stabilize via other plausible internal modes may become increasingly 
important.   
A second type of stabilization may arise based on the availability of the lone electron pair 
on an acyl type protecting group at O-2, which is capable of providing stabilization via 
the formation of an acyloxonium ion intermediate, like in disarmed glycosyl donor B.  
Crich et al.
67
 emphasized that the anchimeric assistance was particular to the 1,2-trans 
orientation of the 2-O-acyl and 1-SBox leaving group, as stabilization presumably takes 
place via the concerted displacement of the leaving group.  However, if no source of 
secondary stabilization is available, as in case of 2-O-benzyl substituent in C, this 
combination will give rise to the overall “superdisarming” protecting group pattern. 
 
Figure 1.4.  O-2/O-5 Cooperative effect in glycosidation of the 
superdisarmed building blocks 
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1.4. Superarmed building blocks 
 
In contrast to superdisarmed building blocks, possessing reactivity even lower than that 
of the per-acylated disarmed building blocks, other super reactive glycosyl donors have 
also been discovered.  The term superarmed was first coined by Bols for describing the 
reactivity of conformationally armed building blocks.  Herein however, we apply the 
term superarmed to all building blocks that are more reactive than conventional per-
alkylated armed building blocks.   
 
1.4.1. Superarming by conformational effects. 
As it was previously noted, the substituent orientation can have a strong effect on the 
reactivity of a molecule.  A model study of the relative pKa values for protonated 
heterocyclic amines showed that equatorial substituents are significantly more 
deactivating than their axial counterparts (compare 1.67 and 1.68 on Figure 1.5).
63
  
Further revealed by these findings, was that a perturbation of the equilibrium between 
ring conformations may also occur upon protonation of the heterocyclic amine.
68
  This 
was found to result from the desire for substituents to reside axially, as they have a 
greater ability to provide charge stabilization through charge-dipole interactions.  For 
example, cyclic amine derivative 1.68 was found to exist predominantly in the 
conformation wherein the electron-withdrawing hydroxyl substituents are axial.  This 
study further suggests that positively charged oxacarbenium ion intermediates may also 
spontaneously undergo conformational changes in an attempt to maximize the number of 
axial substituents. If so, this conformational change would be made easier if the starting 
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material already had a number of axial substituents;
69
 for example, galactose has been 
long known to be more reactive than glucose (compare hydrolysis rates for compounds 
1.69 and 1.70, Figure 1.5).  Furthermore, when conformationally restricted 3,6-
anhydroglucoside 1.71, having all-axial hydroxyl groups, was investigated, it was shown 
to hydrolyze much faster than its all-equatorial counterpart 1.69.
70
   
 
Figure 1.5.  Basicity and reactivity increase with the increase of the 
number of axial hydroxyls: conformational change to increase reactivity 
 
This result implies that if all-equatorial glucosyl donors were converted into their all-
axial counterparts, the reactivity could be dramatically increased.  Based on the 
knowledge that steric congestion at the equatorial C-3 and C-4 positions causes 
conformational changes,
71, 72
 Bols and co-workers were able to exploit this 
phenomenon.
70, 73, 74
  However, when TBS protection was applied to glucose derivative 
1.72, the product 1.73 was found to exist in more of a skew-boat conformation,
75
 
(Scheme 1.13) rather than the anticipated 
1
C4 conformation adopted by analogous 
xylopyranose derivatives,
76
 perhaps due to the added steric bulk of the substituent at C-5.  
Nevertheless, a sufficient conformational change was induced, reconfiguring the 
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substituents perpendicular to the sugar ring.  As such, this conformationally superarmed 
glucosyl donor 1.73 showed a dramatic 20-fold increase in reactivity, relative to the 
traditional armed benzylated derivatives, as shown by direct competition experiments.
73
  
Furthermore, superarmed glycosyl donor 1.73 could be successfully coupled with 
“armed” acceptor 1.74 to afford the resulting disaccharide 1.75 in 85% yield.77  Similar 
observations have also been made with glycosyl donors of the manno, rhamno, and 
galacto series.
74
 
 
Scheme 1.14.  Chemoselective activation of the conformationally 
superarmed glycosyl donor 1.73 over armed glycosyl acceptor 1.74. 
 
1.4.2. Superarming by electronic effects  
As aforementioned, a mixed protecting group pattern could unexpectedly and profoundly 
affect glycosyl donor reactivity.
40
  Along these lines, a glycosyl donor containing a 
participating benzoyl group at C-2 and electron donating groups at the remaining 
positions, was also investigated.  Interestingly, these glycosyl donors proved to be even 
more reactive (superarmed) than their armed per-benzylated counterparts.
78, 79
  Thus, the 
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reaction of armed SBox donor 1.61 with glycosyl acceptor 1.14 in the presence of 
dimethyl(thiomethyl)sulfonium trifluoromethanesulfonate (DMTST), proceeded 
smoothly, and product 1.77 was isolated in 91% yield (Entry 1, Table 1.2).  Furthermore, 
it was discovered that the disarmed per-benzoylated SBox glycoside 1.58 failed to react 
under essentially the same reaction conditions.  Unexpectedly, the glycosidation of 2-O-
benzoyl-tri-3,4,6-O-benzyl protected SBox glucoside 1.76 proceeded almost 
instantaneously, and disaccharide 1.78 was obtained in 90% yield (for comparison, the 
glycosidation of armed donor 1.61 took 2 h).   
 
Table 1.2.  Comparative glycosidations of glycosyl donors 1.58, 1.61 and 1.76.  
 
Entry Donor Time Product Yield α/β ratio 
 
1 
1.61 
 
2 h 
 
1.77 
 
91% 
 
1.2/1 
 
2 
1.58 
 
16 h 
 
-- 
 
No reaction 
 
 
 
3 
1.76 
 
< 5 min 
 
1.78 
 
90% 
 
β only 
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Scheme 1.14.  Superarmed (1.76) and armed (1.61) glycosyl donors in 
competitive glycosylation. 
 
The reactivity of the superarmed donors was illustrated in a direct competitive 
glycosylation experiment, wherein both the superarmed and armed donors (1.76 and 1.61, 
respectively), were placed in the same reaction vessel with glycosyl acceptor 1.14.  As 
depicted in Scheme 1.14, superarmed glycosyl donor 1.76 proved to be significantly 
more reactive than its per-benzylated analogue 1.61; this was reflected in the formation of 
disaccharide 1.78 (95%) with only trace amount of disaccharide 1.77 present (<5%).  In 
addition, unreacted glycosyl donor 1.61 was recovered in 87% yield.  Furthermore, this 
concept was found to be universal and applicable to glycosidation of O-pentenyl, S-ethyl, 
S-phenyl, S-tolyl and S-thiazolinyl building blocks.
80
  This observed reactivity pattern 
was also rationalized by the occurrence of the “O-2/O-5 Cooperative Effect.”40  As 
described in Figure 1.4, stabilization of the glycosyl cation can be achieved either from 
the lone electron pair on the neighboring endocyclic ring oxygen (O-5) or from the lone 
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electron pair on an acyl type protecting group at O-2, as it is capable of providing 
stabilization via the formation of the acyloxonium ion intermediate.  If both sources of 
stabilization are available, as in case of 2-O-benzoyl-3,4,6-tri-O-benzyl, this combination 
gives rise to an overall “superarming” protecting group pattern.  Alternatively, this type 
of superarmed glycosyl donor may be also viewed as an armed donor, capable of a 1,2-
trans stereoselective glycosylation, allowing for the chemoselective introduction of a 1,2-
trans linkage prior to other linkages.   
 
Figure 1.6.  O-2/O-5 Cooperative effect in glycosidation of the 
superarmed building blocks 
 
1.5. The involvement of superdisarmed and superarmed building blocks 
in oligosaccharide synthesis. 
 
The expeditious preparation of complex oligosaccharides remains a significant challenge 
to synthetic organic chemistry.  The combined demands of regio- and stereoselectivity in 
glycosidic bond formation, has led to complex synthetic schemes and extensive 
protecting group manipulations.  As aforementioned, the use of a chemoselective 
activation strategy avoids such extraneous manipulations, thus offering significant 
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advantages for expeditious glycoside synthesis.  Combining the strategic and conceptual 
updates to the original Fraser-Reid strategy for armed-disarmed oligosaccharide 
synthesis, with the novel concepts for superarming and superdisarming of building 
blocks, has expanded the applicability of chemoselective synthesis to encompass a 
variety of oligosaccharide sequences.  For example, utilization of the cooperative effect 
allows for the acquisition of cis-cis linked oligosaccharides, similar to that discussed 
previously (see Scheme 1.7).  As shown in Scheme 15, armed STaz glycosyl donor 1.79 
was chemoselectively activated over superdisarmed 3,4-di-O-benzoyl-2-O-benzyl 
protected STaz glycosyl acceptor 1.80 in the presence of Cu(OTf)2 to give disaccharide 
1.81 in 89% yield.
81
  Superdisarmed disaccharide 1.81 was then glycosidated with 
standard glycosyl acceptor 1.14 in the presence of AgOTf to give the desired cis-cis-
linked trisaccharide 1.82 in 75% yield. 
 
Scheme 1.15.  Sequential activation of armed  superdisarmed building 
blocks for direct synthesis of cis-cis-linked oligosaccharide 1.82 
 
Along similar lines, it was demonstrated that a combination of the trans-directing 
picolinyl functionality of armed glycosyl donor 1.83 and the cis-directing functionality of 
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its subsequent superdisarmed disaccharide 1.84, led to a trans-cis glycosylation pattern, 
inverse to that of the classic armed-disarmed approach which gives a cis-trans pattern.
81
  
The coupling between building blocks 1.83 and 1.80 was performed in the presence 
Cu(OTf)2/TfOH, to give trans-linked disaccharide 1.84 in 70% yield (Scheme 1.16).  The 
superdisarmed disaccharide 1.84 was then coupled with glycosyl acceptor 1.14 in the 
presence of AgOTf, affording the desired inverse-patterned trans-cis trisaccharide 1.85 in 
54% yield. 
 
Scheme 1.16.  Sequential activation of picolylated armed  
superdisarmed building blocks: synthesis of trans-cis-linked trisaccharide 
1.85. 
 
It was also demonstrated that disarmed disaccharide 1.87 (obtained by classic armed-
disarmed approach from building blocks 1.61 and 1.86, Scheme 1.17), could be further 
chemoselectively activated over superdisarmed building block 1.88.  Thus, disarmed 
disaccharide 1.87 was activated in the presence of Cu(OTf)2/TfOH to produce 
trisaccharide 1.89 in 70% yield.
40
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Scheme 1.17.  Sequential activation of armed  disarmed  
superdisarmed building blocks 1.61, 1.86, 1.88, respectively.
40
 
 
This concept of conformational superarming was clearly demonstrated by performing a 
one-pot coupling wherein all three reaction components (thioglycosides 1.73, 1.90, and 
1.91) were mixed from the beginning (Scheme 1.18).
74
  This type of one-pot technique 
requires differentiation between the reactivity levels of both glycosyl donors (1.73 and 
1.90) and both glycosyl acceptors (1.90 and 1.91), while all bearing the same anomeric 
leaving group (phenylthio).  The first reaction took place between the superarmed 
glycosyl donor 1.73 and the more reactive primary (and also more electron rich due to the 
neighboring benzyl substituents) glycosyl acceptor 1.90.  The resulting disaccharide 
derivative then reacted with the remaining glycosyl acceptor 1.91.  As a result of this 
one-pot coupling in the presence of NIS/TfOH, trisaccharide 1.92 was obtained in 64% 
yield. 
A similar sequence, yet with the execution of the traditional stepwise approach, was 
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explored with the electronically superarmed glycosyl donors.  Thus, the superarmed 
glycosyl donor 1.93 was activated over “armed” acceptor 1.94 in the presence of iodine 
to provide disaccharide 1.95 in 80% yield (Scheme 1.19).  This disaccharide was then 
glycosidated with the disarmed acceptor 1.96 to provide trisaccharide 1.97 in 55% yield.  
The resultant trisaccharide was glycosidated with glycosyl acceptor 1.14 to obtain the 
target tetrasaccharide 1.98 in which monosaccharide residues are connected via 
alternating trans-cis-trans linkages.  
 
Scheme 1.18.  Superarmed  armed  disarmed activation for the 
synthesis of trisaccharide 1.92 in one-pot.   
 
In principle, examples of using electronically superarmed building blocks are rather 
abundant; however, the use of these building blocks was not linked to their superarmed 
properties.  These examples include the synthesis of HIV viral protein gp120 
glycopeptide fragment;
82
 the synthesis of core tetrasaccharide corresponding to GPI-
related mucins of T. cruzi Y-strain;
83
 the synthesis of a complex branched 
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oligosaccharide of F1α antigen 9;84 etc. 85, 86  The involvement of superdisarmed glycosyl 
donors in electrochemical glycosylations was also investigated.
87, 88
 
 
Scheme 1.19.  Synthesis of tetrasaccharide 1.98 using superarmed  
armed  disarmed sequential activations.80 
 
1.6. Conclusions and Outlook 
 
It is critical to make complex carbohydrates more accessible to the general chemical, 
biochemical, and industrial audience to keep pace with the exploding area of 
glycobiology.  This aim can be only achieved by the development of methods and 
strategies for efficient oligosaccharide synthesis that would be applicable for both 
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laboratory and industrial preparation.  A number of excellent strategies that offer a 
reasonably efficient route to oligosaccharide assembly have already emerged and the 
armed-disarmed approach for chemoselective oligosaccharide synthesis is undoubtedly 
amongst them.  Although recent advancements discussed herein have expanded the scope 
of the armed-disarmed methodology it is clear that further development of efficient and 
general methods for the expeditious synthesis of complex carbohydrates will remain an 
important and active arena for scientific endeavors during the 21
st
 century.   
Other remarkable improvements in oligosaccharide synthesis have also emerged, 
including one-pot protection
89
 and glycosylation strategies,
50, 51, 90
 polymer-supported
91-93
 
and automated synthesis,
94, 95
 fluorous tag assisted synthesis in microreactors,
96
 and 
surface-tethered iterative carbohydrate synthesis (STICS).
97
 The chemoselective strategy, 
however, is still occupying an important niche in the arsenal of available methods.  In the 
coming years, glycoscientists are expected to have developed simple, efficient, and 
flexible approaches to oligosaccharide assembly that will complement existing 
methodologies and bring our ability to obtain complex oligosaccharides up to a 
significantly higher level.  
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Superarming common glycosyl donors by 
electronic effects 
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2.1 Introduction 
 
Traditional strategies for oligosaccharide synthesis often require extensive protecting 
and/or leaving group manipulations between each glycosylation step, thereby increasing 
the total number of synthetic steps while decreasing both the efficiency and yield. In 
contrast, expeditious strategies allow for the rapid chemical synthesis of complex 
carbohydrates by minimizing extraneous chemical manipulations.  The armed-disarmed 
approach for chemoselective oligosaccharide synthesis is one such strategy that addresses 
these challenges.  The significant improvements that have recently emerged in the area of 
chemoselective activation were discussed in Chapter 1. These advancements have 
expanded the scope of the armed-disarmed methodology so that it can now be applied to 
a wider range of oligosaccharide sequences, in comparison to the original concept.  
Surveyed in this chapter, is the superarmed glycosyl donors developed by electronic 
effects and the versatility of this developed technique in application to a sequential 
chemoselective oligosaccharide synthesis 
According to the initially developed armed –disarmed strategy introduced by Fraser-
Reid
1, any glycosyl donor bearing all ether-protecting groups (i.e. OBn) will be 
significantly more reactive than its ester-protected (i.e. OBz) analog,
2
 and are thus 
referred to as “armed” and “disarmed,” respectively (Figure 2.1). Furthermore, it is 
thought that this effect predominates from the neighboring substituent at C-2,
3
 and in 
addition, it is presumed that the overall reactivity of the glycosyl donor corresponds to 
the total number of ether substituents.
2, 4
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The strategic placement of common protecting groups opens up a new method for 
“superarming” the glycosyl donors. Thus, the story became interesting to us, when 
glycosyl donors containing mixed protecting group patterns, such as 2-O-benzoyl-3,4,6-
tri-O-benzyl derivative 2.1, were considered. As per the total number and location of the 
benzyl substituent(s), it was believed that the reactivity of compound 2.1 would lie in 
between that of the fully ether-protected, armed donor 2,2 and the fully ester-protected, 
disarmed donor 2.3. Unexpectedly, however, glycosyl donor 2.1 was experimentally 
determined to be more reactive (superarmed) than the classic armed donors, 2.2.  
Superarming glycosyl donors by the simple 2-O-benzoyl-3,4,6-tri- O-benzyl protection 
was first pioneered in our laboratory with S-benzoxazolyl (SBox) glycosyl donors.
5
 To 
this end, we have explored the reactivities with D-glucose, D-galactose and D-mannose 
series. (e.g. glycosyl donors 2.4-2.6, Figure 2.1).  
 
 
Figure 2.1 Superarmed glycosyl donors 
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Conceptualized from our studies on the O-2/O-5 Cooperative Effect,
6
 (Figure 2.2) it was 
determined that S-benzoxazolyl (SBox) glycosides possessing both a participating moiety 
at O-2 (benzoyl) and remote benzyl substituents that electronically arm the lone pair at O-
5 (e.g., glycosyl donors 2.4-2.6, Figure 2.1) are exceptionally reactive
5
 and they have 
been appropriately titled as “superarmed.” (first coined by Bols)7, 8 Furthermore, these 
building blocks possess the desirable quality of being both arming and participating 
glycosyl donors, traits not commonly found in other systems.
9
 We have now been able to 
broaden the scope of possible linkages obtained in chemoselective activation strategies, 
through the use of our “superarmed” donors, allowing for the efficient installation of any 
and all linkage sequences, cis-trans, cis-cis, trans-cis, and trans-trans.
6, 10
 
 
Figure 2.2.  Cooperative arming and disarming effects 
 
2.2 Comparative glycosylations 
 
However it remained unclear whether this principle could be applied to other classes of leaving 
group.  Herein, we describe the investigation of stable glycosyl donors of the armed (2.7) and 
superarmed (2.8) series, bearing common leaving groups: O-pentenyl, S-ethyl, S-phenyl, S-tolyl, 
and S-thiazolinyl (STaz, Figure 2.3). All test glycosylations were performed with the standard 
glycosyl acceptor 2.9
11
 to afford disaccharides 2.10
12
 and 2.11
12
 from the armed and superarmed 
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glycosyl donors, respectively (Table 2.1). Additionally, the obtained results were compared to the 
previously investigated SBox glycosides 2.7a
13
 and 2.8a.
5
   
 
Figure 2.3.  Glycosyl donors of the armed and superarmed series 
 
It should be noted that the key feature of any chemoselective activation is the 
application of mild promoter/reaction conditions that allows for the efficient 
differentiation of the reactivity levels among the building blocks. However, establishing a 
reactivity differentiation becomes increasingly difficult with the highly reactive 
superarmed and armed glycosyl donors. In our earlier work, we described that the 
reactivity of armed and superarmed SBox glycosides, 2.7a and 2.8a, respectively, can be 
effectively separated in the presence of dimethyl(methylthio)sulfonium 
trifluoromethansulfonate
14
 (DMTST) as promoter (Table 2.1, Entries 1 and 2).
5
  Herein, 
we also determined that an equally successful differentiation can be achieved in the 
presence of copper(II) trifluoromethanesulfonate (Entries 3 and 4).  This result offers 
further significance, as Cu(OTf)2 is a promoter unique to thioimidoyl leaving groups.  
In order to differentiate between armed and superarmed O-pentenyl glycosides, 2.7b
15
 
and 2.8b,
16
 respectively, we chose iodonium(di--collidine)perchlorate17 (IDCP), as this 
mild promoter has proven effective for chemoselectively activating armed pentenyl 
glycosides over their disarmed counterparts at rt.
1
  However, these reaction conditions 
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were found to be too powerful, as both glycosyl donors 2.7b and 2.8b were activated in a 
matter of minutes at rt.  Additionally, no significant difference in reactivity was observed 
when O-pentenyl glycosides were investigated in the presence of NIS (rt), NBS (45 
o
C), 
or NIS/TfOH (-20 
o
C), albeit in a majority of comparative glycosylations, super-armed 
donor 2.7b was slightly more reactive (the extended experimental results are available as 
a part of the SI).  Ultimately, the application of IDCP at low temperature (-10 
o
C) was 
deemed the most successful in terms of the differential activation of O-pentenyl 
glycosides. Thus, 20 h was required for the glycosidation of 2.7b, whereas the 
glycosidation of 2.8b was complete in about 3 h (Entries 5 and 6). The yields obtained 
with both armed and superarmed pentenyl glycosides under these reaction conditions, 
however, remained unimpressive (62% and 53%, respectively).   
Consequently, we investigated S-ethyl glycosides 2.7c
18
 and 2.8c
19
 in the presence of 
relatively mild promoters, including IDCP, DMTST, and MeOTf at reduced temperatures 
(Table 2.1, Entries 7-12).  While reactions in the presence of IDCP or MeOTf showed 
insufficient difference in reactivity (Table 2.1, Entries 7-8), the best differentiation was 
achieved with MeOTf at 0 
o
C or DMTST at -20 
o
C, wherein three-fold and six-fold 
increase in reactivity was achieved, respectively (Table 2.1, Entries 9-12). Additionally, 
the yields for both armed and disarmed glycosyl donors were good to excellent across the 
board.  The reactivity difference, however, still rendered these conditions insufficient for 
any subsequent chemoselective activation studies, which are essential for applying this 
methodology toward oligosaccharide synthesis.  Therefore, we continued to search for 
even milder reaction conditions to activate the S-ethyl glycosides.   
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Table 2.1.  Comparative activation of armed (2.7) and superarmed (2.8) glycosyl donors 
 
 
Entry D P Temp. Time CP Yield α:β 
1 2.7a DMTST 0 
o
C 2 h 2.10 92% 2:1 
2 2.8a DMTST 0 
o
C 5 min 2.11 86% β only 
3 2.7a Cu(OTf)2 0 
o
C 2 h 2.10 99% 2:1 
4 2.8a Cu(OTf)2 0 
o
C 20 min 2.11 96% β only 
5 2.7b IDCP -10 
o
C 20 h 2.10 62% 3:1 
6 2.8b IDCP -10 
o
C 3 h 2.11 53% β only 
   7 2.7c IDCP -10 
o
C 96 h 2.10 82% 2:1 
   8 2.8c IDCP -10 
o
C 96 h 2.11 78%     β only 
9 2.7c MeOTf 0 
o
C 18 h 2.10 95% 2:1 
10 2.8c MeOTf 0 
o
C 6 h 2.11 96% β only 
11 2.7c DMTST -20 
o
C 1 h 2.10 90% 2:1 
12 2.8c DMTST -20 
o
C 10 min 2.11 89% β only 
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Upon investigating a variety of other known thioglycoside promoters,
20-22
 we found 
results with molecular iodine, introduced by Field as a mild promoter for the activation of 
methyl thioglycosides,
23
 at -25 
o
C to be the most impressive.  Thus, while activation of 
the armed glycosyl donor 2.7c required at least 10 h, the reaction of its superarmed 
counterpart 2.8c completed in less than 1 h, displaying a ten-fold reactivity increase 
(Table 2.2, Entries 1 and 2). Encouraged by these results, iodine was chosen as the 
promoter for the subsequent studies with O-pentenyl donors (1b and 2b), as well as 
common classes of thioglycosides donors,
20-22
 S-phenyl (2.7d
24
 and 2.8d
25
), S-tolyl 
(2.7e
26
 and 2.8e), and STaz glycosides (2.7f
27
 and 2.8f).  Although, we observed that the 
superarmed glycosyl donors of both the S-phenyl and S-tolyl series reacted faster (Table 
2.2, Entries 3-6), no differentiation that would be of practical application to 
chemoselective oligosaccharide synthesis was achieved at this stage.   
Furthermore, no reactivity differentiation could be established in the presence of iodine 
between the armed and superarmed STaz glycosyl donors 2.7f and 2.8f, nor between O-
pentenyl glycosides 2.7b and 2.8b, respectively (Entries 7-10).  Under these conditions, 
both armed and superarmed glycosyl donors of these classes reacted smoothly, but at a 
similar pace.  Although both O-pentenyl and STaz glycosides easily react in accordance 
with the conventional armed-disarmed activation scheme,
1, 9
 we have found the 
differentiation between the more closely positioned superarmed and armed glycosides, to 
be challenging.  It is possible, that the protecting group effect is decreased in cases of 
remote activation,
28
 typical for both the O-pentenyl and STaz glycosides (alkene
29
 and 
nitrogen atom of the thiazoline ring,
30
 respectively); opposite to that of the direct 
activation
13
 cases (i.e. S-ethyl or SBox glycosyl donors).   
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Table 2.2.  Activation of armed (2.7) and superarmed (2.8) glycosyl donors in the  
presence of iodine (3 mol equiv) 
 
Entry Donor Time Product Yield Ratio α:β 
1 2.7c 10 h 2.10 89% 1:4 
2 2.8c 1 h 2.11 93% β only 
3 2.7d 15 h 2.10 74% 1:2 
4 2.8d 8 h 2.11 78% β only 
5 2.7e 15 h 2.10 63% 1:2 
6 2.8e 12 h 2.11 72% β only 
7 2.7f 19 h 2.10 87% 1:2 
8 2.8f 19 h 2.11 85% β only 
9 2.7b 17 h 2.10 82% 1:2.8 
10 2.8b 17 h 2.11 84% β only 
11 2.7a 48 h 2.10 NR
a
 - 
12 2.8a 20 h 2.11 95% β only 
a
 NR – no reaction; although glycosyl donor 2.7a smoothly reacted at rt in 13 h 
affording disaccharide 2.10 in 95% (:β=1:2) 
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Following this rationale, we found that the reactivity difference between the armed and 
superarmed SBox derivatives 2.7a and 2.8a was remarkable in the presence of iodine at -
25 
o
C (Entries 11 and 12).  While no reaction took place with the armed glycosyl donor 
2.7a, the superarmed glycosyl donor 2.8a reacted very smoothly, and afforded the 
corresponding disaccharide 2.11 in 20 h (95%).  It should be noted that the armed SBox 
glycoside 2.7a could also be activated with iodine, but this could be only accomplished at 
rt.  The fact that the SBox glycosides reacted much slower than their S-ethyl counterparts 
was rather unanticipated, as SBox glycosides are typically much more reactive and can be 
selectively activated in the presence of alkyl/aryl thioglycosides.
13, 31
  
 
2.3 Competitive glycosylations 
 
As verification of the promising results obtained with S-ethyl glycosides in the presence 
of iodine, we set up direct competitive glycosylations.  To optimize the reaction 
conditions for a chemoselective oligosaccharide assembly, the competitive glycosylations 
were investigated at a variety of reaction temperatures (Table 2.3).  These reactions were 
carried out by placing equimolar amounts (1.1 equiv each) of the armed 2.7c and 
superarmed 2.8c glycosyl donors in the same reaction vessel with glycosyl acceptor 2.9 
(1 equiv).  Upon the addition of iodine (3 equiv), both glycosyl donors competed for the 
same acceptor to form either disaccharide 2.10 or 2.11.  The highest product ratio in these 
competitive glycosylations was also obtained at -25 
o
C, wherein the 1,2-trans-linked 
disaccharide 5 (derived from superarmed glycosyl donor 2.8c) was isolated in 62% yield 
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(entry 3).  Conversely, the disaccharide 2.10 (derived from armed glycosyl donor 2.7c) 
was isolated in only 14% yield ( = 1/4).  
 
Table 2.3.  Competitive activations of S-ethyl glycosyl donors: 2.7c (armed) 
vs. 2.8c (superarmed) 
 
Entry Temp. Time Ratio  
2.10:2.11 
Yield 2.10  
(α/β) 
Yield 2.11 
(α/β) 
1 rt 1 h 56:44 53%  
(1:1.7) 
45%  
(β only) 
2 -10 
o
C 1 h 29:71 22% 
(1:4) 
51% 
(β only) 
3 -25 
o
C 3 h 20:80 14% 
(1:4) 
62% 
(β only) 
4 -35 
o
C 24 h 40:60 11% 
(1:5) 
26% 
(β only) 
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2.4 Chemoselective oligosaccharide synthesis 
 
Having investigated the superarming and arming effects in direct competitive 
glycosylations with glycosyl donors of the S-ethyl series, we now turned our attention to 
a sequential tetrasaccharide synthesis.  To begin, the chemoselective activation of the 
superarmed glycosyl donor 2.8c over the “armed” glycosyl acceptor 2.1232 was 
successfully carried out in the presence of iodine, at -25 
o
C (Scheme 1).  Subsequently, 
the resulting armed disaccharide 2.13, obtained in 80% yield, was directly coupled with 
“disarmed” glycosyl acceptor 2.14.33  This chemoselective activation was also performed 
in the presence of iodine, but this time at rt.  The resulting trisaccharide 2.15, obtained in 
55% yield (α/β = 1:2.6), was then reacted with glycosyl acceptor 2.9 in the presence of 
NIS/TfOH, and the resulting tetrasaccharide 2.16 was isolated in 72% yield.  Overall, this 
synthesis serves as ultimate proof of the utility of this superarmed approach in 
chemoselective oligosaccharide synthesis. 
 
2.5 Conclusion 
 
In conclusion, a promising new concept for superarming glycosyl donors through the use 
of common protecting groups has now been extended to encompass a range of common 
glycosyl donors.  Although it was initially necessary to fine-tune the reaction conditions 
and carefully select an adequate (mild) promoter, once established, the reactivity of the 
superarmed glycosyl donors was able to be exploited.  This approach ultimately provides 
an additional synthetic building block that can be integrated into the conventional 
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chemoselective armed-disarmed strategy.  Results obtained herein were both consistent 
and high yielding, thus, offering this approach as a general method whereby a 1,2-trans 
linkage has to be introduced prior to other linkages.  Additionally, the superarmed 
glycosyl donors can be easily obtained by conventional synthetic methods.  Currently, the 
application of the superarmed glycosyl donor concept toward selective activation and 
orthogonal approaches to oligosaccharide synthesis is under pursuit in our laboratory. 
 
Scheme 2.1.  Sequential activation of differently protected S-ethyl building blocks:  
synthesis of tetrasaccharide 2.16 
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2.6 Experimental  
 
Preparation of superarmed glycosyl donors 2.8e and 2.8f 
p-Methylphenyl 2-O-benzoyl-3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (2.8e).  
The title compound was obtained using a modified protocol similar to that previously 
reported.
7,8,14  
CH2Cl2 (9.0 mL) and p-toluenethiol (1.6 g, 13.03 mmol)  were added to 
3,4,6-tri-O-benzyl-1,2-O-(1-methoxybenzylidene)-α-D-glucopyranose14 (740 mg, 1.31 
mmol) and molecular sieves (3Å, 850 mg), and the resulting mixture was stirred under 
argon for 45 min.  Trimethylsilyl trifluoromethanesulfonate (6 µL, 0.328 mmol) was 
added and the reaction mixture was stirred under argon for 16 h at rt.  After that, the 
reaction mixture was neutralized by the addition of triethylamine (~0.1 mL), diluted with 
CH2Cl2, the solid was filtered-off and was rinsed successively with CH2Cl2.  The 
combined filtrate (~30 mL) was washed with water (10 mL), 20% aq. NaHCO3 (10 mL), 
and water (3 x 10 mL).  The organic phase was separated, dried, and concentrated in 
vacuo.  The residue was purified by column chromatography on silica gel (ethyl 
acetate/hexanes gradient elution) to afford the title compound 2.8e as a white solid in 
70% yield.  Analytical data for 2.8e: Rf = 0.54 (ethyl acetate/hexanes, 3/7, v/v); m. p. 
134-135 
o
C (diethyl ether/hexanes); []D
22 
+32.5
o
 (c = 1, CHCl3);  
1
H-n.m.r: δ, 2.18 (s, 
3H, SPhCH3), 3.48 (m, 1H, J5,6a = 1.9 Hz, J5,6b = 3.6 Hz, H-5), 3.62 (dd, 1H, J4,5 = 9.5 Hz, 
H-4), 3.65-3.78 (m, 3H, H-3, 6a, 6b), 4.42-4.75 (m, 6H, 3 × CH2Ph), 4.61 (d, 1H, J1,2 = 
10.0 Hz, H-1), 5.14( dd, 1H, J2,3 = 9.0 Hz, H-2), 6.80-8.00 (m, 24H aromatic) ppm;  
13
C-
n.m.r.: δ, 21.3, 69.1, 72.7, 73.7, 75.2, 75.5, 76.8, 77.2, 77.4, 77.7, 78.0, 79.7, 84.5, 86.4, 
127.7 (×3), 127.8 (×3), 127.8 (×3), 128.0, 128.1 (×2), 128.3, 128.4 (×2), 128.5 (×2), 
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128.7 (×2), 128.8 (×2), 128.9 (×2), 128.9 (×3), 129.1, 130.0 (×2), 130.3 (×2), 130.4, 
133.6, 133.9 (×3), 138.1, 138.4, 138.5, 138.7, 165,3 ppm; HR-FAB MS [M+Na]
+
 calcd 
for C41H40O6SNa
+
 683.2443, found 683.2624. 
 
Thiazolinyl 2-O-benzoyl-3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (2.8f).  The 
title compound was obtained using a modified protocol similar to that previously 
reported.
34  
3,4,6-tri-O-benzyl-1,2-O-(1-methoxybenzylidene)-α-D-glucopyranose14 (200 
mg, 0.35 mmol) was mixed with molecular sieves (3Å, 0.8 g) and 2-mercaptothiazoline 
(420 mg, 3.52 mmol), and dried in vacuo for 15 min.  Acetonitrile (2.6 mL) was added 
and the resulting mixture was stirred under argon for 1 h.  Mercuric bromide (13 mg, 
0.035 mmol) was added and the resulting reaction mixture was heated at reflux for 16 h.  
The volatiles have been evaporated under reduced pressure, the residue was diluted with 
CH2Cl2, the solid was filtered-off and rinsed successively with CH2Cl2.  The combined 
filtrate (30 mL) was washed with 1N aq. NaOH (10 mL) and water (3 x 10 mL).  The 
organic phase was separated, dried, and concentrated in vacuo. The residue was purified 
by column chromatography on silica gel (ethyl acetate/hexane gradient elution) to afford 
the title compound 2.8f as a white solid in 70% yield.  Analytical data for 2.8f: Rf = 0.47 
(ethyl acetate/hexane, 4/6, v/v); m. p. 141-143 
o
C (diethyl ether-hexanes); []D
22 
+81.2
o
 
(c = 1, CHCl3);  
1
H-n.m.r: , 3.43 (m, 2H, NCH2), 3.82 (m, 1H, H-5), 3.88-3.98 (m, 2H, 
H-6a, 6b), 4.03 (dd, 1H, J4,5 = 9.1 Hz, H-4), 4.05 (dd, 1H, J3,4 = 8.8 Hz, H-3), 4.30 (m, 
2H, CH2S), 4.75 (dd, 2H, J
2 
= 11.9 Hz, CH2Ph), 4.85 (dd, 2H, J
2 
= 10.9 Hz, CH2Ph), 4.87 
(dd, 2H, J
2 
= 11.0 Hz, CH2Ph), 5.55 (dd, 1H, J2,3 = 8.5 Hz, H-2), 5.67 (d, 1H, J1,2 = 10.3 
Hz, H-1), 7.22-8.20 (m, 20H, aromatic) ppm;  
13
C-n.m.r.: δ, 35.6, 64.3, 68.8, 72.4, 73.6, 
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75.3, 75.5, 77.8, 80.0, 83.1, 84.3, 127.8, 127.9, 128.0, 128.1 (×2), 128.1 (×2), 128.2 (×2), 
128.5 (×2), 128.6 (×3), 128.6 (×2), 129.7, 130.1 (×2), 133.5, 137.9, 138.2, 138.3, 163.7, 
165.4 ppm; HR-FAB MS [M+Na]
+
 calcd for C37H37NO6S2Na
+
 678.1959, found 
678.1977. 
 
Preparation of di- and oligosaccharides (2.10, 2.11, 2.13, 2.15, and 2.16) 
Method A: Typical DMTST-promoted glycosylation procedure:  A mixture containing the 
glycosyl donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (4Å, 200 mg) in 1,2-dichloroethane (DCE, 1.6 mL) was stirred under 
argon for1 h.  The mixture was chilled to 0 or -20 
o
C (see Table 1), DMTST
14
 (0.33 
mmol) was added and the reaction mixture was stirred for 5 min – 2 h (see Table 1). 
Upon completion, the mixture was diluted with CH2Cl2, the solid was filtered-off and 
rinsed successively with CH2Cl2. The combined filtrate (30 mL) was washed with 20% 
aq. NaHCO3 (10 mL) and water (3 x 10 mL).  The organic phase was separated, dried and 
concentrated in vacuo.  The residue was purified by column chromatography on silica gel 
(ethyl acetate-hexane gradient elution). 
 
Method B:  Typical Cu(OTf)2-promoted glycosylation procedure: A mixture containing 
the glycosyl donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (4Å, 200 mg) in DCE (1.6 mL) was stirred under argon for 1 h followed 
by the addition of freshly conditioned Cu(OTf)2 (0.22 mmol).  The reaction mixture was 
stirred for 20 min - 2h at 0 
o
C (see Table 1) then diluted with CH2Cl2, the solid was 
filtered-off and rinsed successively with CH2Cl2. The combined filtrate (30 mL) was 
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washed with 20% aq. NaHCO3 (10 mL) and water (3 x 10 mL). The organic phase was 
separated, dried and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate-hexane gradient elution).  
 
Method C: Typical IDCP-promoted glycosylation procedure: A mixture containing the 
glycosyl donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (4Å, 200 mg) in DCE (1.6 mL) was stirred under argon for 1 h. The 
reaction mixture was then chilled to -10 
o
C, IDCP
17
 (0.22 mmol) was added and the 
reaction mixture was stirred for 3 -96 h (see Table 1). Upon completion, the mixture was 
diluted with CH2Cl2, the solid was filtered-off and rinsed successively with CH2Cl2. The 
combined filtrate (30 mL) was washed with 20% NaHCO3 (10 mL) and water (3 x 10 
mL). The organic phase was separated, dried and concentrated in vacuo. The residue was 
purified by column chromatography on silica gel (ethyl acetate-hexane gradient elution). 
 
Method D: Typical MeOTf-promoted glycosylation procedure: A mixture containing the 
glycosyl donor (0.13 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (3Å, 200 mg) in DCE (1.6 mL) was stirred under argon for 1 h. The 
mixture was chilled to 0 
o
C, MeOTf (0.39 mmol) was added and the reaction mixture was 
stirred for 6-18 h (see Table 1).  The mixture was then diluted with CH2Cl2, the solid was 
filtered-off and the residue was rinsed successively with CH2Cl2. The combined filtrate 
(30 mL) was washed with 20% aq.NaHCO3 (10 mL) and water (3 x 10 mL). The organic 
phase was separated, dried and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate-hexane gradient elution). 
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Method E: Typical iodine-promoted glycosylation procedure: A mixture containing the 
glycosyl donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (3Å, 200 mg) in DCE (1.6 mL) was stirred under argon for 16 h.  The 
mixture was chilled to -25 
o
C (or as indicated in Table 3 or Scheme 1), iodine (0.33 
mmol) was added and the reaction mixture was stirred for 1 – 48 h (see Table 2). Upon 
completion, the mixture was quenched with Et3N and diluted with CH2Cl2, the solid was 
filtered-off and the residue was rinsed successively with CH2Cl2. The combined filtrate 
(30 mL) was washed with 10% aq.Na2S2O3 (10 mL) and water (3 x 10 mL). The organic 
phase was separated, dried and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate-toluene gradient elution). 
 
Method F: Typical NIS/TfOH-promoted glycosylation procedure: A mixture containing 
the glycosyl donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (4Å, 200 mg) in DCE (1.6 mL) was stirred under argon for 16 h. NIS 
(0.22 mmol) and TfOH (0.022 mmol) were added and the reaction mixture was stirred for 
1 h. Upon completion, the mixture was diluted with CH2Cl2, the solid was filtered-off and 
the residue was rinsed successively with CH2Cl2. The combined filtrate (30 mL) was 
washed with 10% aq.Na2S2O3 (10 mL) and water (3 x 10 mL). The organic phase was 
separated, dried and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate-toluene gradient elution). 
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Methyl O-(2,3,4,6-tetra-O-benzyl-D-glucopyranosyl)-(16)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside (2.10).  The spectroscopic and analytical data for the title compound 
were in good agreement with those reported previously.
12
  
 
Methyl O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl)-(16)-2,3,4-tri-O-
benzyl-α-D-glucopyranoside (2.11).  The spectroscopic and analytical data for the title 
compound were in good agreement with those reported previously.
12
  
 
Ethyl O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl)-(16)-2,3,4-tri-O-
benzyl-1-thio-β-D-glucopyranoside (2.13).  The title compound was obtained as a 
colorless syrup from 1c
18
 and 6
32
 by method E in 80% yield.  Analytical data for 7: Rf = 
0.4 (ethyl acetate/hexanes, 3/7, v/v); [α]D
23 
+18.4
o
 (c=1, CHCl3); 
1
H-n.m.r:  δ, 1.13 (t, 3H, 
J = 8.0 Hz, SCH2CH3), 2.51 (m, 2H, SCH2CH3), 3.31 (dd, 1H, J2,3 = 9.0 Hz, H-2), 3.32-
3.46 (m, 2H, H-4, 5), 3.48-3.65 (m, 3H, H-3, 5‟, 6a), 3.67-3.82 (m, 4H, H-3‟, 4‟, 6a‟, 
6b‟), 4.10 (d, 1H, J5,6b = J6a,6b = 10.5 Hz, H-6b), 4.32 (d, 1H, J1,2 = 9.7 Hz, H-1), 4.40-4.87 
(m, 13H, H-1‟, 6 x CH2Ph), 5.31 (br dd, 1H, H-2‟), 7.05-8.00 (m, 35H, aromatic) ppm; 
13
C-n.m.r.: δ, 15.2, 24.7, 29.9, 68.4, 69.2, 74.0, 75.4, 75.7, 75.8, 75.8, 76.0, 77.6, 78.4, 
79.1,  82.0, 83.3, 84.9, 86.9, 101.4, 128.0 (×2), 128.1 (×4), 128.2 (×3), 128.2 (×4), 128.4 
(×4), 128.4 (×4), 128.6 (×3), 128.8 (×6), 128.8 (×5), 128.8 (×5), 130.2 (×2), 138.2, 138.4 
(×2), 138.5, 166.0 ppm; HR-FAB MS [M+Na]
+
 calcd for C63H66O11SNa
+
 1053.4224, 
found 1053.4238  
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Ethyl O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl)-(16)-O-(2,3,4-tri-O-
benzyl-D-glucopyranosyl)-(16)-2,3,4-tri-O-benzoyl-1-thio-β-D-glucopyranoside 
(2.15).  The title compound was obtained as a pale-yellow syrup from 2.13 and 2.14
33
 by 
method E (rt) in 55% yield (α:β = 1:2.6).  Analytical data for 2.15: Rf = 0.3 (ethyl 
acetate/hexane, 3/7, v/v); 
1
H-n.m.r. (selected data for β-9):  δ, 1.13 (t, 3H, J = 8.0 Hz, 
SCH2CH3), 2.65 (m, 2H, SCH2CH3), 3.26 (dd, 1H, J2‟,3‟ = 8.9 Hz, H-2‟), 3.30-3.58 (m, 
4H, H-3‟, 4‟, 5‟, 6a), 3.62-4.20 (m, 9H, H-3”, 4”, 5, 5”, 6a‟, 6a‟‟, 6b, 6b‟, 6b”), 4.35 (d, 
1H, J1‟,2‟= 7.7 Hz, H-1‟), 4.35-4.95 (m, 14H, H-1, 1”, 12 x CH2Ph), 5.32 (dd, 1H, J2”,3” = 
9.5 Hz, H-2”), 5.38 (dd, 1H, J4,5 = 7.0 Hz, H-4), 5.49 (dd, 1H, J2,3 = 9.7 Hz, H-2), 5.86 
(dd, 1H, J3,4 = 9.7 Hz, H-3), 7.05-8.15 (m, 50H aromatic) ppm;  
13
C-n.m.r.: δ, 15.0 (×2), 
24.4, 29.9, 69.0, 70.4, 70.9, 73.7 (×2), 74.1, 74.4, 74.9 (×2), 75.2, 75.2, 75.4, 75.6, 77.7, 
78.1, 78.4 (×2), 82.3, 83.0, 83.9, 84.6, 101.4, 103.9, 127.6 (×2), 127.8 (×2), 127.8 (×2), 
127.9, 128.0, 128.1 (×4), 128.2 (×2), 128.4, 128.4 (×4), 128.5 (×4), 128.6 (×5), 128.7, 
129.0, 129.1, 129.5, 129.9 (×2), 130.0, 130.0 (×2), 130.1, 133.2, 133.4 (×2), 133.6 (×2), 
138.1 (×2), 138.2 (×2), 138.3, 138.4 (×2), 138.8 (×4), 165.3 (×2), 165.4 (×2), 165.6 (×3), 
166.0 (×2) ppm; HR-FAB MS [M+Na]
+
 calcd for C90H88O19SNa
+
 1527.5538, found 
1527.5558.  
 
Methyl O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl)-(16)-O-(2,3,4-tri-
O-benzyl-D-glucopyranosyl)-(16)-O-(2,3,4-tri-O-benzoyl-β-D-glucopyranosyl)-
(16)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.16).  The title compound was 
obtained as colorless syrup 3 and 9 by method F in 72% yield.  Selected analytical data 
for β-2.16:  Rf = 0.66 (ethyl acetate/hexane, 2/3, v/v);  
1
H-n.m.r.: δ, 4.24 (d, 1H, J1”,2” = 
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7.8 Hz, H-1”), 4.29 (d, 1H, J1,2 = 3.3 Hz, H-1), 4.44 (d,1H, H-1‟), 4.47 (d, 1H, H-1”‟) 
ppm;
 13
C-n.m.r.: δ, 55.7, 67.7, 68.4, 68.8, 69.8, 70.0, 72.2, 73.3, 73.9, 74.3, 74.8, 74.9, 
75.0, 75.4, 75.6, 75.8, 77.6 (×2), 77.9, 78.2, 79.6 (×2), 80.1, 82.2, 83.1, 98.3, 98.5, 101.0, 
101.6, 127.4 (×3), 127.8, 128.0 (×3), 128.2 (×6), 128.3 (×4), 128.3 (×4), 128.4, 128.5 
(×3), 128.7 (×5), 128.7 (×6), 128.8 (×7), 128.8 (×7), 128.8 (×6), 129.0 (×5), 129.1, 129.2, 
129.4 (×3), 129.4, 129.6, 130.0, 130.1 (×3), 130.3, 130.4, 133.5, 133.6, 133.9, 136.2, 
138.1, 138.3, 138.4, 138.6, 138.8, 139.3, 165.2, 165.4, 165.8, 166.1 ppm; HR-FAB MS 
[M+Na]
+
 calcd for C116H114O25Na
+
 1929.7547, found 1929.7583. 
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CHAPTER 3 
 
 
 
Superarming of glycosyl donors by 
cooperative electronic and conformational 
effects  
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3.1 Introduction 
 
Traditional strategies for oligosaccharide synthesis often require extensive protecting 
and/or leaving group manipulations between each glycosylation step, thereby leading to 
the increase in the total number of synthetic steps and,consequently, decrease in both 
efficiency and over-all yield.  The past two decades have witnessed a dramatic 
improvement of the methods and strategies used for oligosaccharide synthesis.
1,2
  These 
developments include but are not limited to one-pot protection
3
 and glycosylation 
strategies,
4,6
 orthogonal assembly,
7,8
 polymer-supported
9-11 
and automated synthesis,
12,13
 
ionic liquid supported,
14,15
 fluorous tag assisted,
16,17
 and surface-tethered synthesis 
(STICS).
18
   
The armed-disarmed approach for chemoselective oligosaccharide synthesis is occupying 
an important niche in the arsenal of available methods.
19,20
 for oligosaccharide synthesis.  
This strategy, introduced by Fraser-Reid et al., utilizes only one leaving group, and the 
building block reactivity is modulated entirely through the choice of protecting groups to 
allow the direct chemoselective coupling between an activated (armed) glycosyl donor 
A1 and a deactivated (disarmed) glycosyl acceptor A2 (Scheme 3.1A).
19
  Since the 
anomeric configuration of the product is influenced by the protecting group at O-2, a 1,2-
cis-linked disaccharide is preferentially obtained in the first step, due to the use of the 
non-participating, ether-type (O-benzyl) arming substituent. The resulting disaccharide 
can then be used directly in subsequent glycosidation to form cis-trans-patterned 
oligosaccharides.  Recent improvements have expanded the scope of the armed-disarmed 
methodology so that it can now be applied to a wider range sequences: cis-cis by using a 
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remote protecting group capable of powerful electron-withdrawal,
21,22
 trans-trans using 
picolinyl arming participating group,
23
 and trans-cis patterned oligosaccharides by O2/O5 
cooperative effect in glycosylation as we demonstrated in the previous chapter. 
24
 
 
Scheme 3.1. Chemoselective strategies for oligosaccharide synthesis: A. Armed-
disarmed; B. Conformational superarming; C. Electronic superarming
 
 
Derived from the discovery of the O2/O5 cooperative effect in glycosylation that showed 
how the mixed protecting group pattern could unexpectedly and profoundly affect 
glycosyl donor reactivity,
24
 our group reported in 2008 that a glycosyl donor containing a 
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participating benzoyl group at C-2 and electron donating groups at the remaining 
positions is significantly more reactive (superarmed) than their armed per-benzylated 
counterparts.
39,40
  Thus, the glycosidation of 2-O-benzoyl-tri-3,4,6-O-benzyl protected 
SBox glucoside C1 was affected with the corresponding armed glycosyl acceptor C2 in 
the presence of dimethyl(methylthio)sulfonium triflate (DMTST), and the resulting 
disaccharide was isolated in 70% yield (Scheme 3.1C).  This concept for superarming 
was found to be universally applicable to glycosidation of O-pentenyl, S-ethyl, S-phenyl, 
S-tolyl and S-thiazolinyl building blocks as investigated in chapter 2.
41
   
Springing from a model study of the relative pKa values for protonated heterocyclic 
amines wherein it was shown that equatorial substituents are significantly more 
deactivating than their axial counterparts,
31
 Bols„ group reported in 2007 that 
conformationally modified glycosyl donors are significantly more reactive than their 
respective counterparts residing in 
4
C1 conformation.
32-34
  In this study conformational 
changes were induced by creating steric congestion at the equatorial C-3 and C-4 
positions.
35,36
 As such, the modified to a skew-boat conformation
37
 glucosyl donor B1 
showed a dramatic 20-fold increase in reactivity relative to the traditional armed 
benzylated derivatives.
33
 Furthermore, superarmed glycosyl donor B1 could be 
successfully coupled with “armed” acceptor B2 in the presenece of NIS/TfOH at -78 oC 
to afford the corresponding disaccharide in 85% yield (Scheme 3.1B).
38
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3.2 Comparing the reactivities of electronically and conformationally 
superarmed donors 
 
With two different approaches to superarming of glycosyl donors, we wondered which 
superarmed donor is more reactive.  To investigate this, we performed direct competition 
experiment wherein the conformationally superarmed glycosyl donor 3.1a was set to 
compete with electronically superarmed glycosyl donor 3.1b for glycosyl accetor 3.2
42
 
(Scheme 3.2).  The most reliable comparison was achieved in the NIS/TfOH-promoted 
competition experiment at -78 
o
C, essentially the same reaction conditions as reported in 
Bols„et al. study, wherein the rate of the formation of disaccharide 3.3a derived from the 
conformationally superarmed glycosyl donor 3.1a was slightly higher. Ultimately, this 
was reflected in a slightly higher yield for disaccharide 3.3a (47%), whereas disaccharide 
3.3b derived from the electronically superarmed donor 3.1b was isolated in 40% yield. 
 
Scheme 3.2. Competition experiment between conformationally superarmed donor 3.1a 
and electronically superarmed donor 3.1b 
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This result made us wonder whether further enhancement in reactivity could be achieved 
by using conventions of both conformational and electronic superarming approaches.  To 
address this question and with the goal of incorporating all key structural features from 
both approaches into a single building block, we obtained glycosyl donors equipped with 
2-O-benzoyl substituent and remote O-TBDMS substituents either at all remaining 3,4,6-
positions (glycosyl donor 3.1c) or at 3,4-positions in combination with 6-O-benzyl 
(glycosyl donor 3.1d, Scheme 3.3 ).   
 
Scheme 3.3 Synthesis of glycosyl donor 3.1c and 3.1d 
 
Since the new building blocks are equipped with 2-O-benzoyl substituents, the 
stereoselectivity was expected to be excellent, which would be of benefit because the 
stereoselectivity obtained with donor 3.1a bearing TBDMS at C-2 could be poor.  From 
preliminary NMR experiments it has become apparent that the conformations of new 
glycosyl donors 3.1c and 3.1d have departed from the basic 
4
C1 chair conformation, 
typical for most glucopyranose derivatives.  The 
1
H-NMR spectra recorded at room 
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temperature showed sets of poorly resolved broad signals presumably due to the 
relatively slow equilibration between several conformers.  The resolution of spectra 
recorded in DMSO could be enhanced at 80 
o
C presumably due to significantly faster 
equilibration between different conformations.  Recording spectra at -40 
o
C in order to 
elucidate the conformational features of different contributors was proven cumbersome. 
Therefore, we turned our efforts toward computational methods that could reveal a 
number of energy minima conformers. Examination of the most stable conformations of 
these donors is still underway. 
 
3.3 Comparative glycosylations 
 
Having synthesized new glycosyl donors 3.1c and 3.1d, which indicated that the induced 
structural changes would be sufficient to enhance the reactivity of 3.1c and 3.1d via the 
conformational superarming concept, we turned our attention to investigating their 
glycosyl donor properties. For this purpose, we performed initial side-by-side comparison 
of glycosyl donors 3.1a-d under standard reaction conditions (NIS/TfOH, -78 
o
C).  The 
results of this study are summarized in Table 3.1.  Somewhat unexpectedly, reaction of 
3.1a was significantly faster than that of 3.1b performed at essentially the same reaction 
conditions (Entries 1 and 2).  This large difference in reactivity was not clearly evident 
from our preliminary competition experiment (vide supra, Scheme 3.2) wherein similar 
reaction rates and yields of the resulting products have been observed.  Consequent in-
situ NMR monitoring of these reactions showed that the seemingly large difference in 
reactivity judged by the reaction time listed in Table 3.1 can be explained as follows.  
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While both reactions start relatively fast, glycosidation of 3.1a gets surpassed by 
competing hydrolysis of the glycosyl donor (or a preactivated intermediate derived 
therefrom) resulting in a rapid consumption of 3.1a. However, only 60% gets converted 
into the corresponding disaccharide 3.6a, which was formed as a mixture of 
diastereomers since no participating group is present at C-2 (Entry 1).  Very differently, 
after the initial fast reaction, further glycosidation of donor 3.1b can be smoothly driven 
to completion with minimal or no side reactions observed or by-product formation 
detected. Resultantly, disaccharide 3.3b was isolated in 96% yield (Entry 2).  
 
Table 3.1.  Comparative study of glycosyl donors 3.1a-d. 
 
Entry donor Conditions
 
time 
Product, 
yield (α/β ratio) 
1 3.1a NIS/TfOH, -78 
o
C 10 min 3.3a, 60% (1:1.8) 
2 3.1b NIS/TfOH, -78 
o
C 2.5 h 3.3b, 96% (β only) 
3 3.1c NIS/TfOH, -78 
o
C 45 min 3.3c, 20% (1:1.0)
[b]
 
4 3.1d NIS/TfOH, -78 
o
C 10 min 3.3d, 70% (β only)[a] 
5 3.1b NIS/TMSOTf, -78 
o
C 3 h 3.3b, 95% (β only) 
6 3.1d NIS/TMSOTf, -78 
o
C 30 min 3.3d, 86% (β only)[a] 
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7 3.1b MeOTf, 0 
o
Crt 48 h 3.3b, 88% (β only) 
8 3.1b I2, 0 
o
C 8 h 3.3b, 95% (β only) 
9 3.1d I2, 0 
o
C 30 min 3.3d, 30% (β only) 
10 3.1b DMTST, -30 
o
C 2 h 3.3b, 90% (β only) 
11 3.1d DMTST, -30 
o
C 2 h 3.3d, 85% (β only)[a] 
12 3.1a NIS, rt 3 h 3.3a, 55% (1:1.0) 
13 3,1b NIS, rt 22 h 3.3b, 88% (β only) 
14 3,1d NIS, rt 3 h 3d, 85% (β only) 
[a] 
Presented yields are combined total yields for 3d and partially desilylated 
disaccharide. The latter accounts for: entry 4 - 14%, entry 6 – 11%, and entry 11 - 
45%. 
[b]
 1,6-anhydride was observed in 75%. 
 
Further experiments showed rather limited practicality of glycosyl donor 3.1c, which 
showed very high propensity toward 6-O-silyl transfer to the 6-hydroxyl of glycosyl 
acceptor 3.2 followed by rapid self-condensation of the donor to afford the corresponding 
1,6-anhydro derivative. Similar observations were made using methyl triflate and 
DMTST as promoters.  To our surprise, disaccharide 3.3c was forming as a mixture of 
anomers, sometimes with no stereoselectivity at all (Table 3.2). 
To our understanding this was an indication that the participation of the 2-O-benzoyl 
substituent in 3.1c is not sufficiently strong to provide anchimeric assistance to form β-
glycosides stereoselectively. Hence, the superarming by electronic effect would be also 
very week if at all possible.  Therefore, further study of glycosyl donor 3.1c was 
abandoned and we refocused our attention on studying glycosyl donor 3.1d equipped 
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with stable 6-O-benzyl substituent.  Very rapidly it has become apparent that glycosyl 
donor 3.1d is able to provide higher yields for the formation of disaccharide 3.3d (70%, 
Entry 4, Table 3.1). In addition, disaccharide 3.3d was obtained with complete β-
stereoselectivity.   
We also noticed that some TBDMS groups would still migrate post-glycosylationally, for 
example disaccharide 3.3d (Entry 4) contained about 14% of partially desilylated 
disaccharide.  This finding served as a motivation for us to conduct a systematic search of 
other suitable reaction conditions that would have a positive impact on our comparative 
study.  First, we were interested in identifying the reaction conditions that would allow 
for efficient differentiation of reactivity levels of different glycosyl donors. Second, from 
the practicality standpoint these conditions should provide high yields and clean reactions 
across the entire series of superarmed glycosyl donors.  Upon screening common reaction 
conditions for the activation of thioglycosides
[43]
 we determined that NIS/TMSOTf, 
MeOTf, or I2 allow for efficient differentiation of the reactivity levels of 3.1b and 3.1d.  
In all of these experiments glycosidation of donor 3.1d was significantly faster than that 
of electronically superarmed donor 3.1b (Entries 5-10, Table 3.1).  And it is only in the 
presence of DMTST, donors 3.1b and 3.1d showed comparable rates of glycosylation 
(Entries 11 and 12).  Iodine-promoted glycosidation of 3.1d gave very modest result 
(30% of 3.3d, Entry 10) because of a rapid transfer of a 3-O-TBDMS group of the donor 
to the primary hydroxyl of glycosyl acceptor 3.2. Presumably, this was mediated by 
TBDMSI formed in situ.   
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Table 3.2: Comparative glycosylation studies of donor 3.1b and 3.1c 
 
Entry Donor Promoter Temp/ Time Product Yield 
(α/β ratio) 
1 3.1b DMTST -30 oC/ 2 h 3.3b 90 
(β only) 
2 3.1c DMTST -30 
o
C/ 30 min 3.3c 65 
(1:16.1) 
3 3.1b MeOTf 0 
o
C-rt/ 2 days 3.3b 88 
(β only) 
4 3.1c MeOTf 0 
o
C-rt/ 2 days 3.3c 67 
(1:1.3) 
5 3.1b NIS/TfOH -30 
o
C/ 10 min 3.3b 90 
(β only) 
6* 3.1c NIS/TfOH -30 
o
C/ 10 min 3.3c - 
*1,6-anhydrosugar was isolated in 75% yield 
 
General drawback of most glycosidations of 3.1d is the presence of a partially desilylated 
disaccharide product. The amount of the deprotected products formed varied and in most 
reactions would not exceed 10-15%. Occasionally, significant amount of the deprotected 
disaccharide was observed (45%) like in DMTST-promoted glycosylation (Entry 12).  
And it is only in the presence of NIS with no additives at room temperature high yields 
and no desilylation was observed.  Resultantly, the requisite disaccharide 3.3d was 
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isolated in 85% yield (Entry 15).  Based on the reaction times required to glycosidate 
donors 3.1a, 3.1b, and 3.1d (Entries 13-15), one could assume that 3.1d is closer in 
reactivity to the conformationally superarmed donor 3.1a (both glycosylation were 
complete in 3 h) rather than that of the electronically superarmed donor 1b, which 
required 22 h.  As a verification of these results, we also deemed it necessary to carry out 
a series of competitive glycosylations where 3.1b, 3.1d and 3.1a compete for the 
common acceptor.  
 
3.4 Competitive glycosylation 
 
In this study, glycosyl donor 3.1b set to compete with donor 3.1d for glycosyl acceptor 
3.2 leading to the formation of disaccharide 3.3d in 81%, while only trace amounts of 
disaccharide 3.3b (<10%) could be detected (Scheme 3.4).  In addition, the unreacted 
glycosyl donor 3.1b was recovered in 86% yield.  
 
Scheme 3.4 Competitive experiment between 3.1b and 3.1d   
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3.5 Conclusion 
In conclusion, we have discovered differently reactive glycosyl donors through the use of 
bulky silyl protecting groups which allows for the conformational change in superarmed 
glycosyl donors. So far, the results evident that the donor 3.1d is clearly more reactive 
than the previously discovered electronically superarmed donor 3.1b However, it shows 
almost similar reactivity to the conformationally superarmed donor 3.1a. Further 
exploration of these superarming methods is very important in the field for 
chemoselective oligosaccharide synthesis.  
 
3.6 Experimental 
 
General remarks. Column chromatography was performed on silica gel 60 (EM Science, 
70-230 mesh), reactions were monitored by TLC on Kieselgel 60 F254 (EM Science). The 
compounds were detected by examination under UV light and by charring with 10% 
sulfuric acid in methanol. Solvents were removed under reduced pressure at < 40 
o
C. 
CH2Cl2 and ClCH2CH2Cl were distilled from CaH2 directly prior to application. 
Anhydrous DMF (EM Science) was used as is. Methanol was dried by refluxing with 
magnesium methoxide, distilled and stored under argon. Pyridine was dried by refluxing 
with CaH2 and then distilled and stored over molecular sieves (3 Å). Molecular sieves (3 
Å or 4 Å), used for reactions, were crushed and activated in vacuo at 390 °C during 8 h in 
the first instance and then for 2-3 h at 390 °C directly prior to application. AgOTf (Acros) 
was co-evaporated with toluene (3 x 10 mL) and dried in vacuo for 2-3 h directly prior to 
application. DMTST was prepared in accordance to previously reported methods. Optical 
Premathilake, Hemali D., UMSL, p.106 
 
rotations were measured at „Jasco P-1020‟ polarimeter. 1H-n.m.r. spectra were recorded 
in CDCl3 at 300 MHz, DMSO at 500 MHz, 
13
C-NMR spectra were recorded in CDCl3 at 
500 MHz unless otherwise noted. HR FAB-MS determinations were made with the use of 
JEOL MStation (JMS-700) Mass Spectrometer, matrix m-nitrobenzyl alcohol, with NaI 
as necessary. 
 
Synthesis of glycosyl donors  
Phenyl  2-O-benzoyl-3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (3.1b) was 
obtained from the orthoester 3.2 
40
 in a procedure similar to that previously reported . 
Analytical data for the title compound was essentially the same as previously described 
10
 
 
Phenyl 6-O-benzyl-2,3,4,-tri-O-tert-butyldimethylsilyl-1-thio-β-D-glucopyranoside 
(3.1a). Analytical data for the title compound was essentially the same as previously 
described 
44
 
 
Methyl 6-O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-
α-D-glucopyranoside (3.15) was obtained from 3.3 and 3.14 as a clear film.  Analytical 
data for 3.15 is the same as reported previously.
34 
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Phenyl 2-O-benzoyl-3,4,6-tri-O-tert-butyldimethylsilyl-1-thio-β-D-glucopyranoside 
(3.6) 
 
Phenyl 3-O-tert-butyldimethylsilyl-4,6-O-benzylidene-1-thio-β-D-glucopyranosid A: 
The solution of phenyl 4,6-benzylidene-1-thio-β-D-glucopyranoside 3.5 (4.0 g, 12.82 
mmol) was heated under reflux with Bu2SnO (3.5 g, 14.10 mmol) in a flask equipped 
with a Dean-Stark device in anhydrous toluene (200 mL) for 3h and concentrated to 
approximately 50 mL. After cooling the reaction mixture down to room temperature, 
anhydrous DMF (77 mL) was added followed by addition of imidazole (3.1 g, 
44.87mmol) and TBDMSCl (2.13 g, 14.10 mmol) and the obtained solution was stirred 
for 48 h at 130 
o
C. After the reaction was complete, DMF was removed under reduced 
pressure. The residue was dissolved in CH2Cl2 (300 mL) and washed with water (100 
mL), saturated NaHCO3 (100 mL) and water (3 × 100 mL). The organic phase was dried 
over MgSO4 and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate-hexane gradient elution) to afford compound 
A in 92% yield.  Analytical data for A: Rf = 0.69 (ethyl acetate-hexane, 2/3, v/v). 
 1
H-
n.m.r (300 MHz, CDCl3, rt): δ,-0.05 (s, 3H), 0.02 (s, 3H), 0.79 (s, 9H), 2.48 (d, 1H, J = 
Premathilake, Hemali D., UMSL, p.108 
 
2.6 Hz, OH), 3.31-3.39 (m, 3H, H-2, H-6a, H-6b), 3.633.71 (m, 2H, H-3, H-5), 4.26 (dd, 
1H, J2,3 =  4.23Hz, H-2), 4.55 (d, 1H, J1,2 = 9.84 Hz, H-1), 5.41 (s, 1H, CHPh), 7.21-7.40 
(m, 10H, aromatic) ppm. 
 
Phenyl 2-O-benzoyl-3-O-tert-butyldimethylsilyl-4,6-O-benzylidene-1-thio-β-D-
glucopyranosid (B). To a stirred solution of A (6.2 g, 14.55 mmol) and DMAP (0.5 g) in 
pyridine (24 mL) at 0 
o
C, was added dropwise benzoyl chloride (3.4 mL, 29.11 mmol).  
The reaction was stirred under argon for 30 minutes, upon which it was allowed to warm 
to 60 
o
C and continue stirring for 24 h.  The reaction was quenched with dry MeOH (2 
mL), and concentrated in vacuo.  The residue was then diluted with CH2Cl2 (300 mL) and 
washed successively with water (50 mL), saturated NaHCO3 (50 mL), water (3 x 50 mL), 
dried over MgSO4, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (Acetone – toluene gradient elution) to afford compound B 
in 89% yield.  Analytical data for B: Rf = 0.68 (acetone-toluene, 1/19, v/v). 
 1
H-n.m.r 
(300 MHz, CDCl3, rt): δ -0.24 (s, 3H), -0.19 (s, 3H), 0.59 (s, 9H), 3.46-3.56 (m, 2H, H-4, 
H-5), 3.85-3.94 (m, 2H, H-6a, H-6b), 4.16-4.24 (m, 1H, H-3), 5.03 (d, 1H, J1,2 = 10.1Hz, 
H-1), 5.18 (dd, 1H, J2,3 = 8.7 Hz, H-2), 5.46 (s, 1H, CHPh), 7.19-7.99 (m, 15H, aromatic) 
ppm. 
 
Phenyl 2-O-benzoyl-3-O-tert-butyldimethylsilyl-1-thio-β-D-glucopyranoside (C). 
Starting material B (3.4 g) was dissolved in 10% trifluoroacetic acid in CH2Cl2 (34 mL), 
followed by the addition of H2O (0.1 mL). The reaction was stirred at room temperature 
for 2 h. Upon completion, the reaction mixture was diluted with CH2Cl2 (100 mL), 
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washed with water (50 mL), saturated NaHCO3 (50 mL) and water (3×50 mL) dried over 
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate-hexane gradient elution) to afford compound C in 75% yield.  
Analytical data for C: Rf = 0.38 (ethyl acetate-hexane, 2/3, v/v). 
1
H-n.m.r (300 MHz, 
CDCl3, rt): δ -0.14 (s, 3H), 0.07 (s, 3H), 0.75 (s, 9H), 2.37 (s, 1H, OH), 2.65 (s, 1H, OH), 
3.46-3.49 (m, 1H, H-5), 3.67 (dt, 1H, H-4), 3.79-3.86 (m, 2H, H-6a, H-6b), 3.94-3.98 (m, 
1H, H-3), 4.83 (d, 1H, J1,2 = 10.0Hz, H-1), 5.16 (t, 1H, J2,3 = 9.5Hz, H-2), 7.24-8.06 (m, 
10H, aromatic) ppm. 
 
Phenyl 2-O-benzoyl-3,4,6-tri-O-tert-butyldimethylsilyl-1-thio-β-D-glucopyranoside 
(3.1c). To a stirred solution of a C (0.5 g, 1.05 mmol) in DMF (5 mL) was added tert-
butyldimethylsilyl triflate (0.96 mL, 4.20 mmol)  at 0 
o
C, then 2,6-lutidine (0.25 mL, 2.10 
mmol) was added. The resulting mixture was then heated to 150 
0
C. After 24 h the 
reaction was quenched with saturated NaHCO3, and extracted with Et2O (3× 50 mL). The 
organic layer was washed with water, HCl (1 N), and brine. The organic phase was dried 
over Mg2SO4 and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate – hexane gradient elution) to afford the title 
compound as colorless syrup (0.660 g, 88 %). Analytical data for 3.6: Rf = 0.69 (ethyl 
acetate-hexanes, 1/4, v/v); 
1
H-n.m.r (500 MHz, CDCl3, rt): δ, 0.01 (br. s, 8H), 0.68 (br. s, 
27H), 3.69 (br. m, 5H), 5.02 (m, 2H), 7.04-7.87 (m, 10H, aromatic) ppm. 
13
C NMR (300 
MHz, CDCl3): δ, -5.0, -4.3, -4.2, -4.0, -3.7, 18.1, 18.2, 18.6, 26.0 (×3), 26.1 (×3), 26.2 
(×3), 64.0, 70.5, 74.5, 75.5, 83.5, 83.9, 127.3, 128.4 (×2), 128.9 (×2), 130.1 (×2), 130.2 
(×2), 131.5 (×2), 133.3, 134.6, 165.6 ppm.  
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1
H-n.m.r (500 MHz, DMSO, 50 
oC): δ, 0.04 (s, 3H), 0.05 (s, 3H), 0.07 (s, 3H), 0.09 (s, 
3H), 0.10 (s, 3H), 0.12 (s, 3H), 0.81 (s, 3H), 0.84 (s, 3H), 0.86 (s, 3H), 0.87 (s, 3H), 0.88 
(s, 3H), 0.89 (s, 3H), 3.73-3.78 (m, 2H, H-5, H-6a), 3.83 (t, 1H, J4,5 = 9.7 Hz, H-4), 3.86-
3.90 (m, 1H, H-6b), 4.03 (t, 1H, J3,4 = 4.9 Hz, H-3), 5.01 (dd, J2,3 = 4.5 Hz, H-2), 5.29 (d, 
1H, J1,2 = 8.7 Hz, H-1), 7.27-7.97 (m, 10H, aromatic) ppm. 
1
H-n.m.r (500 MHz, CDCl3, -40 
oC): δ, -0.05 (s, 6H), 0.03 (s, 6H), 0.08 (s, 6H), 0.71 (s, 
9H), 0.90 (s, 18H), 3.63 (m, 2H, H-6a, H-6b), 3.70 (m, 1H, H-5), 3.84 (t, 1H, J4,5 = 
7.0Hz, H-4), 3.96 (m,1H, H-3), 4.98 (d, 1H, J1,2 = 9.8 Hz, H-1), 5.19 (dd, 1H, J2,3 = 
7.2Hz, H-2), 7.21-8.04 (m, 10H, aromatic) ppm. HR-FAB MS [M+Na]
+
 calcd for 
C37H62O6SSi3Na
+
  741.3473, found 741.3464. 
 
Phenyl 2-O-benzoyl-6-O-benzyl-3,4,-di-O-tert-butyldimethylsilyl-1-thio-β-D-
glucopyranoside (3.1d) 
 
Phenyl 2-O-benzoyl-6-O-benzyl-3,-O-tert-butyldimethylsilyl-1-thio-β-D-
glucopyranoside (D). To a stirred solution of a C (2.0 g, 4.08 mmol) in CH2Cl2 (26 mL) 
was added Ag2O (1.89 g, 8.16 mmol) followed by benzyl bromide (0.60 mL, 4.90 mmol). 
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The resulting mixture was heated to 30 
o
C. After 24 h the reaction mixture was filtered 
through Celite and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate – hexane gradient elution) to afford the title 
compound as colorless syrup (1.9 g, 80 %). Analytical data for D: Rf = 0.78 (ethyl 
acetate-hexanes, 2/3, v/v); 
1
H-n.m.r : δ, -0.25 (s, 3H, CH3), -0.05 (s, 3H, CH3), 0.62 (s, 
9H, C(CH3)3), 2.45 (d, 1H, J = 4.7 Hz, OH), 3.44-3.54 (m, 2H, H-6a, H-6b), 3.66-3.72 
(m, 3H, H-3, H-4, H-5),  4.47 (dd, 2H, 
2
J = 10.2 Hz, CH2Ph), 4.67 (d, 1H, J1,2 = 10.1 Hz, 
H-1), 5.06 (t, 1H, J2,3 = 9.9 Hz, H-2), 7.07-7.95 (m, 15H, aromatic) ppm. 
 
Phenyl 2-O-benzoyl-6-O-benzyl-3,4,-di-O-tert-butyldimethylsilyl-1-thio-β-D-
glucopyranoside (3.1d). To a stirred solution of a D (1.5 g, 2.59 mmol) in DMF (16 mL) 
was added tert-butyldimethylsilyl triflate (1.19 mL, 5.17 mmol)  at 0 
o
C, then 2,6-lutidine 
(0.60 mL, 5.17 mmol) was added. The resulting mixture was then heated to 150 
0
C. After 
48 h the reaction was quenched with saturated NaHCO3, and extracted with Et2O (3× 100 
mL). The organic layer was washed with water, HCl (1 N), and brine. The organic phase 
was dried over Mg2SO4 and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate – hexane gradient elution) to afford the title 
compound as colorless syrup (1.12 g, 62 %). Analytical data for 3.7: Rf = 0.65 (ethyl 
acetate-hexanes, 1/4, v/v); 
1
H-n.m.r (500 MHz, DMSO, rt): δ, -0.01 (s, 3H), 0.04 (s, 3H), 
0.06 (s, 3H), 0.07 (s, 3H), 0.73 (s, 9H), 0.81 (s, 9H), 3.56 (dd, 1H, J 5,6a = 7.6Hz, J6a,6b = 
10.1Hz, H-6a), 3.69-3.75 (m, 2H, H-4, H-6b), 3.87-3.91 (m, 1H, H-5), 4.06 (t, 1H, J2,3 = 
6.6Hz, H-3), 4.53 (dd, 2H, 
2
J = 12.1Hz, CH2Ph), 5.00 (dd, 1H, H-2), 5.29 (d, 1H, J1,2 = 
9.1Hz, H-1), 7.23-7.97 (m, 15H, aromatic) ppm. 
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1
H-n.m.r (500 MHz, DMSO, 80 
oC): δ, 0.05 (s, 3H), 0.07 (s, 3H), 0.08 (s, 3H), 0.09 (s, 
3H), 0.84 (s, 18H), 3.69 (dd, 1H, J6a-6b = 10.2 Hz, J5,6a = 6.6 Hz, H-6a), 3.77  (dd, 1H, J5,6b 
= 5.36Hz, H-6b)  3.87 (t, 1H, J4,5 = 4.2Hz, H-4), 3.98  (m, 1H, H-5), 4.03 (t, 1H, J3,4 = 4.3 
Hz, H-3), 4.54  (dd, 2H, 
2
J = 12.2Hz, CH2Ph), 5.06 (dd, 1H, J2,3 = 3.45Hz, H-2), 5.30  (d, 
1H, J1,2 = 8.1 Hz, H-1), 7.23-7.98 (m, 15H, aromatic) ppm. HR-FAB MS [M+Na]
+
 calcd 
for C38H54O6SSi2Na
+
  717.3076, found 717.3083. 
 
Synthesis of glycosides 
Method A: Typical DMTST-promoted glycosylation procedure: A mixture the glycosyl 
donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (4Å, 200 mg) in (ClCH2)2 (1.6 mL) was stirred under an atmosphere of argon for1 
h The mixture was chilled to 0 
o
C and DMTST (0.30 mmol) was added and the reaction 
mixture was stirred at 0 
o
C. Upon completion, the mixture was diluted with CH2Cl2, the 
solid was filtered-off and the residue was washed with CH2Cl2. The combined filtrate (30 
mL) was washed with NaHCO3 (10 mL) and water (3 x 10 mL). The organic phase was 
separated, dried with MgSO4 and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate-hexane gradient elution). 
 
Method B: Typical MeOTf-promoted glycosylation procedure: A mixture of glycosyl 
donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (3Å, 300 mg) in 1,2-dichloroethane (1.4 mL) was stirred under argon for 1 h. 
MeOTf (0.33 mmol) was added and the reaction mixture was monitored by TLC. Upon 
completion (see Tables), the solid was filtered off and the residue was rinsed successively 
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with CH2Cl2. The combined filtrate (30 mL) was washed with 20% NaHCO3 (10 mL) 
and water (3 x 10 mL). The organic layer was separated, dried with MgSO4 and 
concentrated in vacuo. The residue was purified by silica gel column chromatography 
(ethyl acetate- hexane gradient elution) to afford the corresponding oligosaccharide. 
 
Method C: Typical TMSOTf-promoted glycosylation procedure: A mixture of glycosyl 
donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (4Å, 150 mg) in 1,2-dichloroethane (2.5 mL) was stirred under argon for 1 h. 
TMSOTf (0.22 mmol) was added and the reaction mixture was monitored by TLC. Upon 
completion (see Tables), the solid was filtered off and the residue was rinsed successively 
with CH2Cl2. The combined filtrate (30 mL) was washed with 20% NaHCO3 (10 mL) 
and water (3 x 10 mL). The organic layer was separated, dried with MgSO4 and 
concentrated in vacuo. The residue was purified by silica gel column chromatography 
(ethyl acetate- hexane gradient elution) to afford the corresponding oligosaccharide. 
 
Method D: Typical NIS/TfOH-promoted glycosylation procedure:. A mixture of glycosyl 
donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (4Å, 150 mg) in 1,2-dichloroethane (1.6 mL) was stirred under argon for 1 h. NIS 
(0.22 mmol) and TfOH (0.022 mmol) was added and the reaction mixture was monitored 
by TLC. Upon completion, the mixture was diluted with CH2Cl2, the solid was filtered 
off, and the residue was rinsed successively with CH2Cl2, The combined filtrate (30 mL) 
was washed with 10% Na2S2O3 (10 mL) and water (3 x 10 mL). The organic layer was 
separated, dried with MgSO4 and concentrated in vacuo. The residue was purified by 
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silica gel column chromatography (ethyl acetate- hexane gradient elution) to afford the 
corresponding oligosaccharide. 
 
Method E: Typical NIS promoted glycosylation procedure:. A mixture of glycosyl donor 
(0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular sieves (4Å, 
150 mg) in 1,2-dichloroethane (1.6 mL) was stirred under argon for 1 h. NIS (0.33 mmol)  
was added and the reaction mixture was monitored by TLC. Upon completion, the 
mixture was diluted with CH2Cl2, the solid was filtered off, and the residue was rinsed 
successively with CH2Cl2, The combined filtrate (30 mL) was washed with 10% Na2S2O3 
(10 mL) and water (3 x 10 mL). The organic layer was separated, dried with MgSO4 and 
concentrated in vacuo. The residue was purified by silica gel column chromatography 
(ethyl acetate- hexane gradient elution) to afford the corresponding oligosaccharide. 
 
Method F: Typical NIS/TMSOTf-promoted glycosylation procedure: A mixture of 
glycosyl donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (4Å, 150 mg) in 1,2-dichloroethane (1.6 mL) was stirred under argon 
for 1 h. NIS (0.22 mmol) and TMSOTf (0.022 mmol) was added and the reaction mixture 
was monitored by TLC. Upon completion, the mixture was diluted with CH2Cl2, the solid 
was filtered off, and the residue was rinsed successively with CH2Cl2, The combined 
filtrate (30 mL) was washed with 10% Na2S2O3 (10 mL) and water (3 x 10 mL). The 
organic layer was separated, dried with MgSO4 and concentrated in vacuo. The residue 
was purified by silica gel column chromatography (ethyl acetate- hexane gradient 
elution) to afford the corresponding oligosaccharide. 
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Method G: Typical iodine-promoted glycosylation procedure: A mixture the glycosyl 
donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (3Å, 200 mg) in 1,2-DCE (1.6 mL) was stirred under an atmosphere of argon 
overnight. Iodine (0.30 mmol) was added and the reaction mixture was stirred at -25 
o
C, 
Upon completion, the reaction mixture was quenched with TEA, diluted with CH2Cl2 and 
the solid was filtered-off and the residue was washed with CH2Cl2. The combined filtrate 
(30 mL) was washed with Na2S2O3 (10 mL) and water (3 x 10 mL), the organic phase 
was separated, dried with MgSO4 and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate-toluene gradient elution). 
 
Methyl 6-O-(2-O-Benzoyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl)-2,3,4-tri-O-
benzyl-α-D-glucopyranoside (3.3b) was obtained from 3.1b and 3.2 as a clear film. 
Analytcal data for 3.3b was essentially the same as previously described. 
44
 
 
Methyl 6-O-(2-O-Benzoyl-3,4,6-tri-O-tert-butyldimethylsilyl-β-D-glucopyranosyl)-
2,3,4-tri-O-benzyl-α-D-glucopyranoside (3.3c) The title compound was obtained from 
3.1c and 3.2 by method A, B or D as a clear film. Selected analytical data for 3.3c: Rf = 
0.52 (ethyl acetate-hexanes, 1/4, v/v); 
1
H-n.m.r (300 MHz, CDCl3, rt): δ, 0.02 (s, 6H), 
0.04 (s, 6H), 0.05 (s,6H), 0.07 (s, 6H), 0.08 (s, 6H), 0.12 (s, 6H), 0.86 (s, 27H), 0.89 (s, 
27H), 3.24 (s, OCH3), 3.37 (s, OCH3), 3.99 (t, 1H, H-3), 4.13 (m, 1H, H-6b), 4.61 (s, 
1H, H-1), 4.95 (s, 1H, H-1‟), 5.06 (dd, 1H, H-2‟), 7.09-7.97 (m, 40H, aromatic) ppm. 
13C NMR (300 MHz, CDCl3): δ, -5.3, -5.2, -4.3, -4.1, -4.0, -3.7, 18.1, 18.8, 19.2, 25.8 
(×8), 55.2, 67.9, 69.8, 71.1, 71.2, 73.5, 73.6, 75.1, 75.2, 75.7, 77.4, 79.6, 79.9, 82.2, 
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98.5, 100.1, 127.6, 127.7 (×3), 128.3 (×4), 128.4 (×3), 128.5 (×4), 128.6 (×4), 130.8 
(×2), 133.1, 138.4, 138.5, 138.6, 139.1, 166.4 ppm. HR-FAB MS [M+Na]
+
 calcd for 
C59H88O12Si3Na
+
  1095.5481, found 1095.5479. 
 
Methyl 6-O-(2-O-Benzoyl-6-O-Benzyl-3,4,-di-O-tert-butyldimethylsilyl-β-D-
glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (3.3d). The title compound 
was obtained from 3.1d and 3.2 by method A, D-G as a clear film. Analytical data for 
3.3d: Rf = 0.51 (ethyl acetate-hexanes, 1/4, v/v); 
1
H-n.m.r (300 MHz, CDCl3, rt): δ, -0.02 
(s, 3H), 0.01(s, 3H), 0.02 (s, 3H), 0.08 (s, 3H). 0.80 (s, 9H), 0.81 (s, 9H), 3.20 (s, 3H, 
OCH3), 3.40-3.46 (m, 2H, H-2, H-4), 3.62-3.95 (m, 8H, H-3, H-5, H-6a, H-3‟, H-4‟, H-
5‟, H-6‟a H-6‟b), 4.12 (d, 1H, J = 9.1 Hz, H-6b), 4.46 (d, 1H, J1,2 = 3.3 Hz, H-1), 4.36 (d, 
1H, 
2
J = 10.7 Hz, ½ CH2Ph),  4.48-4.73 (m, 7H, 7/2 CH2Ph), 4.91 (d, 1H, J1‟,2‟ = 6.5 Hz, 
H-1‟), 5.06 (dd, 1H, H-2‟), 7.06-7.95 (m, 25H, aromatic) ppm. 13C NMR (300 MHz, 
CDCl3): δ, -4.3, -4.1, 4.0, -3.8, 18.1, 18.2, 26.1 (×5), 55.2, 67.9, 69.8, 71.1, 71.2, 73.5, 
73.6, 75.1, 75.2, 75.7, 77.4, 79.6, 79.9, 82.2, 98.1, 100.2, 127.6, 127.7 (×3), 128.0 (×4), 
128.3 (×4), 128.4 (×4), 128.5 (×4), 128.6 (×4), 130.8 (×2), 133.1, 138.4, 138.5, 138.6, 
139.1, 165.4 ppm. HR-FAB MS [M+Na]
+
 calcd for C60H80O12Si2Na
+
  1071.5086, found  
1070.5070. 
 
Methyl 6-O-(6-O-Benzyl-2,3,4,-tri-O-tert-butyldimethylsilyl-α/β-D-glucopyranosyl)-
2,3,4-tri-O-benzyl-α-D-glucopyranoside (3.3a). The title compound was obtained from 
3.1a and 3.2 by method D or E as a clear film. Selected analytical data for 3.3aβ: Rf = 
0.49 (ethyl acetate-hexanes, 1/4, v/v); 
1
H-n.m.r (300 MHz, CDCl3, rt): δ, -0.02 (s, 3H), 
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0.01(s, 3H), 0.02 (s, 3H), 0.08 (s, 3H). 0.79 (s, 9H), 0.80 (s, 9H), 0.81 (s, 9H), 3.20 (s, 
3H, OCH3), 3.42-3.47 (m, 2H, H-2, H-4), 4.46 (d, 1H, J1,2 = 3.3 Hz, H-1), 4.66 (t, 1H, 
J2,3 = 5.9 Hz, H-3‟), 4.94 (d, 1H, J1‟,2‟ = 11.0 Hz, H-1‟), 7.06-7.95 (m, 20H, aromatic) 
ppm. HR-FAB MS [M+Na]
+
 calcd for C59H90O11Si3Na
+
  1081.5791, found  1081.5702. 
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CHAPTER 4 
 
 
 
Toward a better understanding of the 
reactivity of sialosides 
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4.1 Introduction 
 
While the prior three chapters have focused on  the reactivity variations of neutral sugars 
(glucose, galactose and mannose) by the electronic nature of the O-2/O-5 cooperative 
effect and the conformational effects, this chapter explores the reactivity of the sialic 
acids donors and the ultimate goal is to compare those reactivities with neutral sugars. 
Sialic acids structure is different from neutral sugars and these are nine carbon 
monosaccharides which is a diverse family of naturally occurring 2-keto-3-deoxy-
nononic acids that are involved in wide range of biological processes.
1,2
 Their unique 
structure is characterized by the presence of a carboxylic group (ionized at physiological 
pH), deoxygenated C-3, glycerol chain at C-6, and differently functionalized C-5 (figure 
4.1). The sugar ring of Neu5Ac has a 
2
C5 conformation in which the bulky side chain and 
C-5 acetamido moiety adopt equatorial orientations (figure 4.1).  
 
Figure 4.1 Sialic acid and glucose 
 
Among the 50 derivatives so far reported, N-acetylneuraminic acid (5-acetamido-3,5-
dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid, Neu5Ac) is the most 
widespread, although N-glycolylneuraminic acid (Neu5Gc) and 2-keto-3-deoxy-D-
glycero-D-galacto-non-2-ulopyranosonic acid (KDN) which is an important form of 
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sialic acid that does not have an amino functionality are also commonly found in 
biological systems (Figure 4.2). 
1,
 
2
 
 
Figure 4.2 Major naturally occurring sialic acids. 
 
Most sialic acids occur as glycosides of oligosaccharides, glycoproteins and glycolipids. 
Sialic acids appear essentially at the terminal position, in which they are most commonly 
found (α2-3) - or (α2-6)-glycosidically linked to galactose or (α2-6)-linked to N-
acetylgalactosamine. Being at the terminus of natural cell-surface glycoconjugates, sialic 
acids are ideally positioned to mediate carbohydrate-protein interactions in cell-cell 
recognition phenomena. For example, sialic acids are involved in the sialyl Lewis X-
section binding that occurs in the recruitment of leukocytes during the inflammation 
process. Also sialic acids act as receptors for some microbial toxins, for microbial 
adhesion which mediate attachment to a host cell and for animal lectins that are important 
for cell-cell adhesion. Sialic acids also play important roles as masks to prevent 
biological recognition.
3
 For example, acetylation of the C-9 hydroxyl prevents this 
monosaccharide to be a receptor for the attachment of influenza A and B viruses.
4
 
Modifications of sialic acids can interfere with the mode of cell interaction. For example, 
O-acetylation or N-acetyl hydroxylation hinders the action of sialidases leading to a 
longer lifespan of rat erythrocytes.
5
 Advances in both chemical and enzymatic synthesis 
have provided reliable routes to the production of many complex sialosides. These 
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compounds are of key importance to determine the biological roles of these 
glycoconjugates. 
 
4.2 Chemical synthesis and reactivity of sialosides 
 
Glycosidic bond formation is generally achieved by condensing a fully protected glycosyl 
donor, which bears a potential leaving group at its anomeric center, with a suitably 
protected glycosyl acceptor that often contains only one free hydroxyl group. The nature 
of the protecting group at C-2 of the glycosyl donor is a major determinant of the 
anomeric reactivity as we discussed in the previous chapters. The C-2 protecting group 
which performs neighboring group participation can favor the 1, 2-trans glycosidic 
linkage.  If no participating functionality is present at C-2, the reaction conditions 
(solvent, temperature, and promoter) will become main factors to determine the anomeric 
selectivity.  Also, the constitution of the glycosyl donor and acceptor (e.g., type of 
saccharide donor, leaving group at the anomeric center, protection and substitution 
pattern) have a major effect on the stereoselectivity (Scheme 4.1). 
 
Scheme 4.1 Typical glycosylation reaction 
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Glycosylations of sialic acid donors which is called chemical sialylation is an important 
method used to synthesize homogeneous sialylated glycoconjugates. Glycosides of N-
acetylneuraminic acid can be introduced by similar glycosylation approaches, and these 
coupling procedures are classified as direct methods. The direct method of O-sialylation 
happens in one synthetic step involving a coupling of glycosyl accepter having free 
hydroxyl group and a donor with an appropriate leaving group at C-2. The use of 
glycosyl donor of Neu5Ac is, however, complicated by the fact that no neighboring C-3 
functionality is present to direct the stereochemical outcome of glycosylations. In fact, 
upon leaving group departure, the oxacarbenium ion is destabilized by the electron-
withdrawing carboxylate functionality at C-1. In addition, the lack of a participating 
group at C-3 results in nucleophilic attack from the top or bottom of the intermediate 
(Scheme 4.2).  The other possible side reactions are hydrolysis, as well as the synthesis of 
a 2, 3-dehydro derivative due to elimination.  
 
Scheme 4.2 Typical sialylation reaction 
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 To be summarized, the accomplishment of sialylation reactions in high yields with 
excellent stereoselectivity is still a challenge due to the peculiar structure of sialic acid: 
1. No neighboring C-3 functionality that can direct the stereochemical outcome of 
glycosylations; 
2. The electron withdrawing carboxylic acid at the anomeric center, which may 
favor the formation of glycal (2,3-dehydro derivative); 
3. Sterically hindered C-2 position that blocks the approach to the hydroxyl group of 
an acceptor. 
To address these problems alternative chemical methodologies and strategies focusing on 
the structure of sialyl donor have been developed in the field, primarily focusing on 
solvent, leaving groups and promoters. The introduction of participating auxiliaries at the 
C-3 position (indirect method) also has been investigated.
6,
 
7
 In addition, modifications of 
the C-1 carboxyl group
8,
 
9
  as well as modification of C-5 acetamido group,
10,11,12
 have 
been reported as alternative strategies to optimize chemical sialylation. Among these, C-5 
modifications have been probably the most exploited. N-acetylacetamido (NAc2) 
10
, azido 
(N3)
13
, N-trifluoroacetyl (NHTFA)
14
, N-trichloroethoxycarbonyl (NHTroc)
15
, 5-N,4-O-
oxazolidinone
16
 and its N-acetylated version
11
 are the common C-5 structural 
modifications available in the area. 
.  
Figure 4.3 modifications of C-5 acetamido group 
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Herein we are interested in 5,4-N,O-oxazolidinone protected sialosides which are 
generally considered more reactive than N-acetylacetamido derivative but slightly lower 
than the corresponding N-trifluroacetamido derivative (NTFA). It has also demonstrated 
that the oxazolidinone fused ring enhances the stereoselectivity of glycosylation reactions 
with the large number of acceptors.  Thus 5,4-N,O-oxasolidinine donors are established 
as a versatile intermediate for the stereoselective synthesis of a (2, 3) and a (2, 6)-linked 
sialosides.  
 
4.3 Effect of C-5 modification (5,4-N,O-oxazolidinone) on the reactivity 
of sialyl donors 
 
4.3.1 Comparative studies with neutral sugars 
4.3.1.1 Comparative studies with glucose 
To complement classic armed-disarmed theory, our recent studies revealed that certain 
mixed protecting group patterns of neutral sugars can significantly affect reactivity of 
building blocks in glycosylation (detailed discussion on chapter 1-3). Thus the discovery 
of superarmed glycosyl donors
17,18,19
. which along with an earlier discovery of O-2/O-5 
cooperative effect in glycosylation (superdisarmed donors)
20
 created an excellent toolkit 
for expeditious oligosaccharide synthesis. Superarmed glycosyl donors are more reactive 
than the traditional armed donors and Superdisarmed donors even less reactive than 
additional disarmed donors as shown in Figure 4.4. Certain observations of the reactivity 
have already been made with building blocks of other.
17,21 It is well known that deoxy 
sugars are much more reactive than the corresponding neutral sugars. Furthermore, the 
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acidic sugars (uronic acids) are much less reactive than their neutral counterparts. To this 
end the reactivity of glycosyl donors derived from sialic acids has been deemed low in 
comparison to the neutral sugars (galactose).  Recent advances in the field discovered 
modified sialic acid donors (Figure 4.3) which are significantly more reactive than classic 
sialosyl donors (NAc). It is still remains uncertain how their reactivity would compare to 
neutral sugars. 
 
Figure 4.4 Reactivity sequences of neutral sugars (glucose) 
 
We would like to address this challenge by investigating the relative reactivities of 5-N-
4-O-oxazolidinone protected phenylthio donor and neutral sugars through comparative 
glycosidations. We have synthesized 5,4-N,O-oxazolidinone protected phenylthio donor 
4.8
16
 and the serious of glucose donors (4.4-4.7) by the well-known procedures. It is 
important to note, that in order to easily differentiate among the reactivity levels of the 
various substrates, the choice of activator (promoter) is key. Thus upon investigating a 
range of activators we selected N-iodosuccinimide (NIS) and triflic acid to be the most 
suitable promoter. As such, the results of the NIS/ TfOH mediated glycosylations in 1, 2-
dichloroethane are summarized in Table 4.1. These comparative glycosylations were 
performed in acetonitrile at -40 
oC which are the established conditions for a better α-
stereoselectivity (kinetic product) and good yields
16
. Glycosylation of the 5,4-N,O-
oxazolidinone protected donor 4.8 
22
 with glycosyl acceptor 4.9 proceeded smoothly and  
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Table 4.1 Comparative glycosylation studies of 5,4-N,O-oxazolidinone donor 4.8 with 
neutral sugars (glucose) 
Entry Donor Acceptor Temp/Time Disaccharide Yield/Ratio 
1 
  
 
-40 
o
C/ 
30 min 
 
 
99% 
(16.0:1) 
2 
 
 
4.9 
 
-40 
o
C/ 
5 min 
 
 
85% 
(β only) 
3 
 
 
4.9 
 
-40 
o
C/ 
10 min 
 
 
83% 
(1:7.4) 
4 
 
 
4.9 
 
-40 
o
C/ 
30 min 
 
 
88% 
(β only) 
5 
 
 
4.9 
 
-40 
o
C/ 
2 days 
 
 
80% 
(1:12.0) 
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was completed in 30 minutes affording the corresponding disaccharide 4.10 in 99% yield 
with very good α selectivity (Entry 1, Table 4.1). Then the reactions of the superarmed, 
armed, disarmed and superdisarmed glycosyl donors (4.4 - 4.7 respectively) with 
glycosyl acceptor 4.9 were set up under essentially the same reaction conditions in order 
to compare the reactivities. As expected our superarmed donor 4.4
23
 reacted nearly 
instantaneously, to provide disaccharide 4.11 in 85% yield with β stereoselectivity due to 
the participating group at C-2 position (Entry 2). Glycosylation of armed donor 4.5
24 
with the acceptor 4.9 proceeded smoothly within 10 minutes to afford the disaccharide 
4.12 in 83% yield and good α-stereoselectivity due to the solvent effect. However, the 
disarmed donor 4.6
25 
showed the same reactivity as the sialyl donor 4.4 to afford the 
disaccharide 4.13 in 88% yield (Entry 4). Interestingly the superdisarmed donor 4.7 was 
clearly less reactive than the sialyl donor 4.4 and obtained 80% of the corresponding 
disaccharide 4.14 within 2 days (Entry 5). According to these comparative glycosylation 
experiments, it is clear that the 5,4-N,O-oxazolidinone protected sialyl donor 4.8 is more 
reactive than the superdisarmed donor 4.7 in the glucose serious, While showing similar 
reactivity to the disarmed donor 4.6
25 these reaction conditions. 
 
4.3.1.2 Competitive glycosylations 
As a verification of these results, we also deemed it necessary to carry out a series of 
competitive glycosylations, wherein both the superdisarmed donor and sialyl donor 
(4.7and 4.8 respectively), would be placed in the same reaction vessel with the glycosyl 
acceptor 4.9.    Upon addition of the promoter (NIS/TfOH) at -40 
o
C, the two glycosyl 
donors would then compete to react with the one equivalent glycosyl acceptor 4.9. As 
depicted in Scheme 4.3, the 5-N-4-O-oxazolidinone protected glycosyl donor 4.8 was 
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clearly significantly more reactive than its superdisarmed glucose analogue 4.7 and led to 
the formation of the corresponding disaccharide 4.10 which contained trace amount of 
disaccharide 4.14 
26
 for a combined yield of 95%. In addition, the unreacted glycosyl 
donor 4.7 was recovered in 96% yield. 
 
Scheme 4.3 Competitive glycosidations of glycosyl donors 4.7 and 4.8 with glycosyl 
acceptor 4.9 in the presence of NIS/TfOH 
 
4.3.1.3 Comparative studies with galactose 
Having compared the reactivity with glucose donors, our attention turned to the 
comparative studies of 5,4-N,O-oxazolidinone protected sialyl donor with galactose 
moieties. It is well known that galactose sugars are more reactive than their glucose 
counterparts and N-acetylneuraminic acid is less reactive than galactose. Therefore the 
reactivity comparison between 5,4-N,O-oxazolidinone protected sialyl donor and 
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galactose sugars are equally important for the establishment of the reactivity of C-5 
modified sialyl donors. Investigation into the reactivity of 5,4-N,O-oxazolidinone 
protected sialyl donor 4.8 with superdisarmed galactose donor 4.15 
27
 in a similar fashion 
to that of our competitive studies with the superdisarmed glucose moiety.  
 
Scheme 4.4 Competitive glycosidations of glycosyl donors 4.8 and 4.15 with glycosyl 
acceptor 4.9 in the presence of NIS/TfOH 
 
As seen in Scheme 4.4, upon addition of the promoter (NIS/TfOH) at -40 
o
C, the two 
glycosyl donors (4.8 and 4.15) would compete to react with the one equivalent glycosyl 
acceptor 4.9. Form the results of that experiment the 5,4-N,O-oxazolidinone protected 
glycosyl donor 4.8 was clearly significantly more reactive than its superdisarmed 
galactose analogue 4.15 as well. It led to the formation of the corresponding disaccharide 
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4.10 which contained trace amount (~10%) of disaccharide 4.16 for a combined yield of 
60%. In addition, the unreacted glycosyl donor 4.15 was recovered in 76% yield. 
 
4.3.2 Rationalization 
Overall, the results of these investigations strongly suggest that the 5,4-N,O-
oxazolidinone protected sialyl donor is more reactive than the superdisarmed glucose and 
galactose counterparts. This is evident that the C-5 modifications can enhance the 
reactivity of sialyl donors and it will be very important synthetic targets towards the 
biologically important sialylations. 
 
4.4 Study of the C-5 modification effect on the stereoselectivity 
 
Having investigated the effect of C-5 modifications on reactivity of sialosides we 
subsequently turned our attention towards the stereoselective synthesis of sialosides 
through the use of C-5 modifications. From the first modification as N-acetylacetamido 
and N-trifluoroacetamido by Boons et al.;
14
 to the azido modification by Wong; to the 
oxazolidinone trans-fused ring and its N-acetyl derivative, investigated by Tahakashi, De 
Meo and Crich, it has been a general belief that C-5 modifications can dramatically 
improve the synthesis of α-sialosides. Thus, we were extremely intrigued by coming 
across a modification as N-benzoyl acetamido that led to the unnatural β-anomer in all of 
the sialylations reactions tested with per-benzoylated donor 4.17, as reported by Ye et 
al.
12
  The use of per-benzoylated donor, which is not so common in sialic acid chemistry, 
raises the question if it is the C-5 modification or rather the presence of O benzoyl groups 
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that actually lead to the β stereoselectivity. To answer this question we synthesized 
serious of sialyl donors 4.17 and 4.18-4.20 which are benzoylated only at C-5 with 
different leaving groups and primary glycosyl acceptors for initial screening experiments 
(Figure 4.5). 
 
Figure 4.5.  Sialyl donors and primary glycosyl acceptors for initial screening. 
 
In fact, the coupling between per-benzoylated S-tolyl (STol) sialyl donor 4.17 with 
glycosyl acceptor 4.9 and 4.21 led to high yields of the β-anomer in the presence of 
different promoters (Table 4.2, Entries 1 and 2). Sialosyl donors 4.17 to 4.20 were 
coupled with acceptors 4.9 and 4.21 under various reaction conditions.  The reactions 
performed in acetonitrile were carried out at -40 ºC, while the reactions in 
dichloromethane were performed at -72 ºC.  Each reaction was performed using 
NIS/TfOH as promoter and in the presence of molecular sieves 3Å in order to minimize 
hydrolysis. It is noteworthy to mention that the introduction of a benzoyl group at C-5 
creates two rotamers at the C-5-N bond. Hence in order to achieve high resolution of 
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signals, all 
1
H NMR spectra were recorded at 80 
o
C in DMSO, whereas spectra recorded 
at -40 
o
C clearly show two distinctive groups of signals corresponding to each rotamer.  
 
Table 4.2 Comparison of donors 4.18-4.20 with donor 4.17 by coupling with acceptor 4.9 
and 4.21. 
 
 
Entry Donor Acceptor Conditions Product Yield Ratio 
(α:β) 
 
1 
 
4.17 
 
4.9 
 
 
 
A 
 
4.22a 
 
86 
 
1:6.7 
2 4.17 4.21 4.23a 90 β 
3 4.18 4.9 4.22b 62 2.0:1 
4 4.18 4.21 4.23b 86 1.0:1 
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The initial comparative testing of sialosyl donors 4.17-4.20 with glycosyl acceptors 4.9 
and 4.21 (1.5 equiv.) were performed using the conditions A and B. These comparative 
studies clearly show that while per-N,O-benzoylated donor 4.17 provides superior β-
selectivity (Entries 1 and 2), partially benzoylated STol donor 4.18,  SPh donor 4.20 and 
SMe donor  4.19 showed significantly lower preference for the beta-sialylation.(Table 
4.2). Since a vast majority of chemical sialylations are performed in CH3CN, and the 
solvent effect is known to be the most significant factor to obtain high α stereoselectivity 
in sialylations, we decided to investigate whether the participating solvent can 
significantly impact the stereoselectivity of these sialylation reactions. Under the reaction 
condition B (in the presence of participating solvent) sialosyl donor 4.17 again showed 
5 4.19 4.9 4.22b 64 5.8:1 
6 4.19 4.21 4.23b 85 1.7:1 
7 4.20 4.9 4.22b 65 1:1.2 
8 4.20 4.21 4.23b 70 1.0:2 
9 4.17 4.9 
 
 
 
B 
4.22a 94 1:1.8 
10 4.17 4.21 4.23a 95 1:1.6 
11 4.18 4.9 4.22b 75 1.7:1 
12 4.18 4.21 4.23b 80 1.3:1 
13 4.19 4.9 4.22b 74 1.4:1 
14 4.19 4.21 4.23b 86 1.0:1 
15 4.20 4.9 4.22b 75 1.4:1 
16 4.20 4.21 4.23b 79 1.2:1 
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more β selectivity (Entries 9, 10). However, other partially benzoylated donors (4.18-
4.20) did not observe that trend (Entries 11-16).  According to these results we do not see 
any trend of getting good β stereoselectivity due to the C-5 modification (NAcBz). We 
only observed good β stereoselectivity with the per-benzoylated donor 4.17.  
Having investigated the effect of primary acceptors, we turned our attention to the 
secondary hydroxyl acceptors to get the broader view of this effect. Partially protected 
galactoside acceptor 4.24
28
 was selected for these studies. As reported by Ye et al.,
12
 
again we observed pure β-selectivity with of the per-benzoylated donor 4.17 (Entry 1, 
Table 4.3). However, as expected we did not see considerable selectivity of partially 
benzoylated donor 4.18 and 4.20 with the secondary acceptor 4.24. Donor 4.18 gave 1:1 
and donor 4.20 gave 1.8:1 mixtures of diastereomers (Entries 2 and 3, respectively). 
These observations follow the same trend observed with the coupling of primary 
acceptors (Table 4.2). 
 
4.5. Conclusion 
 
Based on these sialylation experiments performed with modified donors, it is very clear 
that there is no direct effect on C-5 modification (NAcBz) itself on the stereoselectivity 
of sialosides.  However, bulky O-protecting group manipulations at O-4 and at the 
glycerol chain might be an important factor. The nature of this effect is uncertain, and it 
can be steric, electronic or a combination of both. To our knowledge, no systematic study 
of O-modifications has been reported for sialyl donors, and resultantly the impact of such 
modifications on the stereoselectivity of sialylations is yet unknown. To fill this gap, the 
Premathilake, Hemali D., UMSL, p.140 
 
investigation of the effect of O-substitution on the stereoselectivity of sialosides is 
ongoing in our laboratory. 
 
Table 4.3 Comparison of donors 4.18 and 4.20 with donor 4.17 by coupling with the 
secondary acceptor 4.24 
 
 
 
*Reactions performed with 2 equivalent of acceptor 
  
Entry Donor Yield* Ratio (α:β) 
1 4.17 52 β only 
2 4.18 57 1.0:1 
3 4.20 85 1.8:1 
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4.6 Experimental 
 
General remarks. Column chromatography was performed on silica gel 60 (EM Science, 
70-230 mesh) and size exclusion column chromatography was performed on Sephadex 
LH-20 (MeOH-CH2Cl2, 1:1, v:v elution). Reactions were monitored by TLC on Kieselgel 
60 F254 (EM Science). The compounds were detected by examination under UV light and 
by charring with 10% sulfuric acid in methanol. Solvents were removed under reduced 
pressure at < 40 
o
C. CH2Cl2 and ClCH2CH2Cl were distilled from CaH2 directly prior to 
application. Anhydrous DMF (EM Science) was used as is. Methanol was dried by 
refluxing with magnesium methoxide, distilled and stored under argon. Pyridine was 
dried by refluxing with CaH2 and then distilled and stored over molecular sieves (3 Å). 
Molecular sieves (3 Å or 4 Å), used for reactions, were crushed and activated in vacuo at 
390 °C during 8 h in the first instance and then for 2-3 h at 390 °C directly prior to 
application. Optical rotations were measured at „Jasco P-1020‟ polarimeter. 1H-n.m.r. 
spectra were recorded in CDCl3 at 300 MHz, DMSO at 80 
o
C and 
13
C-NMR spectra were 
recorded in CDCl3 at 500 MHz  unless otherwise noted. HR FAB-MS determinations 
were made with the use of JEOL MStation (JMS-700) Mass Spectrometer, matrix m-
nitrobenzyl alcohol, with NaI as necessary. 
 
Synthesis of glycosyl donors 
Methyl (phenyl 7,8,9-tri-O-acetyl-4,5-O,N-carbonyl-3,5-dideoxy-2-thio-D-glycero-α-
D-galacto-non-2-ulopyranoside)onate (4.8). Analytical data for the title compound was 
essentially the same as previously reported. 
16
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Phenyl  2-O-benzoyl-3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (4.4). Analytical 
data for the title compound was essentially the same as previously reported.
23
 
 
Phenyl  2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (4.5). Analytical data for 
the title compound was essentially the same as previously reported.
24
 
 
Phenyl  2,3,4,6-tetra-O-benzoyl-1-thio-β-D-glucopyranoside (4.6). Analytical data for 
the title compound was essentially the same as previously reported.
25
 
 
Phenyl  3,4,6-tri-O-benzoyl-2-O-benzyl-1-thio-β-D-galactopyranoside (4.15). 
Analytical data for the title compound was essentially the same as previously reported.
27
 
 
Methyl (p-methylphenyl 5-acetamido-4,7,8,9-tetra-O-benzoyl-5-N-benzoyl-3,5-
dideoxy-2-thio-D-glycero-β-D-galacto-non-2-ulopyranoside)onate (4.17).  Analytical 
data for the title compound was essentially the same as previously reported. 
12
 
 
Methyl (p-methylphenyl 5-acetamido-4,7,8,9-tetra-O-acetyl-5-N-benzoyl-3,5-
dideoxy-2-thio-D-glycero-β-D-galacto-non-2-ulopyranoside)onate (4.18). To a stirring 
solution of methyl (p-methylphenyl 5-acetamido-3,5-dideoxy-2-thio-D-glycero-β-D-
galacto-non-2-ulopyranoside)onate
29
 (1.5 g, 2.51 mmol) and 4-dimethylaminopyridine 
(0.09 g, 0.75 mmol) in pyridine (10 mL) at 0 
o
C, was added drop wise benzoyl chloride 
(0.58 mL, 5.02 mmol). The reaction was allowed to stir under argon for 15 minutes, upon 
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which it was allowed to warm to 60 
o
C and continued stirring for 6 hours. The reaction 
was then cooled to 0 
o
C, quenched with dry MeOH (0.15 mL), and concentrated in vacuo. 
The residue was then diluted with CH2Cl2 (50 mL) and washed successively with water 
(20 mL), 1N aq. HCl (20 mL), water (3× 20 mL), dried over MgSO4, and concentrated in 
vacuo. The residue was purified by column chromatography on silica gel (acetone-hexane 
gradient elution) to afford compound 4.18 in 90% yields. Analytical data for 4.18: Rf = 
0.46 (acetone/hexane, 2/3 v/v); 
1
H NMR (500 MHz, DMSO-d6, 80 
o
C) δ 7.66 (m, 3H; 
Ar), 7.56 (t, J1 = 4.6 Hz, J2 = 4.4 Hz, 2H; Ar), 7.35 (d, J = 4.9 Hz, 2H; Ar), 7.19 (d, J = 
4.8 Hz, 2H; Ar), 5.88 (dt, J3e,4 = 2.8 Hz, J3a,4 = J4,5 = 6.2 Hz, 1H; H-4), 5.40 (dd, J5,6 = 6.1 
Hz, J6,7 = 1.0 Hz, 1H; H-6), 5.30 (m, 1H; H-7), 4.90 (m, 1H; H-8), 4.61 (t, J4,5 = J5,6 = 6.1 
Hz, 1H, H-5), 4.29 (dd, J8,9a = 1.8 Hz, J9a,9b = 7.3 Hz, 1H; H-9a), 4.06 (dd, J8,9b = 4.5 Hz, 
J9b,9a = 7.3 Hz, 1H; H-9b), 3.59 (s, 3H, OCH3), 2.69 (dd, J3e,3a = 8.3 Hz, J3e,4 = 2.9 Hz, 
1H, H-3e), 2.32 (s, 3H, OCH3), 2.10 (dd, J3a,3e = 8.3 Hz, J3a,4 = 6.5 Hz, 1H; H-3a), 2.09 (s, 
3H; PhCH3), 1.94 (s, 9H, 3×OCH3), 1.77 (s, 3H, OCH3)ppm. 
13
C NMR 20.9 (×2), 
21.1(×2), 21.5(×2), 38.1, 52.8, 62.5, 68.1, 68.5, 68.8, 69.6, 70..5, 72.1, 72.7,  88.5, 125.8, 
129.2 (×3), 130.0 (×3), 136.7(×2), 140.2, 168.4, 169.6, 169.9, 170.4, 170.5, 171.0, 173.6, 
ppm; HR-FAB MS [M+Na]
+
 calcd for C34H39NO13SNa
+ 
 724.2040, found 724.2023. 
 
Methyl (methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-5-N-benzoyl-3,5-dideoxy-2-thio-
D-glycero-β-D-galacto-non-2-ulopyranoside)onate (4.19). To a stirring solution of 
methyl (methyl 5-acetamido-3,5-dideoxy-2-thio-D-glycero-β-D-galacto-non-2-
ulopyranoside)onate (1.5 g, 2.51 mmol) and 4-dimethylaminopyridine (0.09 g, 0.75 
mmol) in pyridine (10 mL) at 0 
o
C, was added drop wise benzoyl chloride (0.58 mL, 5.02 
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mmol). The reaction was allowed to stir under argon for 15 minutes, upon which it was 
allowed to warm to 60 
o
C and continued stirring for 6 hours. The reaction was then 
cooled to 0 
o
C, quenched with dry MeOH (0.15 mL), and concentrated in vacuo. The 
residue was then diluted with CH2Cl2 (50 mL) and washed successively with water (20 
mL), 1N aq. HCl (20 mL), water (3 × 20 mL), dried over MgSO4, and concentrated in 
vacuo. The residue was purified by column chromatography on silica gel (acetone-hexane 
gradient elution) to afford compound 4.19 in 89% yields. Analytical data for 4.19: Rf = 
0.46 (acetone/toluene, 1/4 v/v); [α]D = +5.5 (c 1, CHCl3); 
1
H NMR (500 MHz, DMSO-
d6, 80 
o
C);  δ 7.53-7.68 (m, 5H; Ar), 5.73 (dt, J3e,4 = 2.8Hz, J 3a,4 =  J4,5 = 6.2 Hz, 1H; H-
4), 5.28 (dd, J6,7 = 0.8 Hz, J7,8 = 3.1 Hz, 1H; H-7), 5.19 (dd, J5,6 = 6.1 Hz, J6,7 = 0.8 Hz, 
1H; H-6), 5.11 (m, 1H; H-8), 4.57 (t, J4,5 = J5,6 = 6.1 Hz, 1H; H-5), 4.48 (dd, J8,9a = 1.7 
Hz, J9a,9b = 7.4 Hz, 1H; H-9a), 4.13 ( dd, J8,9b = 3.9 Hz, J9a,9b = 7.4 Hz, 1H; H-9b), 3.77 (s, 
3H; OCH3), 2.63 (dd, J 3a3e = 8.3 Hz, J3e,4 = 2.9 Hz, 1H; H-3e), 2.14 (dd, J3a,3e = 8.3 Hz, 
J3a,4 = 2.9 Hz, 1H; H-3a), 2.11 (s, 3H; SCH3), 2.04 (s, 3H; OCH3), 1.97 (s, 3H; OCH3), 
1.95 (s, 3H; OCH3), 1.92 (S, 3H; OCH3), 1.76 (S, 3H; OCH3). 
13
C NMR (300 MHz, 
CDCl3, 25 
o
C) δ 174.9, 174.1, 173.2, 170.6, 170.5, 169.4, 168.1, 136.1, 133.3, 
133.0,129.7, 129.0, 128.9, 128.6, 84.6, 76.5, 72.2, 71.2, 69.2, 68.5, 68.3,  68.1, 67.7, 62.0, 
57.0, 56.0, 52.7, 38.1, 37.7, 28.7, 27.8, 20.93, 20.9, 20.7, 11.6. HR-FAB MS [MH]
+
 calcd 
for C28H35NO13S [M+Na]
+
 648.1829 found: 648.1800. 
 
Methyl (phenyl 5-acetamido-4,7,8,9-tetra-O-acetyl-5-N-benzoyl-3,5-dideoxy-2-thio-
D-glycero-β-D-galacto-non-2-ulopyranoside)onate (4.20). To a stirring solution of 
methyl (phenyl 5-acetamido-3,5-dideoxy-2-thio-D-glycero-β-D-galacto-non-2-
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ulopyranoside)onate
30
 (1.5 g, 2.51 mmol) and 4-dimethylaminopyridine (0.09 g, 0.75 
mmol) in pyridine ( 10 mL) at 0 
o
C, was added drop wise benzoyl chloride (0.58 mL, 
5.02 mmol). The reaction was allowed to stir under argon for 15 minutes, upon which it 
was allowed to warm to 60 
o
C and continued stirring for 6 hours. The reaction was then 
cooled to 0 
o
C, quenched with dry MeOH (0.15 mL), and concentrated in vacuo. The 
residue was then diluted with CH2Cl2 (50 mL) and washed successively with water (20 
mL), 1N aq. HCl (20 mL), water (3× 20 mL), dried over MgSO4, and concentrated in 
vacuo. The residue was purified by column chromatography on silica gel (acetone-hexane 
gradient elution) to afford compound 4.20 in 88% yields. Analytical data for 4.20: Rf = 
0.48 (acetone/toluene, 1/4 v/v); [α]D = -37.7  (c 1, CHCl3); 
1
H NMR (500 MHz, DMSO-
d6, 80 
o
C) δ 1.77 (s, 3H, OCH3), 1.94 (s, 9H, 3 × OCH3), 2.12 (dd, 1H, J3e,3a = 8.3 Hz, 
J3a,4 = 1.8 Hz, H-3a),  2.72 (dd, 1H, J3e,4 = 2.9 Hz, H-3e), 3.59 (s, 1H, OCH3), 4.04 (dd, 
1H, J8,9b = 4.5 Hz, J9a,9b = 7.3Hz, H-9b), 4.30 (dd, 1H, J8,9a = 1.8 Hz, H-9a),  4.62 (t, 1H, 
J4,5 = J5,6 = 6.1 Hz, H-5), 4.92 (m, 1H, H-8), 5.31 (m, 1H, H-7), 5,45 (dd, 1H, J6,7 = 1.0 
Hz, H-6), 5.89 (dt, 1H, J3e,4 = 2.8Hz, J3a,4 = 6.1Hz, H-4), 7.387.68 (m, 10H, aromatic) 
ppm.  
13C NMR: δ: 169.6, 169.1, 135.2, 132.2, 128.4, 128.0, 127.8, 127.5, 127.3, 87.2, 
69.1, 67.3, 66.6, 61.1, 54.6, 51.4, 36.9, 19.7, 19.6 ppm. HR-FAB MS [M+Na]
+
 calcd for 
C33H37NO13SNa  710.1886 found: 710.1864. 
 
Synthesis of glycosyl acceptors 
1,2,3,4-di-O-isopropylidene-α-D-galactopyranoside (4.9). Analytical data for the title 
compound was essentially the same as previously reported. 
31
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Methyl 2,3,4-tri-O-benzyl-α-D-galactopyranoside (4.21). Analytical data for the title 
compound was essentially the same as previously reported. 
32
 
 
Methyl 2,6-di-O-benzyl-β-D-galactopyranoside (4.24). Analytical data for the title 
compound was essentially the same as previously reported. 
28
 
 
Synthesis of glycosides. 
Typical NIS/TfOH-promoted glycosylation procedure in dichloromethane. A mixture of 
glycosyl donor (0.15 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (3Å, 300 mg) in dichloromethane (1.6 mL) was cooled down to -72 
o
C 
and stirred under argon for 16 h. NIS (0.30 mmol) and TfOH (0.03 mmol) were added 
and the reaction mixture was monitored by TLC. Upon completion, the mixture was 
diluted with CH2Cl2, the solid was filtered off, and the residue was rinsed successively 
with CH2Cl2, The combined filtrate (30 mL) was washed with 10% Na2S2O3 (10 mL) and 
water (3 x 10 mL). The organic layer was separated, dried with MgSO4 and concentrated 
in vacuo. The residue was purified by silica gel column chromatography (acetone - 
dichloromethane gradient elution) to afford the corresponding oligosaccharide. 
 
Typical NIS/TfOH-promoted glycosylation procedure in acetonitrile. A mixture of 
glycosyl donor (0.15 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (3Å, 300 mg) in acetonitrile ( 1.6 mL) was cooled down to -40 
o
C and 
stirred under argon for 16 h. NIS (0.30 mmol) and TfOH (0.03 mmol)  were added and 
the reaction mixture was monitored by TLC. Upon completion, the mixture was diluted 
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with CH2Cl2, the solid was filtered off, and the residue was rinsed successively with 
CH2Cl2, The combined filtrate (30 mL) was washed with 10% Na2S2O3 (10 mL) and 
water (3 x 10 mL). The organic layer was separated, dried with MgSO4 and concentrated 
in vacuo. The residue was purified by silica gel column chromatography (acetone - 
dichloromethane gradient elution) to afford the corresponding oligosaccharide. 
 
O-(Methyl  5-acetamido-4,7,8,9-tetra-O-benzoyl-5-N-benzoyl-3,5-dideoxy-D-glycero-
D-galacto-non-2-ulopyranosylonate)-(26)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose (4.22a). Analytical data for the title compound was essentially the same 
as previously described. 
12
 
 
O-(Methyl  5-acetamido-4,7,8,9-tetra-O-acetyl-5-N-benzoyl-3,5-dideoxy-D-glycero-
D-galacto-non-2-ulopyranosylonate)-(26)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose (4.22b). Selected analytical data for 4.22b: Rf = 0.57 
(acetone/dichloromethane, 1/19, v/v); 
1
H NMR (500 MHz, DMSO-d6, 80 
o
C) δ 7.53-7.65 
(m, 5H; Ar), 5.44 (d, J1,2 = 4.9 Hz, 1H; H-1), 5.23 (m, 1H; H-7‟), 5.18 (m, 1H, H-8‟), 
4.79 (dd, 1H; H-3), 4.59-4.57 (m, 2H; H-2, H-4), 4.32-4.30 (m, 2H; H-5‟, H-9a‟), 4.12 
(dd, J8,9b = 3.4 Hz, J9a,9b = 7.3 Hz, 1H; H-9b‟), 3.81 (s, 3H, COOCH3), 3.73-3.77 (m, 2H; 
H-5, H-6a), 3.61 (dd, J5,6b = 3.7 Hz, J6a,6b = 6.0 Hz, 1H, H-6b), 2.76 (dd, J4,3e = 3.0 Hz, 
J3a,3e = 7.7 Hz, 1H, H-3e), 2.12 (s, 3H), 2.00 (s, 3H), 1.92 (S, 3H), 1.76 (s, 3H), 1.46 (S, 
3H), 1.30-1.35 (m, 15H ). 
13
C NMR (500 MHz, DMSO-d6, 25 
o
C) ; 19.0, 20.6, 20.8, 
24.3, 24.8, 25.8, 28.4, 52.8, 66.5, 69.9, 95.4, 98.1, 99.6, 107.7, 108.4, 128.6, 128.7, 129.2, 
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129.6, 167.5, 169.8, 170.0,177.7 ppm; HR-FAB MS [M+Na]
+
 calcd for C39H51NO19Na
+ 
 
860.2955, found 860.2947. 
 
Methyl O-(methyl  5-acetamido-4,7,8,9-tetra-O-benzoyl-5-N-benzoyl-3,5-dideoxy-D-
glycero-D-galacto-non-2-ulopyranosylonate)-(26)-2,3,4-tri-O-benzyl-α-D-
galactopyranoside (4.23a). Analytical data for the title compound was essentially the 
same as previously described. 
12
 
 
Methyl O-(methyl  5-acetamido-4,7,8,9-tetra-O-acetyl-5-N-benzoyl-3,5-dideoxy-D-
glycero-D-galacto-non-2-ulopyranosylonate)-(26)-2,3,4-tri-O-benzyl-α-D-
galactopyranoside (4.23b). Selected analytical data for 4.23b: Rf = 0.61 
(acetone/dichloromethane, 1/9, v/v); 
1
H NMR (500 MHz, DMSO-d6, 80 
o
C) δ 7.30-7.68 
(m, 20H; aromatic), 5.20 (m,1H, H-4‟), 4.46-4.60 (m, 2H; H-6‟, H-8‟), 4.29 (dd, J8,9a = 
3.0 Hz, J9a,9b = 12.2 Hz, 1H; H-9a‟), 3.76 (s, 3H; COOCH3), 3.32 (s, 3H; OCH3), 
2.75(dd, J4,3e = 5.2 Hz, J3a,3e = 13.0 Hz, 1H, H-3‟eα), 2.59(dd, J4,3e = 5.0 Hz, J3a,3e = 13.0 
Hz, 1H, H-3‟eβ) ppm. 13C NMR (500 MHz, DMSO-d6, 25 oC) 20.4, 20.6, 20.7, 20.8, 
20.9, 27.1, 52.7, 52.9, 54.2, 54.6, 55.1, 55.3, 56.2, 61.4, 61.6, 63.4, 66.6, 66.7, 66.9, 67.6, 
68.6, 68.7, 69.0, 70.1, 71.5, 71.6, 73.9, 74.3, 74.6, 75.3, 75.6, 75.77.9, 97.3, 97.6, 98.2, 
98.3, 98.4, 100.8, 127.4, 127.5, 127.6, 127.7, 127.8, 127.9, 128.0, 128.1, 128.2, 128.3, 
128.4, 128.6, 128.7, 129.2, 129.5, 131.0, 131.7, 133.4, 135.4, 135.9, 136.0, 138.8, 138.9, 
166.7, 167.5, 169.3, 169.4, 169.5, 169.7, 169.8, 170.0, 170.1, 173.0, 173.1, 174.1, 174.3, 
174.5 ppm;HR-FAB MS [M+Na]
+
 calcd for C55H63NO19Na
+ 
1064.3984, found 
1064.3917. 
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Methyl O-(methyl  5-acetamido-4,7,8,9-tetra-O-benzoyl-5-N-benzoyl-3,5-dideoxy-D-
glycero-D-galacto-non-2-ulopyranosylonate)-(23)-2,6-di-O-benzyl-β-D-
galactopyranoside (4.25a). Analytical data for the title compound was essentially the 
same as previously described. 
12
 
 
Methyl O-(methyl  5-acetamido-4,7,8,9-tetra-O-acetyl-5-N-benzoyl-3,5-dideoxy-D-
glycero-D-galacto-non-2-ulopyranosylonate)-(23)-2,6-di-O-benzyl-β-D-
galactopyranoside (4.25b). Analytical data for the title compound was essentially the 
same as previously described.
27
 
 
6-O-(2-O-Benzoyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl)-1,2:3,4-di-O-
isopropylidene-α-D-galactopyranose (4.11).  Analytical data for the title compound was 
essentially the same as previously described. 
33
 
 
6-O-(2,3,4,6-Tetra-O-benzoyl-β-D-glucopyranosyl)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranose (4.13). Analytical data for the title compound was essentially the same 
as previously described. 
34
 
 
6-O-(2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl)-1,2:3,4-di-O-isopropylidene-α-D-
galactopyranoside (4.12). Analytical data for the title compound was essentially the 
same as previously described. 
35
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CHAPTER 5 
 
2-Allylphenyl glycosides as complementary 
building blocks for oligosaccharide and 
glycoconjugate synthesis 
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5.1 Introduction 
 
Current knowledge about the key roles of carbohydrates is still limited.  However, thanks 
to the explosive growth of the field of glycobiology in recent years, we have already 
learned that carbohydrates are involved in a broad range of vital biological processes (e.g., 
fertilization, anti-inflammation, immunoresponse, joint lubrication, antigenic 
determination).
1
  Carbohydrates are also involved in many harmful processes (e.g., 
bacterial and viral infections, development of tumors, metastasis, tissue rejection, 
congenital disorders).  The fact that many of these processes are directly associated with 
pathogenesis of deadly diseases including AIDS, cancer, pneumonia, septicemia, 
hepatitis and malaria
2-4 
has been particularly stimulating for major scientific efforts in the 
field of modern glycosciences. The development of novel and efficient methodologies to 
construct the glycosydic bond has gained an immense attention in the field. Most of the 
efforts have focused on the invention of new glycosyl donors, the discovery of reagent 
combinations for their activation, and the applications in experditious oligosacchaaride 
synthesis.  
 
5.1.1 Orthogonal activation strategy 
Traditional chemical assembly of oligosaccharides is lengthy because it involves multiple 
protecting and/or leaving group manipulations between glycosylation steps.
5
 Many 
advanced strategies that streamline the oligosaccharide assembly by minimizing or even 
eliminating additional manipulations between coupling steps are based either on 
chemoselective or on selective activation of leaving groups.
6
  The use of selective 
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activation
7
 offers more flexibility than that of the chemoselective activation that relies on 
the nature of protecting groups,
8
 and Ogawa‟s orthogonal strategy is conceptually the 
most attractive strategy developed to date.
9-12
  This technique implies the use of two 
orthogonal leaving groups, LGa and LGb, selective activation of which can be reiterated 
to give streamlined access to oligosaccharide sequences (Scheme 5.1).  
 
Scheme 5.1. Outline of the orthogonal strategy introduced by Ogawa et al.
[9] 
 
Yet, the orthogonal strategy remains somewhat underdeveloped with too few known 
examples to become universally applicable. Only the original Ogawa‟s S-phenyl (SPh) vs. 
fluoride
9,10,13 
and thioimidate-based approaches
14-16 
developed by our group are known. A 
very good promice of orthogonality was shown for O-pentenyl vs. O-propargyl 
glycosides by Hotha et al.
17
 and for S-glycosyl O-methyl phenylcarbamothioate (SNea) 
vs. thioglycosides/thioimidates by our group.
18
  There approaches, however, still remain 
underdeveloped to clearly state their utility for multi-step syntheis.  Working to expand 
this concept, our group reported a related, albeit less flexible, semi-orthogonal approach 
with the use of S-ethyl (SEt) and O-pentenyl leaving groups,
19
 which was extended to 
fluoride/O-pentenyl combination by Fraser-Reid and Lopez.
20
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5.1.2 Involvement of oxygen based and sulfer based leaving groups in orthogonal 
stratergy 
Oxygen
21
 and sulfur-based
22
 leaving groups have found broad application in synthesis 
and fit into many expeditious strategies.
6
  However, suitable reaction conditions for 
orthogonal activation of these two classes leaving groups are yet to be found.  Commonly, 
O-glycosides are too stable to be used as effective glycosyl donors.
21
  Pent-4-enyl O-
glycosides introduced by Fraser-Reid are unique in this category of leaving groups 
because they can be glycosidated under mild conditions using I
+ 
generated in situ.  Being 
a distinguishing feature of these O-glycosyl donors, these activation conditions also 
represent a noticeable limitation of this leaving group in the context of oligosaccharide 
synthesis.  That is because no other promoters for O-pentenyl activation are known, and 
since I
+
 can also activate thioglycosides, only a semi-orthogonality of O-pentenyl and SEt 
leaving groups could be established.
19
 Additionally, 4-pentenol is rather expensive 
($323/50g, Aldrich), and although O-pentenyl can be introduced from the anomeric 
acetate directly, the most economical synthesis includes three-step protocol – halide, 
orthoester, and the rearrangement of the latter to glycoside.   
 
5.2 Investigation of new O-based leaving group: ortho-allylphenyl (AP) 
leaving group 
 
As a part of the ongoing research effort in our laboratory to develop versatile building 
blocks for chemical glycosylation and expeditious oligosaccharide synthesis, presented 
herein is the development of a new ortho-allylphenyl (AP) leaving group.  This leaving 
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group was specifically designed with the purpose to address drawbacks of the O-pentenyl 
leaving group and to create a more flexible and economical approach both for 
glycosylation and for oligosaccharide synthesis.  The following considerations were of 
particular relevance to aid in our design.  First, chemists have been making aryl 
glycosides for some 130 years,
23
 and many excellent protocols for their synthesis are 
available.
24
  Indeed, we determined that AP glycosides can be readily obtained from the 
corresponding per-acetate using inexpensive 2-allylphenol ($35/100g, Aldrich) in the 
presence of BF3-Et2O.  For instance AP β-D-glucopyranoside was obtained in 92% yield 
(Scheme 5.2). 
 
Scheme 5.2 Synthesis of the ortho-allylphenyl analogues 
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Second, we anticipated that promoters used for O-pentenyl activation
25
 can also activate 
the AP leaving group.  However, since AP glycosides bear structural features of both aryl 
and pentenyl glycosides they would offer a more versatile activation profile than either 
class of the leaving group (Scheme 5.3).   
 
5.3 Activation pathways of AP glycosides 
 
Our working hypothesis is that activation of the AP leaving group with I
+
 takes place via 
the formation of epi-iodonium ion, which is then opened with the anomeric oxygen, 
similarly to that known for O-pentenyl glycosides.
25
  It is possible that the activation of 
AP can be also achieved with Lewis acids, such as TMSOTf.  This activation pathway, 
typical for aryl glycosides, is expected to become the key feature of the AP-mediated 
glycosylation approach because Lewis acids alone neither can activate O-pentenyl nor 
thioglycosides.  Resultantly, this pathway may offer a suitable platform for developing a 
fully orthogonal approach in combination with thioglycosides that was not feasible for O-
pentenyl glycosides. 
 
Scheme 5.3.  Anticipated pathways for activation of AP glycosides in glycosidation 
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5.3.1 Glycosylations of ortho-allylphenyl donor under different conditions 
To pursue this concept we obtained a range of differently protected AP glucosides 
including per-benzylated 5.1a, per-benzoylated 5.1b (Section I, Scheme 5.2), and 
derivative 5.1c (Section II) equipped with the superarming protecting group pattern (2-
benzoyl-3,4,6-tribenzyl).
26
  For comparison, we also obtained AP donors of the D-galacto 
derivative  5.1d (Section III).  With glycosyl donors 5.1a-d in hand, we began evaluating 
their applicability to chemical glycosidation using a range of standard glycosyl acceptors 
5.2-5.5.
18
 Aryl glycosides show high propensity towards hydrolysis that may occur as the 
main side reaction to glycosylation. Therefore, particular care was taken to ensure strictly 
anhydrous reaction conditions, which is a common requirement for most glycosylations. 
Encouragingly, reaction of glycosyl donor 5.1a with the primary glycosyl acceptor 5.2 in 
the presence of TMSOTf was completed in 15 min and provided the corresponding 
disaccharide 5.6a in 82% yield (Table 5.1, entry 1).  Expectedly, when a control 
experiment was set up with MeOTf, no glycosidation of 5.1a took place (Entry 2).  The 
fact that the AP leaving group in 5.1a can be activated with TMSOTf, but not with MeOTf 
offers a basis for exploring its orthogonality with thioglycosides. This is because 
thioglycosides show completely opposite reactivity trend under these activation 
conditions: no reaction with TMSOTf and smooth glycosidation with MeOTf.
27
 
N-Iodosuccinimide (NIS) in combination with TMSOTf is a very powerful promoter 
system for the activation of both O-pentenyl and thioglycosides.  It was also found 
effective for the activation of AP glycosyl donor 5.1a, upon which disaccharide 5.6a was 
obtained in 80%.  Even faster reaction and higher yield was obtained using NIS/TfOH 
promoter system, wherein the resulting disaccharide 5.6a was obtained in 90% yield 
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(Entry 4).  The latter reaction conditions were chosen to investigate glycosylation of the 
secondary glycosyl acceptors 5.3-5.5.  These couplings were also proven feasible, and the 
corresponding disaccharides 5.7a-5.9a were obtained in 72-82% yield (Entries 5-7). 
Having investigated the reactivity of per-benzylated (armed) glycosyl donor 5.1a, we 
turned our attention to testing its per-benzoylated (disarmed) counterpart 5.1b.  As 
anticipated, the reactivity of 5.1b was significantly lower than that of 5.1a, and 
particularly NIS-promoted glycosidations were proven of preparative value. Thus, the 
desired disaccharides 5.6b and 5.9b were isolated in 71-78% yield (Entries 10-12). 
Expectedly, no reaction took place in the presence of MeOTf (Entry 8); less predictably 
TMSOTf-promoted glycosidation of 5.1b was practically ineffective either (Entry 9).  
The observation that the armed AP leaving group in 5.1a can be readily activated with 
TMSOTf (Entry 1), whereas the disarmed AP leaving group in 5.1b remains inert under 
essentially the same reaction conditions suggests that AP glycosides can be applied in 
accordance with the classic armed-disarmed strategy (vide infra).
28
  
In order to develop a flexible route to the synthesis of 1,2-trans glycosides we also 
investigated AP glycosyl donor 5.1c, bearing a superarming protecting group pattern
26
 As 
expected, all previously established reaction conditions were very effective and 
glycosidation of 5.1c with acceptor 5.2 readily produced disaccharide 5.6c (Entries 13-
15). Again, particularly efficient was NIS/TfOH-promoted reaction wherein disaccharide 
5.6c was produced in 93% yield (Entry 15).  In order to broaden the scope of the AP 
glycosylation approach, we tested its applicability to the synthesis of D-galactosides and 
2-amino-2-deoxygalactosides, highly important and abundant sugar series.
29-31
 
Glycosidation of AP galactosyl donor 5.1d with glycosyl acceptors 5.2-5.5 in the 
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presence of NIS/TfOH preceded smoothly and the corresponding disaccharides 5.6d-5.9d 
were obtained in 80-85% yield (Entries 16-19).   
 
Table 5.1.  Glycosidation of AP glycosyl donors 5.1a-d with glycosyl acceptors 5.2-5.5. 
 
Entry 
Donor + 
acceptor 
Conditions
[a] 
Time 
Product 
(yield, α/β ratio) 
1 5.1a + 5.2 TMSOTf, rt 15 min 5.6a (82%, 2.7/1) 
2 5.1a + 5.2 MeOTf, rt 24 h No reaction 
3 5.1a + 5.2 NIS/TMSOTf, 0 
o
C 40 min 5.6a (80%, 1.4/1) 
4 5.1a + 5.2 NIS/TfOH, 0 
o
C 15 min 5.6a (90%, 1/1.5) 
5 5.1a + 5.3 NIS/TfOH, 0 
o
C 4 h 5.7a (73%, 1.2/1) 
6 5.1a + 5.4 NIS/TfOH, 0 
o
C 30 min 5.8a (82%, 1.0/1) 
Premathilake, Hemali D., UMSL, p.163 
 
7 5.1a + 5.5 NIS/TfOH, 0 
o
C 3 h 5.9a (72%, 1/1.3) 
8 5.1b + 5.2 MeOTf, rt 24 h No reaction 
9 5.1b + 5.2 TMSOTf, rt 24 h No reaction 
10 5.1b + 5.2 NIS/TMSOTf, 0 
o
C 6 h 5.6b (77%, β only) 
11 5.1b + 5.2 NIS/TfOH, 0 
o
C 2 h 5.6b (71%, β only) 
12 5.1b +5.5 NIS/TfOH, 0 
o
C 3 h 5.9b (78%, β only) 
13 1c + 2 MeOTf, rt 24 h No reaction 
14 5.1c + 5.2 TMSOTf, - 20 
o
C 2.5 h 5.6c (73%, β only) 
15 5.1c + 5.2 NIS/TMSOTf, 0 
o
C 10 min 5.6c (84%, β only) 
16 5.1c + 5.2 NIS/TfOH, -20 
o
C 15 min 5.6c (93%, β only) 
17 5.1d + 5.2 NIS/TfOH, 0 
o
C 15 min 5.6d (85%, 1.5/1) 
18 5.1d + 5.3 NIS/TfOH, 0 
o
C 4 h 5.7d (81%, 1.2/1) 
19 5.1d + 5.4 NIS/TfOH, 0 
o
C 30 min 5.8d (82%, 1.0/1) 
20 5.1d + 5.5 NIS/TfOH, 0 
o
C 2 h 5.9d (80%, 2.0/1) 
[a]
 performed in the presence of molecular sieves 4 Å or 3 Å (MeOTf);   
 
5.3.2 Rationalization of direct and remote activation pathways 
In order to verify the two anticipated activation pathways by which the AP group may 
depart we repeated the two key experiments wherein glycosyl donor 5.1a reacted with 
glycosyl acceptor 5.2 in the presence of TMSOTf and NIS/TMSOTf (Entries 1 and 3, 
respectively, Table 5.1).  Upon completion of the reactions, judged by the disappearance 
of 5.1a and formation of 5.6a, we separated and analyzed all components of the reaction 
mixture.  In the first reaction, (o-allylphenoxy) trimethylsilane 5.10 was isolated and its 
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identity was proven by comparison with the authentic commercial sample.  The result of 
this test reaction indicated that the activation of the AP moiety under Lewis acid 
promotion takes place via the anomeric oxygen atom (I, Pathway A, Scheme 5.4) 
similarly to that of O-aryl glycosides. 
 
Scheme 5.4.  Determination of the direct and remote activation pathways for 
glycosidation of AP glycosyl donors 
 
In the NIS/TMSOTf-promoted reaction, 2-iodomethyl-2,3-dihydrobenzofuran 5.11
32
 was 
isolated and its identity was proven by spectral methods. The result of this test reaction 
indicates that activation of the AP moiety under iodonium ion promotion takes place via 
the remote allyl moiety (J, Pathway B, Scheme 5.4) similarly to that found previously for 
O-pentenyl glycosides.
25
  In addition, in the latter experiment we detected the presence of 
adduct 5.12 that has been formed as a result of a competing attack of the glycosyl 
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acceptor oxygen as opposed to endocyclization of J via the anomeric oxygen of glycosyl 
donor leading to oxacarbenium intermediate K.  Although still remains to be confirmed, 
it is also possible that if the anomeric oxygen is too deactivated, such as in disarmed or 
superdisarmed glycosyl donors, the epi-iodonium ring would be preferentially opened by 
the intermolecular attack of glycosyl acceptor or other nucleophiles present in the 
reaction mixture. 
 
5.4 Armed-diarmed activation 
 
Results presented in Table 5.1 (compare entries 1 and 9) indicate that the reactivity of AP 
can be adjusted by varying protecting groups on the sugar ring, similar to the method 
established for O-pentenyl glycosides.
33
 Thus, in accordance with Fraser-Reid‟s armed-
disarmed approach, electronically activated (armed) glycosyl donor is chemoselectively 
activated over deactivated (disarmed) glycosyl acceptor bearing the same type of a 
leaving group.
25,33
  To explore this venue we obtained a disarmed (benzoylated) 6-OH AP 
glycosyl acceptor 5.13 (see the SI for the synthesis of all building blocks), which was 
coupled with the armed AP glycosyl donor 5.1a in the presence of TMSOTf.  As 
anticipated, this reaction was feasible and the expected disaccharide 5.14 was obtained in 
78% yield (Table 5.2, Entry 1).   
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Table 5.2.  AP glycosides in selective activations. 
 
Entry Donor + Acceptor
[a]
 Promoter
 
Time 
Product 
(yield, α/β ratio) 
1 
5.1a (LG
1
=OAP, R
1
=Bn) 
5.13 (LG
2
=OAP, R
2
=Bz) 
TMSOTf 10 min 5.14 (78%, 1.0/1) 
2 
5.1a (LG
1
=OAP, R
1
=Bn) 
5.15 (LG
2
=SEt, R
2
=Bn) 
TMSOTf 15 min 5.16 (71%, 1.0/1) 
3 
5.1a (LG
1
=OAP, R
1
=Bn) 
5.17 (LG
2
=STol, R
2
=Bz) 
TMSOTf 1 h 5.18 (75%, 4.2/1) 
4 
5.1a (LG
1
=OAP, R
1
=Bn) 
5.19 (LG
2
=SPh, R
2
=Bn) 
TMSOTf 1 h 5.20 (90%, 1.4/1) 
5 
5.1a (LG
1
=OAP, R
1
=Bn) 
5.21 (LG
2
=SPh, R
2
=Bz) 
TMSOTf 2 h 5.22 (98%, 1.8/1) 
6 
5.23 (LG
1
=SEt, R
1
=Bn) 
5.24 (LG
2
=OAP, R
2
=Bn) 
MeOTf 2 h 5.25 (82%, 1.0/1) 
7 
5.26 (LG
1
=STaz, R
1
=Bn) 
5.24 (LG
2
=OAP, R
2
=Bn) 
MeOTf 1 h 5.25 (78%, 1.0/1) 
8 
5.27 (LG
1
=STol, R
1
=Bn) 
5.24 (LG
2
=OAP, R
2
=Bn) 
MeOTf 4 h 5.25 (97%, 1.2/1) 
9 
5.28 (LG
1
=SPh, R
1
=Bn) 
5.24 (LG
2
=OAP, R
2
=Bn) 
MeOTf 6 h 5.25 (90%, 1.0/1) 
 
[a]
 Performed in the presence of molecular sieves 4 Å (TMSOTf) or 3 Å (MeOTf) at rt;   
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5.5 Orthogonal activation strategy 
 
5.5.1 Selective activation of AP glycosides 
With the ultimate goal of developing an efficient and distinct orthogonal differentiation 
of AP and thioglycosides, we next obtained acceptor 5.15 equipped with ethylthio leaving 
group. Very encouragingly, TMSOTf-promoted glycosylation between building blocks 
5.1a and 5.15 produced the expected disaccharide 5.16 in 71% yield (Entry 2).  In a 
similar fashion, glycosyl acceptors 5.17 and 5.19 equipped with S-tolyl (STol) and SPh 
leaving groups, respectively, were glycosylated with glycosyl donor 5.1a.  Resultantly, 
disaccharides 5.18 and 5.20 were obtained in 75 and 90% respective yields (Entries 3 and 
4). Also the disarmed SPh acceptor 5.21 was found quite usable in this coupling and the 
resulting disaccharide 5.22 was isolated in 98% yield. This series of experiments clearly 
demonstrates that the AP leaving group can be reliably activated with TMSOTf in the 
presence of S-alkyl/aryl leaving group. We next investigated glycosyl acceptor 5.24 
equipped with the AP leaving group. Very encouragingly, MeOTf-promoted 
glycosidation of SEt, STaz, STol, and SPh glycosyl donors 5.23,
34
 5.26,
14
 5.27,
35
 and 
5.28,
36
 respectively, with glycosyl acceptor 5.24 was uneventful, and the respective 
disaccharide 5.25 was isolated in 78-97% yield (Entries 6-9).   
 
5.5.2 Orthogonality of 2-allylphenyl and thioglycosides 
These results, along with results on selective activation of AP over thioglycosides 
acceptors (vide supra), indicate a possibly completely orthogonal character of these two 
classes of leaving groups.  To expand this observation further in the context of 
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oligosaccharide synthesis we investigated the activation of the disaccharide building 
block 5.25.  Thus, its NIS/TfOH-promoted coupling with model acceptor 5.2 resulted in 
the formation of trisaccharide 5.29 in 80% yield (Scheme 5.5).  The coupling of 
disaccharide 5.25 with thioglycoside acceptor 5.21 required a NIS-free activation 
conditions and TMSOTf-promoted reaction led to the corresponding trisaccharide 5.30 in 
90%.  Since trisaccharide 5.30 is equipped with the SPh anomeric leaving group, it is 
available for further chain elongation directly.  
 
Scheme 5.5.  Activation of AP disaccharide donor 5.25 over standard acceptor 5.2 or 
thioglycoside acceptor 5.21 (proof of orthogonality) 
 
In a similar fashion, thioglycoside disaccharide 5.16 was investigated.  Thus, its 
NIS/TfOH-promoted coupling with model acceptor 5.2 resulted in the formation of 
trisaccharide 5.29 in 89% yield (Scheme 5.6).  The coupling of disaccharide 5.16 with 
benzylated and benzoylated AP acceptors 5.24 and 5.13 required a NIS-free activation 
conditions and it was affected in the presence of MeOTf.  The resulting trisaccharides 
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5.31 and 5.32 were obtained in 50 and 80% yield.  Since these trisaccharides are 
equipped with the AP anomeric leaving group, their direct application to the further chain 
elongation can be envisaged.  
 
Scheme 5.6  Activation of thioglycoside donor 5.16 over standard acceptor 5.2 or AP 
acceptors 5.24 and 5.13 
 
We believe that the series of experiments listed in Table 5.2 and depicted in Schemes 5.4 
and 5.5, provide a convincing case of orthogonality of the AP glycosides and 
thioglycosides.  Furthermore, this study demonstrates a promising utility of the AP 
building blocks in oligosaccharide synthesis.  The application of the AP glycosides may 
stretch well beyond their initial purpose because the alkene moiety can be utilized in a 
variety of other modes.  Similar to that of O-pentenyl
25
 it can be temporarily deactivated 
toward the I
+
 activation pathway by addition of Br2, which can be reverted as needed 
(active-latent strategy).  The formation of adduct 5.12 indicates that under certain 
reaction conditions the activation of deactivated AP glycosides may result in the 
formation of useful series of neoglycoconjugates, and degradable oligosaccharide 
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mimetics.  Moreover, direct conjugation of the AP moiety to biomolecules, monolayers, 
arrays, etc., should also be possible by executing thiol-ene chemistry
37
 
ozonolysis/reductive amination
38,40
 or other ligation protocols.
41,42
 
 
5.6 Conclusion 
 
In conclusion, we investigated O-allylphenyl (AP) anomeric moiety as a new leaving 
group that can be activated for chemical glycosylation under a variety of conditions 
including Lewis acid and iodonium ion mediated reaction pathways.  The two possible 
reaction pathways for the AP moiety activation were confirmed via the extended 
mechanistic study.  We also demonstrated that the application of the AP moiety allows 
executing rapid oligosaccharide assembly via orthogonal activation concept. 
 
5.7 Experimental  
 
General remarks. Column chromatography was performed on silica gel 60 (EM Science, 
70-230 mesh), reactions were monitored by TLC on Kieselgel 60 F254 (EM Science). The 
compounds were detected by examination under UV light and by charring with 10% 
sulfuric acid in methanol. Solvents were removed under reduced pressure at < 40 
o
C. 
CH2Cl2 and ClCH2CH2Cl were distilled from CaH2 directly prior to application. 
Anhydrous DMF (EM Science) was used as is. Methanol was dried by refluxing with 
magnesium methoxide, distilled and stored under argon. Pyridine and acetonitrile were 
dried by refluxing with CaH2 and then distilled and stored over molecular sieves (3 Å). 
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Molecular sieves (3 Å or 4 Å), used for reactions, were crushed and activated in vacuo at 
390 °C during 8 h in the first instance and then for 2-3 h at 390 °C directly prior to 
application.. DOWEX MONOSPHERE 650C (H) was washed three times with MeOH 
and stored under MeOH. Optical rotations were measured at „Jasco P-1020‟ polarimeter. 
1
H-n.m.r. spectra were recorded in CDCl3 at 300 MHz, 
13
C-NMR spectra were recorded 
in CDCl3 at 300 MHz (Bruker Avance) unless otherwise noted. HRMS determinations 
were made with the use of JEOL MStation (JMS-700) Mass Spectrometer. 
 
Synthesis of glycosyl donors 
2-Allylphenyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside (B). 2-Allylphenol (1.37 
mL, 10.25 mmol), BF3-OEt2 (1.6 mL, 12.8 mmol), and triethylamine (0.36mL, 2.56 
mmol) were added to a stirring solution of 1,2,3,4,6-penta-O-acetyl-β-D-glucopyranoside 
(2.00 g, 5.13 mmol) in CH2Cl2 (40 mL). The reaction mixture was kept for 16 h at rt, then 
it was diluted with CH2Cl2 (30 mL) and washed with water (10 mL), sat. aq. NaHCO3 (10 
mL), and water (3 × 10 mL).  The organic phase was separated, dried over MgSO4, and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate/hexane gradient elution) to afford the title compound (1.9 g, 90% yield) as 
white crystals.  Analytical data for B: Rf = 0.50 (ethyl acetate - hexane, 1/5, v/v); m. p. 
145-148 
o
C (diethyl ether-hexanes); [α]D
23
 -25.8 (c = 1.0, CHCl3); 
1
H-n.m.r.: δ, 2.02 (s, 
3H, OCH3), 2.03 (s, 3H, OCH3), 2.04 (s, 3H, OCH3), 2.06 (s, 3H, OCH3), 3.23-3.38 (m, 
2H, PhCH2CH=CH2), 3.81-3.87 (m, 1H, H-5), 4.16 (dd, 1H, J = 2.5 Hz, H-6b), 4.27 (dd, 
1H, J = 5.5 Hz, H-6a), 4.95-5.05 (m, 3H, H-2, PhCH2CH=CH2), 5.12-5.19 (m, 1H; H-4), 
5.24-5.35 (m, 2H, J1,2 = 8.7 Hz, H-1,  H-3), 5.83-5.96 (m, 1H; PhCH2CH=CH2), 6.97-
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7.18 (m, 4H; aromatic) ppm. 
13
C-n.m.r.: δ, 20.7, 20.7, 20.8, 21.0, 34.0, 62.1, 68.5, 71.2, 
72.1, 72.9, 99.3, 115.4, 115.9, 123.5, 127.5, 130.0, 130.5, 136.6, 154.6, 169.3, 169.5, 
170.4, 170.7 ppm. HR-FAB MS [M+Na]
+
 calcd for C23H28O10Na
+
 487.1580, found 
487.1562. 
 
2-Allylphenyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside (5.1a). Compound B (1.00 
g, 2.16 mmol) was dissolved in methanol (8 mL) and pH was adjusted (pH 9) by careful 
addition of a 1M solution of NaOCH3 in MeOH (~0.1 mL). The reaction mixture was 
kept for 1 h at rt, then Dowex (H
+
) was added until neutral pH. The resin was filtered off 
and rinsed with methanol (3 × 5 mL). The combined filtrate (~ 30 mL) was concentrated 
in vacuo and dried. The resultant solid was dissolved in DMF (14 mL) and benzyl 
bromide (1.41 mL, 11.82 mmol) was added.  The resulting mixture was cooled to 0 
o
C 
and NaH (0.426 g, 17.74 mmol) was added portionwise.  The reaction mixture was 
allowed to gradually warm to rt.  Upon stirring for 1 h at rt, the reaction was quenched by 
stirring with ice water (50 mL). The organic phase was extracted with ethyl 
acetate/diethyl ether (1/1, v/v, 3 × 40 mL) and combined organic extract was washed with 
water (3 × 20 mL).  The organic phase was separated, dried with MgSO4 and 
concentrated in vacuo. The residue was purified by column chromatography on silica gel 
(ethyl acetate/ hexane gradient elution) to afford the title compound (1.3 g, 92%) as white 
crystals.  Analytical data for 5.1a:  Rf = 0.50 (ethyl acetate - hexanes, 1/5, v/v); m. p.  94-
97 °C (diethyl ether - hexanes); [α]D
23
 +16.7 (c = 1.0, CHCl3); 
1
H-n.m.r.: δ, 3.34-3.49 (m, 
2H, PhCH2CH=CH2), 3.54-3.55 (m, 1H, H-5), 3.60-3.76 (m, 5H, H-2, H-3, H-4, H-6a, H-
6b ), 4.43-4.54 (m, 2H, CH2Ph), 4.76-4.94 (m, 4H, 2×CH2Ph), 4.94-5.00 (m, 4H, J1,2 =7.8 
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Hz, H-1,  PhCH2CH=CH2, 1/2×CH2Ph), 5.97-6.10 (m, 1H, PhCH2CH=CH2), 6.94-7.28 
(m, 24H, aromatic) ppm; 
13
C-n.m.r.: δ, 34.3, 69.0, 73.7, 75.2, 75.3, 75.4, 76.0, 77.4, 78.0, 
82.3, 85.1, 101.5, 115.6, 116.1, 122.8, 127.6, 127.7, 127.8, 127.9 (×4), 128.0(×2), 
128.1(×2), 128.2(×2), 128.5(×2), 128.6(×3), 128.7(×2), 129.8, 130.1, 136.9, 138.2, 138.3, 
138.4, 138.7, 155.1 ppm; HR-FAB MS [M+Na]
+
 calcd for C43H44O6Na
+
 679.3036, found 
679.3058. 
 
2-Allylphenyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside (5.1b). Compound B (5.40 
g, 11.63 mmol) was dissolved in methanol (44 mL) and pH was adjusted (to pH 9) by 
careful addition of 1M solution of NaOCH3 in MeOH (~0.2 mL). The reaction mixture 
was kept for 1 h at rt, then Dowex (H
+
) was added until neutral pH. The resin was filtered 
off and washed with methanol (3 × 5 mL). The combined filtrate was concentrated in 
vacuo and dried The residue was dissolved in dry pyridine (70 mL), the mixture was 
cooled to 0 
o
C and benzoyl chloride (7.2 mL, 62.5 mmol) was added dropwise.  The 
reaction mixture was allowed to gradually warm to rt.  Upon stirring for 1 h at rt, the 
reaction was quenched by addition of methanol (5 mL). The resulting mixture was 
evaporated and co-evaporated with toluene (3× 10 mL) under reduced pressure.  The 
residue was diluted with CH2Cl2 (20 mL) and washed with water (10 mL), sat. aq. 
NaHCO3 (10 mL) and water (3×10 mL).  The organic layer was separated, dried with 
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate-hexane gradient elution) to afford the title compound (8.8 g, 
90%) as white crystals. Analytical data for 5.1b: Rf  = 0.58 (ethyl acetate - hexanes, 4/10, 
v/v);  m. p. 130-132 °C (diethyl ether - hexanes); [α]D
23
 +26.7 (c = 1, CHCl3); 
1
H-n.m.r.: 
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δ, 3.06 (d, 2H, J = 6.6 Hz, PhCH2CH=CH2), 4.18-4.26 (m, 1H, H-5), 4.39 (dd, 1H, J6a,6b = 
12.0 Hz, H-6a), 4.54-4.69 (m, 3H, H-6b, PhCH2CH=CH2), 5.26 (d, 1H, J1,2 = 6.0 Hz, H-
1), 5.50-5.64 (m, 2H, H-4, PhCH2CH=CH2), 5.77 (dd, 1H, J2,3 = 9.0 Hz, H-2), 5.90 (dd, 
1H, J3,4 = 9.5 Hz, H-3), 6.82-7.92 (m, 24H, aromatic) ppm; 
13
C-n.m.r.: δ, 34.0, 63.4, 69.9, 
71.7, 72.8, 73.0, 99.9, 115.4, 115.7, 123.4, 128.5 (×2), 128.6 (×2), 128.7 (×3), 128.8 (×2), 
128.9, 129.0, 129.3, 129.7, 129.8 (×3), 129.9 (×2), 130.0 (×2), 130.1 (×2), 130.2, 130.3, 
133.4, 133.5, 133.8, 136.4, 154.8, 165.2, 165.5, 166.0, 166.2 ppm; HR-FAB MS 
[M+Na]
+
 calcd for C43H36O10Na 735.2205 found 735.2194 
 
2-Allylphenyl 2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-glucopyranoside (5.1c). A mixture 
of 3,4,6-tri-O-benzyl-1,2-O-methoxybenzylidene- -D-glucopyranose
[1]
 (0.360 g, 0.63 
mmol), molecular sieves (4Å, 400 mg) and 2-allylphenol (0.84 mL, 6.34 mmol) in dry 
dichloromethane (3.6 mL) was stirred under argon for 10 min at rt. TMSOTf (0.03 mL, 
0.16 mmol) was added, and the resulting mixture was stirred at rt for 4 h. After that the 
reaction mixture was filtered through Celite and filtrate was diluted with dichloromethane 
(30 mL) and washed with water (10 mL), sat. aq. NaHCO3 (10 mL), and water (3 × 10 
mL).  The organic phase was separated, dried over MgSO4, and concentrated in vacuo. 
The residue was purified by column chromatography on silica gel (ethyl acetate/hexane 
gradient elution) to afford the title compound (0.120 g, 28% yield) as a white solid. 
Analytical data for 5.1c: Rf = 0.59 (ethyl acetate - hexanes, 3/10, v/v); [α]D
23
 +26.4 (c = 1, 
CHCl3); 
1
H-n.m.r: δ, 3.31 (d, 1H, J = 10.0 Hz, PhCH2CH=CH2), 3.85-4.06 (m, 5H, H-3, 
H-4, H-5, H-6a, H-6b), 4.71-5.01 (m, 8H, PhCH2CH=CH2, 3× CH2Ph),  5.21 (d, 1H, J1,2 
= 7.9 Hz, H-1), 5.76 (dd, 1H, J2,3 = 9.0 Hz, H-2), 5.79-5.89 (m, 1H, PhCH2CH=CH2), 
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7.04-8.14 (m, 24H, aromatic) ppm; 
13
C-n.m.r.: δ, 33.98, 68.99, 73.6, 73.8, 75.3, 75.4, 
75.7, 78.1, 82.9, 99.8, 115.2, 115.5, 122.9, 127.5, 127.8, 127.9, 128.0 (×2), 128.1, 128.2 
(×4), 128.4 (×3), 128.5 (×2), 128.6 (×2), 128.7 (×2), 130.0 (×2), 130.1 (×2), 133.3, 136.7, 
137.9, 138.0, 138.3, 155.2, 165.3ppm; HR-FAB MS [M+Na]
+
 calcd for C43H42O2Na 
693.2831, found 693.2834. 
 
2-Allylphenyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside (F). 2-Allylphenol (1.37 
mL, 10.25 mmol), BF3-OEt2 (1.6 mL, 12.8 mmol), and triethylamine (0.36mL, 2.56 
mmol) were added to a stirring solution of 1,2,3,4,6-penta-O-acetyl-β-D-
galactopyranoside (2.00 g, 5.13 mmol) in CH2Cl2 (40 mL). The reaction mixture was 
kept for 16 h at rt, then it was diluted with CH2Cl2 (30 mL) and washed with water (10 
mL), sat. aq. NaHCO3 (10 mL), and water (3 × 10 mL).  The organic phase was 
separated, dried over MgSO4, and concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (ethyl acetate/hexane gradient elution) to afford the 
title compound (1.8 g, 89% yield) as white crystals. Analytical data for F: Rf = 0.51 
(ethyl acetate - hexane, 2/3, v/v); m. p. 98-101 (diethyl ether - hexanes); [α]D
24
 -13.0 (c = 
1.0, CHCl3); 
1
H-n.m.r.: δ, 2.23-2.42 (m, 12H, 4 × OCH3), 3.55-3.63 (m, 2H, 
PhCH2CH=CH2), 4.33 (m, 1H, H-5), 4.40 (dd, 1H, J6a,6b = 11.3 Hz, J5,6a = 6.1 Hz, H-6a), 
4.48 (dd, 1H, J5,6b = 7.2 Hz, H-6b), 5.23 (d, 1H, J1,2 = 8.0 Hz, H-1), 5.28 (t, 2H, 
PhCH2CH=CH2), 5.36 (dd, 1H, J3,4 = 3.4 Hz, H-3), 5.70 (dd, 1H, H-4), 5.78 (dd, 1H, J2,3 
= 10.4 Hz, H-2), 6.12-6.24 (m, 1H, PhCH2CH=CH2), 7.10-7.29 (m, 4H; aromatic) ppm. 
13
C-n.m.r.: δ, 20.6, 20.7, 20.8, 20.9, 33.8, 61.5, 67.0, 68.6, 70.9, 71.0, 99.6, 115.1, 115.7, 
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123.3, 127.4, 129.8, 130.3, 136.6, 154.6, 169.3, 170.1, 170.3, 170.5 ppm. HR-FAB MS 
[M+Na]
+
 calcd for C23H28O10Na
+
 487.1580, found 487.1573. 
 
2-Allylphenyl 2,3,4,6-tetra-O-benzyl-β-D-galactopyranoside (5.1d). Compound F 
(2.00 g, 4.32 mmol) was dissolved in methanol (16 mL) and pH was adjusted (pH 9) by 
careful addition of a 1M solution of NaOCH3 in MeOH (~0.1 mL). The reaction mixture 
was kept for 1 h at rt, then Dowex (H
+
) was added until neutral pH. The resin was filtered 
off and washed with methanol (3 × 10 mL). The combined filtrate was concentrated in 
vacuo and dried. The resultant solid was dissolved in dry DMF (24 mL) and benzyl 
bromide (2.4 mL, 20.27 mmol). Then the reaction mixture was cooled down to 0 
o
C and 
NaH was added (0.73 g, 30.41 mmol) portion wise. The reaction mixture was allowed to 
gradually warm up. Upon stirring for 1 h at rt, the reaction was quenched by stirring with 
ice water (50 mL). The organic phase was extracted with ethyl acetate/diethyl ether (1/1, 
v/v, 3 × 40 mL) and combined organic extract was washed with water (3 × 20 mL). The 
organic phase was separated, dried with MgSO4 and concentrated in vacuo. The residue 
was purified by column chromatography on silica gel (ethyl acetate/ hexanes gradient 
elution) to afford the title compound (2.6 g, 98%) as white solid. Analytical data for 5.1d:  
Rf = 0.80 (ethyl acetate - hexanes, 2/3, v/v); [α]D
24
 -22.3 (c = 1.0, CHCl3); 
1
H-n.m.r.: δ, 
3.39-3.50 (m, 2H, PhCH2CH=CH2), 3.60-3.71 (m, 4H, H-3, H-4, H-6a, H-6b), 3.97 (m, 
1H, H-5), 4.15 (dd, 1H, J2,3 =8.3 Hz, H-2), 4.43 (dd, 2H, J
2
 = 11.6 Hz, CH2Ph), 4.66 (d, 
1H, J
2
 = 8.4 Hz, ½ × CH2Ph), 4.72-4.80 (s, 2H, CH2Ph), 4.88-5.05 (m, 6H, J1,2 = 7.8 Hz, 
H-1, PhCH2CH=CH2, 1.5×CH2Ph), 5.96-6.01 (m, 1H, PhCH2CH=CH2), 6.96-7.34 (m, 
24H, aromatic) ppm; 
13
C-n.m.r.: δ, 34.2, 69.1, 73.1, 73.2, 73.3, 73.8, 74.1, 74.5, 74.7, 
75.7, 79.2, 82.7, 101.8, 115.1, 115.4, 116.0, 116.2, 127.7, 127.8, 127.9, 128.1, 128.2 (×2), 
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128.3, 128.4, 128.5 (×2), 128.6 (×3), 128.7 (×2), 129.7, 130.0, 136.9, 138.1, 138.5, 138.6, 
138.7, 155.2 ppm; HR-FAB MS [M+Na]
+
 calcd for C43H44O6Na
+
 679.3036, found 
679.3019.  
 
Ethyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside(5.23). Analytcal data for the 
title compound was essentially the same as previously described. 
2
 
 
Thiazolinyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside(5.26). Analytcal data 
for the title compound was essentially the same as previously described. 
3
 
 
Phenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside(5.28). Analytcal data for 
the title compound was essentially the same as previously described.
4
 
 
Tolyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside(5.27). Analytcal data for the 
title compound was essentially the same as previously described. 
5
 
 
Synthesis of glycosyl acceptors.   
Methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside (5.2). Analytcal data for the title 
compound was essentially the same as previously described.
1,6
  
 
Methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside (5.3). Analytcal data for the title 
compound was essentially the same as previously described.
1,7
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 Methyl 2,4,6-tri-O-benzyl-α-D-glucopyranoside (5.4). Analytcal data for the title 
compound was essentially the same as previously described.
7,8
  
 
Methyl 3,4,6-tri-O-benzyl-α-D-glucopyranoside (5.5). Analytcal data for the title 
compound was essentially the same as previously described. 
7,8
 
 
Tolyl  2,3,4-tri-O-benzoyl-1-thio-β-D-glucopyranoside (5.17). Analytcal data for the 
title compound was essentially the same as previously described.
9
 
 
Ethyl  2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (5.15). Analytcal data for the 
title compound was essentially the same as previously described. 
10
 
 
Phenyl  2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (5.19).  Analytcal data for the 
title compound was essentially the same as previously described. 
11
 
 
Phenyl    2,3,4-tri-O-benzoyl-1-thio-β-D-glucopyranoside (5.21). Analytcal data for the 
title compound was essentially the same as previously described. 
12
 
 
2-Allylphenyl 2,3,4-tri-O-benzyl-β-D-glucopyranoside (5.24).   
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2-Allylphenyl  6-O-acetyl-2,3,4-tri-O-benzyl-β-D-glucopyranoside (L). To a stirred 
solution of a 5.1a (0.1 g, 0.15 mmol) in Ac2O/AcOH (2/1, v/v, 0.9 mL) was added freshly 
prepared ZnCl2 (166 mg, 1.22 mmol) solution in Ac2O/AcOH (2/1, v/v, 0.86 mL). The 
reaction mixture was stirred under argon for 4 h at rt. Upon completion, the reaction was 
quenched with H2O, diluted with ethyl acetate (50 mL), and washed with water (20 mL), 
sat. aq. NaHCO3 (20 mL) and water (3 x 20 mL).  The organic phase was separated, dried 
over MgSO4, and concentrated in vacuo. The residue was purified by column 
chromatography on silica gel (ethyl acetate – toluene gradient elution) to afford the title 
compound (98 mg, 99%) as a clear form. Analytical data for L:  Rf = 0.51 (ethyl acetate - 
toluene, 1/10, v/v); [α]D
23
 -5.8 (c = 1.0, CHCl3);  
1
H-n.m.r.: δ, 1.92 (s, 3H, OCH3), 3.29-
3.45 (m, 2H, PhCH2CH=CH2), 3.48-3.65 (m, 2H; H-4, H-5), 3.67-3.71 (m, 2H, H-2, H-
3), 4.14 (dd, 1H, J6a,6b = 11.8 Hz, J5, 6a = 5.1 Hz, H-6a), 4.24 (dd, 1H, J5,6b = 1.7 Hz, H-6b), 
4.51 (d, J
2
 = 10.9 Hz, ½ CH2Ph), 4.74-5.01 (m, 8H, H-1, PhCH2CH=CH2, 2.5 × CH2Ph), 
5.83-5.93 (m, 1H; PhCH2CH=CH2), 6.87-7.27 (m, 19H, aromatic) ppm;  
13
C-n.m.r.: 20.9, 
34.2, 63.3, 73.1, 75.2, 75.3, 75.9, 82.1, 85.0, 101.3, 115.5, 116.1, 123.0, 127.5, 127.9, 
128.0, 128.1, 128.2, 128.3, 128.4 (×3), 128.5, 128.6 (×3), 128.6, 128.7 (×3), 129.9, 130.2, 
136.8, 137.7, 138.2, 138.4, 154.9, 170.8 ppm; HR-FAB MS [M+Na]
+
 calcd for 
C38H40O7Na 631.2674, found 631.2665. 
 
2-Allylphenyl  2,3,4-tri-O-benzyl-β-D-glucopyranoside (5.24).  A solution of a L (0.42 
g, 0.69 mmol) was dissolved in methanol (3.2 mL) and pH was adjusted (pH 9) by 
careful addition of a 1M solution of NaOCH3 in MeOH (~0.1 mL). The reaction mixture 
was kept for 1 h at rt, then Dowex (H
+
) was added until neutral pH. The resin was filtered 
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off and washed with methanol (3 × 5 mL). The combined filtrate was concentrated in 
vacuo and dried. The residue was purified by column chromatography on silica gel (ethyl 
acetate – hexanes gradient elution) to afford the title compound (0.270 g, 69%) as a white 
solid. Analytical data for 5.24: Rf = 0.56 (ethyl acetate - hexanes, 2/5, v/v); [α]D
23
 -15.1 (c 
= 1.0, CHCl3);  
1
H-n.m.r.: δ, 1.82 (s, 1H, OH), 3.35-3.44 (m, 2H, H-4, PhCH2CH=CH2), 
3.55-3.75 (m, 4H, J2,3 = 8.7 Hz, H-2, H-3, H-5, H-6a), 3.80 (dd, 1H, J6a,6b = 12.1 Hz, J5,6b 
= 2.6 Hz, H-6b), 4.59 (d, J
2 
= 10.9 Hz, 1H, ½ CH2Ph), 4.74-4.98 (m, 7H, 
PhCH2CH=CH2, 2.5 × CH2Ph), 5.04 (d, 1H, J1,2 = 7.2 Hz, H-1), 5.83-5.96 (m, 1H, 
PhCH2CH=CH2), 6.91-7.24 (m, 19H, aromatic) ppm; 
13
C-n.m.r.: 34.2, 62.2, 75.3, 75.5, 
75.9, 82.3, 84.9, 101.1, 114.9, 116.2, 122.9, 127.7, 127.9 (×3), 128.0 (×2), 128.1 (×3), 
128.3 (×3), 128.6 (×3), 128.7 (×3), 129.7, 130.4, 136.9, 138.0, 138.3, 138.6, 154.8 ppm; 
HR-FAB MS [M+Na]
+
 calcd for C36H38O6Na 589.2668, found 589.2676.  
 
2-Allylphenyl 2,3,4-tri-O-benzoyl-β-D-glucopyranoside (5.13). 
 
2-Allylphenyl 2,3,4-tri-O-benzoyl-6-O-triphenylmethyl-β-D-glucopyranoside (M)  
Compound B
 
(1.00 g, 2.16 mmol) was dissolved in methanol (8 mL) and pH was adjusted 
(pH 9) by careful addition of a 1M solution of NaOCH3 in MeOH (~0.1 mL). The 
reaction mixture was kept for 1 h at rt, then Dowex (H
+
) was added until neutral pH.  The 
resin was filtered off and rinsed with methanol (3 × 5 mL). The combined filtrate (~ 30 
mL) was concentrated in vacuo and dried.  The resultant solid was dissolved in pyridine 
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(5.3 mL), and triphenylmethyl chloride (1.9 g, 6.76 mmol) was added and the resulting 
reaction mixture was stirred for 16 h. After that, the reaction mixture was cooled to 0 
o
C 
and benzoyl chloride (1.6 mL, 13.5 mmol) was added dropwise.  The reaction mixture 
was allowed to gradually warm to rt and stirred for additional 3 h at rt. The reaction was 
quenched by addition of methanol (10 mL), evaporated under reduced pressure and co-
evaporated with toluene (3 × 20 mL).  The residue was diluted with CH2Cl2 (20 mL) and 
washed with water (10 mL), sat. aq. NaHCO3 (10 mL) and water (3×10 mL).  The 
organic layer was separated, dried with MgSO4, and concentrated in vacuo.  The residue 
was purified by column chromatography on silica gel (ethyl acetate - hexanes gradient 
elution) to afford the title compound (1.5 g, 86%) as a white solid. Analytical data for M: 
Rf = 0.50 (ethyl acetate - hexanes, 2/5, v/v); 
1
H-n.m.r.: δ, 3.33 (d, 2H, J = 6.5 Hz, 
PhCH2CH=CH2), 3.43 (dd, 1H,  J5,6a = 2.2 Hz, H-6a), 3.52 (dd, 1H, J5,6b = 6.1Hz, J6a,6b = 
10.7 Hz, H-6b), 4.03-4.09 (m, 1H; H-5), 4.80-4.92 (m, 2H, PhCH2CH=CH2), 5.40-5.43 
(d, 1H, J1,2 = 7.6 Hz, H-1), 5.65-5.72 (m, 1H; H-4), 5.76-5.89 (m, 1H; PhCH2CH=CH2), 
5.93-6.01 (m, 2H, H-2, H-3), 7.09-8.04 (m, 34H; aromatic) ppm; 
13
C-n.m.r.: δ, 34.1, 60.6, 
62.6, 69.6, 71.9, 73.3, 74.5, 74.6, 87.2 (×2), 100.0, 115.6, 115.7, 115.9, 123.4 (×2), 127.2, 
127.6 (×5), 127.9, 128.4, 128.5, 128.7 (×6), 129.0, 129.1, 129.2, 129.4, 129.9, 129.9, 
130.0 (×2), 130.1, 130.2, 133.4, 133.4, 136.6, 143.7 (×5), 155.1, 165.1 (×2), 165.3 (×2), 
166.0 (×2) ppm; HR-FAB MS [M+Na]
+
 calcd for C55H46O9Na 873.3072, found 873.3064 
 
2-Allylphenyl 2,3,4-tri-O-benzoyl-β-D-glucopyranoside (5.13).  To a stirred solution of 
M (1.1 g, 1.22 mmol) in CH2Cl2 (20 mL), water (0.2 mL) followed by trifluoroacetic acid 
(1.8 mL) were added until persistent yellow color obtained. The resultant mixture was 
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stirred at rt for 45 min, diluted with CH2Cl2 (20 mL), washed with water (10 mL), sat. aq. 
NaHCO3 (10 mL), and water (3×10 mL).  The organic layer was separated, dried with 
MgSO4, and concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (ethyl acetate - hexanes gradient elution) to afford the title compound (0.7 g, 
90%) as a white solid.  Analytical data for 5.13: Rf = 0.56 (ethyl acetate - hexanes, 2/5, 
v/v); [α]D
23
 +15.6 (c = 1.0, CHCl3); 
1
H-n.m.r.: δ, 3.13 (t, J = 6.2 Hz, 1H, OH), 3.35 (d, 
2H, J = 6.5 Hz, PhCH2CH=CH2), 3.87-4.02 (m, 2H, H-6a, H-6b), 4.08-4.13 (m, 1H, H-5), 
4.89 (m, 2H, PhCH2CH=CH2), 5.57 (d, 1H, J1,2 = 7.9 Hz, H-1), 5.73 (dd, 1H, J3,4= 9.7 
Hz, H-4), 5.77-5.90 (m, 1H; PhCH2CH=CH2), 5.99 (dd, 1H, J2,3 = 9.8 Hz, H-2), 6.20 (dd, 
1H, J3,4 = 9.7 Hz, H-3), 7.08-7.56 (m, 13H, aromatic), 7.95-8.09 (m, 6H, aromatic) ppm; 
13
C-n.m.r.: 33.9, 61.6, 69.6, 71.7, 72.9, 75.1, 77.6, 99.6, 114.9, 115.7, 123.3, 127.6, 128.5 
(×3), 128.7 (×3), 128.9 (×2), 129.3, 129.9 (×2), 129.9 (×2), 130.1 (×2), 130.4, 133.5 (x2), 
133.9, 136.5, 154.7, 165.2, 165.9, 166.1 ppm; HR-FAB MS [M+Na]
+
 calcd for 
C36H32O9Na 631.1944, found 631.1937  
 
Synthesis of glycosides 
Typical MeOTf-promoted glycosylation procedure (Method A). A mixture of glycosyl 
donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (3Å, 300 mg) in 1,2-dichloroethane (1.4 mL) was stirred under argon for 1 h. 
MeOTf (0.33 mmol) was added and the reaction mixture was monitored by TLC. Upon 
completion (see Tables), the solid was filtered off and the residue was rinsed successively 
with CH2Cl2. The combined filtrate (30 mL) was washed with 20% NaHCO3 (10 mL) 
and water (3 x 10 mL). The organic layer was separated, dried with MgSO4 and 
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concentrated in vacuo. The residue was purified by silica gel column chromatography 
(ethyl acetate- hexane gradient elution) to afford the corresponding oligosaccharide. 
 
Typical TMSOTf-promoted glycosylation procedure (Method B). A mixture of glycosyl 
donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (4Å, 150 mg) in 1,2-dichloroethane (1.6 mL) was stirred under argon for 1 h. 
TMSOTf (0.22 mmol) was added and the reaction mixture was monitored by TLC. Upon 
completion (see Tables), the solid was filtered off and the residue was rinsed successively 
with CH2Cl2. The combined filtrate (30 mL) was washed with 20% NaHCO3 (10 mL) 
and water (3 x 10 mL). The organic layer was separated, dried with MgSO4 and 
concentrated in vacuo. The residue was purified by silica gel column chromatography 
(ethyl acetate- hexane gradient elution) to afford the corresponding oligosaccharide. 
 
Typical NIS/TfOH-promoted glycosylation procedure (Method C). A mixture of glycosyl 
donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated molecular 
sieves (4Å, 150 mg) in 1,2-dichloroethane (1.6 mL) was stirred under argon for 1 h. NIS 
(0.22 mmol) and TfOH (0.022 mmol) was added and the reaction mixture was monitored 
by TLC. Upon completion, the mixture was diluted with CH2Cl2, the solid was filtered 
off, and the residue was rinsed successively with CH2Cl2, The combined filtrate (30 mL) 
was washed with 10% Na2S2O3 (10 mL) and water (3 x 10 mL). The organic layer was 
separated, dried with MgSO4 and concentrated in vacuo. The residue was purified by 
silica gel column chromatography (ethyl acetate- hexane gradient elution) to afford the 
corresponding oligosaccharide. 
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Typical NIS/TMSOTf-promoted glycosylation procedure (Method D). A mixture of 
glycosyl donor (0.11 mmol), glycosyl acceptor (0.10 mmol), and freshly activated 
molecular sieves (4Å, 150 mg) in 1,2-dichloroethane (1.6 mL) was stirred under argon 
for 1 h. NIS (0.22 mmol) and TMSOTf (0.022 mmol) was added and the reaction mixture 
was monitored by TLC. Upon completion, the mixture was diluted with CH2Cl2, the 
solid was filtered off, and the residue was rinsed successively with CH2Cl2. The 
combined filtrate (30 mL) was washed with 10% Na2S2O3 (10 mL) and water (3 x 10 
mL). The organic layer was separated, dried with MgSO4 and concentrated in vacuo. The 
residue was purified by silica gel column chromatography (ethyl acetate - hexane 
gradient elution) to afford the corresponding oligosaccharide. 
 
Methyl 6-O-(2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside (5.6a). Analytcal data for the title compound was essentially the same 
as previously described.
13
 
 
Methyl 6-O-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside (5.6b). Analytcal data for the title compound was essentially the same 
as previously described.
13
 
 
Methyl 6-O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl)-2,3,4-tri-O-
benzyl-α-D-glucopyranoside (5.6c). Analytcal data for the title compound was 
essentially the same as previously described. 
14 
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Methyl 4-O-(2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranosyl)-2,3,6-tri-O-benzyl-α-D-
glucopyranoside (5.7a). Analytcal data for the title compound was essentially the same 
as previously described.
13
 
 
Methyl  3-O-(2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranosyl)-2,4,6-tri-O-benzyl-α-D-
glucopyranoside (5.8a).  Analytcal data for the title compound was essentially the same 
as previously described. 
15
 
 
Methyl 2-O-(2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (5.9a). Analytcal data for the title compound was essentially the same 
as previously described. 
16
 
 
Methyl 2-O-(2,3,4,6-tetra-O-benzyl-D-galactopyranosyl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (5.9d).  The title compound was obtained as a clear film from 5.1d and 
5.5 by Method C in 80% yield (α/β = 3.0/1). Selected analytical data for α-5.9d: 1H 
n.m.r.: δ, 3.91 (dd, 1H, J2,3 = 2.7 Hz, H-2), 4.02 (dd, 1H, J2‟,3‟ = 9.6 Hz, H‟-2), 4.93 (d, 
1H, J1,2 = 3.4 Hz, H-1), 4.97 (d, 1H, J1‟2‟ = 3.5 Hz, H‟-1) ppm; 
13
C n.m.r.: δ, 94.9 (C-1), 
96.7 (C‟-1) ppm. HR-FAB MS [M+Na]+ calcd for C62H66O11Na
+
 1009.4503, found 
1009.4510.  
 
Methyl 3-O-(2,3,4,6-tetra-O-benzyl-D-galactopyranosyl)-2,4,6-tri-O-benzyl-α-D-
glucopyranoside (5.8d). Analytcal data for the title compound was essentially the same 
as previously described. 
17
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Methyl 4-O-(2,3,4,6-tetra-O-benzyl-D-galactopyranosyl)-2,3,6-tri-O-benzyl-α-D-
glucopyranoside (5.7d). Analytcal data for the title compound was essentially the same 
as previously described. 
18
 
 
Methyl 6-O-(2,3,4,6-tetra-O-benzyl-D-galactopyranosyl)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside (5.6d). Analytcal data for the title compound was essentially the same 
as previously described. 
19
 
 
Methyl 2-O-(2,3,4,6-tetra-O-benzoyl-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-
glucopyranoside (5.9b). Analytcal data for the title compound was essentially the same 
as previously described. 
16 
 
Ethyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-1-thio-β-D-
glucopyranoside (5.16) Analytcal data for the title compound was essentially the same 
as previously described. 
2
 
 
Phenyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-D-glucopyranosyl)-2,3,4-tri-O-benzoyl-1-thio-β-
D-glucopyranoside (5.22). Analytcal data for the title compound was essentially the 
same as previously described. 
16
 
 
2-[3-iodo-2-(methyl 2,3,4-tri-O-benzyl-α-D-glucopyranosid-6-yl)propyl]oxyphenyl 
2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside (5.12). The title compound was isolated as 
Premathilake, Hemali D., UMSL, p.187 
 
a by-product from the synthesis of 5.6a from 5.1a and 5.2 by Method B in 15% yield.  
Selected analytical data for 5.12: 
1H.n.m.r.: δ 3.74 (dd, 1H, J2‟,3‟ = 7.9 Hz, H‟-2), 4.53 (d, 
J1, 2 = 4.1 Hz, H-1), 5.02 (d, 1H, J1‟,2‟ = 8.0 Hz, H‟-1) ppm; 
13
C-n.m.r.: δ, 10.6, 35.9, 55.3, 
68.0, 68.8, 70.4, 73.5, 73.6, 73.7, 74.8, 75.2, 75.3, 75.4, 75.5, 75.8, 75.9, 77.4, 77.8, 77.9, 
79.4, 79.9, 80.1, 82.2, 82.3, 82.4, 85.1, 85.2, 98.2, 101.8, 115.8, 122.8, 122.9, 127.1, 
127.6, 127.7, 127.8, 127.9 (×2), 128.0 (×2), 128.1 (×2), 128.1 (×2), 128.2 (×2), 128.3, 
128.4 (×2), 128.5 (×2), 128.6 (×4), 128.7 (×4), 128.9, 129.2, 132.2, 138.1, 138.2, 138.3, 
138.4, 138.5, 138.6, 138.7, 138.8, 155.5 ppm; HR-FAB MS [M+Na]
+
 calcd for 
C71H75IO12Na
+
 1269.4201, found 1269.4214. 
.  
Tolyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-D-glucopyranosyl)-2,3,4-tri-O-benzoyl-1-thio-β-
D-glucopyranoside (5.18). The title compound was obtained as a clear film from 5.6 and 
5.15 by Method A in 75% yield (α/β = 2.4/1). Selected analytical data for α-5.18: 1H 
n.m.r.: δ, 4.67 (d, 1H, J1‟,2‟ = 3.7 Hz, H‟-1), 4.85 (d, 1H, J1,2 = 9.3 Hz, H-1)ppm. 
13
C-
n.m.r.: δ, 86.1 (C-1), 97.6 (C‟-1) ppm. Selected analytical data for β-5.18: 1H n.m.r.: δ, 
4.52 (d, 1H, J1‟,2‟ = 10.8 Hz, H‟-1) ppm. 
13
C-n.m.r.: δ, 87.2 (C-1), 103.9 (C‟-1) ppm. HR-
FAB MS [M+Na]
+
 calcd for C68H64O13SNa
+
 1143.3965, found 1143.3970.  
 
2-Allylphenyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-β-
D-glucopyranoside (5.25). The title compound was obtained as a clear film from donors 
5.24, 5.27-5.29 and acceptor 5.24 by Method A in 82-90% yield. Selected analytical data 
for α-5.25: 1H n.m.r.: δ, 4.37 (d, 1H, J1‟,2‟ = 2.7 Hz, H‟-1) ppm; 
13
C-n.m.r.: δ, 97.6 (C-1), 
100.6 (C‟-1) ppm;  Selected analytical data for β-5.25: 1H n.m.r.: δ, 4.34 (d, 1H, J1‟,2‟ = 
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5.6 Hz, H‟-1) ppm; 13C-n.m.r.: 13C-n.m.r.: δ, 101.6 (C-1), 104.2 (C‟-1) ppm; HR-FAB 
MS [M+Na]
+
 calcd for C70H72O11Na
+
 1111.5057, found 1111.4980.  
 
2-Allylphenyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-D-glucopyranosyl)-2,3,4-tri-O-benzoyl-
β-D-glucopyranoside (5.14). The title compound was obtained as a clear film from 5.1a 
and 5.13 by Method B in 78% yield (α/β = 1.0/1). Selected analytical data for α-5.14: 1H 
n.m.r.: δ, 4.58 (d, 1H, J1‟,2‟ = 4.6 Hz, H‟-1), 5.28 (d, J1,2  = 7.8 Hz, H-1) ppm. 
13
C-n.m.r.: 
δ, 80.4 (C-1), 98.4 (C‟-1) ppm; Selected analytical data for β-5.14: 1H n.m.r.: δ, 4.42 (d, 
1H, J1‟,2‟ = 11.0 Hz, H‟-1) ppm; 13C-n.m.r.: δ, 82.2 (C-1), 100.1 (C‟-1) ppm;  HR-FAB 
MS [M+Na]
+
 calcd for C70H68O14Na
+
 1155.4609, found 1155.4623. 
 
Phenyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-1-thio-β-
D-glucopyranoside (5.20). The title compound was obtained as clear film from 5.1a and 
5.19 by Method B in 90% yield (α/β = 1.0/1). Selected analytical data for α-5.20: 1H 
n.m.r.: δ, 3.95 (t, 1H, J2,3 = 9.0 Hz, H-3), 4.57 (d, 1H, J1,2 = 9.3 Hz, H-1), 5.00 (d, 1H, J1‟,2‟ 
= 3.5 Hz, H‟-1), ppm. 13C-n.m.r.: δ, 89.2 (C-1), 96.6 (C‟-1) ppm. Selected analytical data 
for β-5.20: 1H n.m.r.: δ, 4.37 (d, 1H, J1‟,2‟ = 7.8 Hz, H‟-1),  
13
C-n.m.r.: δ, 95.2 (C-1), 
103.4 (C‟-1) ppm. HR-FAB MS [M+Na]+ calcd for C67H68O10SNa
+
 1087.4433, found 
1087.4406. 
 
Methyl O-(2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranosyl)-(16)-O-(2,3,4-tri-O-
benzyl-α/β-D-glucopyranosyl)-(16)-2,3,4-tri-O-benzyl-β-D-glucopyranoside (5.29). 
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Analytcal data for the title compound was essentially the same as previously 
described.
[20]
  
 
2-Allylphenyl  O-(2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranosyl)-(16)-O-(2,3,4-tri-
O-benzyl-α/β-D-glucopyranosyl)-(16)-2,3,4-tri-O-benzyl-β-D-glucopyranoside 
(5.31). The title compound was obtained as colorless syrup from 5.16 and 5.25 by method 
A in 50% yield. Selected analytical data for β-5.32: 1H n.m.r.: δ, 4.37 (d, 1H, J1‟,2‟ = 12.4 
Hz, H‟-1), 4.47 (d, 1H, J1‟‟,2‟‟ = 2.5 Hz, H‟‟-1), 4.99 (d, 1H, J1,2 = 6.9 Hz, H-1) ppm; 
13
C-
n.m.r.: δ, 98.2 (C-1), 102.0 (C‟-1), 103.8 (C‟‟-1) ppm; HR-FAB MS [M+Na]+ calcd for 
C97H100O16Na
+
 1543.6909, found 1543.6936. 
 
2-Allylphenyl O-(2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranosyl)-(16)-O-(2,3,4-tri-
O-benzyl-α/β-D-glucopyranosyl)-(16)-2,3,4-tri-O-benzoyl-β-D-glucopyranoside 
(5.32). The title compound was obtained as colorless syrup from 5.16 and 5.13 by method 
A in 80% yield. Selected analytical data for α-5.32: 1H n.m.r.: δ, 4.67 (d, 1H, J1‟,2‟ = 3.2 
Hz, H‟-1), 4.90 (d, 1H, J1‟‟,2‟‟ = 2.5 Hz, H‟‟-1) ppm; 
13
C-n.m.r.: δ, 97.4 (C-1), 97.5 (C‟-1), 
97.6 (C”-1) ppm; Selected analytical data for β-5.32: 5.27 (d, 1H, J1,2 = 7.8 Hz, H-1) 
ppm; 
13
C-n.m.r.: δ, 99.7 (C-1), 99.8 (C‟-1), 103.8 (C‟‟-1) ppm; HR-FAB MS [M+Na]+ 
calcd for C97H94O19Na
+
 1585.7729, found 1585.7762. 
 
Phenyl O-(2,3,4,6-tetra-O-benzyl-α/β-D-glucopyranosyl)-(16)-O-(2,3,4-tri-O-
benzyl-α/β-D-glucopyranosyl)-(16)-2,3,4-tri-O-benzoyl-1-thio-β-D-glucopyranoside 
(5.30). The title compound was obtained as clear film from 5.26 and 5.21 by method B in 
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90% yield. Selected analytical data for 5.30: Selected analytical data for α-5.30: 1H 
n.m.r.: δ, 4.69 (d, 1H, J1‟,2‟ = 3.1 Hz, H‟-1), 4.96 (d, 1H, J1‟‟,2‟‟ = 2.3 Hz, H‟‟-1) ppm; 
13
C-
n.m.r.: δ, 97.4 (C-1), 97.5 (C‟-1), 97.6 (C”-1) ppm; Selected analytical data for β-5.30: 
5.27 (d, 1H, J1,2 = 7.9 Hz, H-1) ppm; 
13
C-n.m.r.: δ, 99.7 (C-1), 99.8 (C‟-1), 103.8 (C‟‟-1) 
ppm; HR-FAB MS [M+Na]
+
 calcd for C94H90O18SNa
+
 1561.5745, found 1561.5731. 
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Selected NMR spectral data 
                                                          
2.8e
 
CDCl3 at 300 MHz 
Figure A-1:  
1
H NMR spectrum of p-Methylphenyl 2-O-benzoyl-3,4,6-tri-O-benzyl-1-
thio-β-D-glucopyranoside (2.8e) 
 
CDCl3 at 75 MHz  
Figure A-2  
13
C-NMR
 
spectrum of p-Methylphenyl 2-O-benzoyl-3,4,6-tri-O-benzyl-1-
thio-β-D-glucopyranoside (2.8e) 
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Figure A-3:  2-D-NMR COSY spectrum of p-Methylphenyl 2-O-benzoyl-3,4,6-tri-O-
benzyl-1-thio-β-D-glucopyranoside (2.8e) 
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                                                                                             2.8f  
                                                                                                 
 
CDCl3 at 300 MHz 
 
Figure A-4:  
1
H NMR spectrum of Thiazolinyl 2-O-benzoyl-3,4,6-tri-O-benzyl-1-thio-β-
D-glucopyranoside  (2.8f) 
 
 
CDCl3 at 75 MHz 
 
Figure A-5:  
13
C NMR spectrum of Thiazolinyl 2-O-benzoyl-3,4,6-tri-O-benzyl-1-thio-β-
D-glucopyranoside  (2.8f)  
3.54.04.55.05.56.06.57.07.58.0 ppm
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CDCl3 at 300 MHz 
 
 
Figure A-6:  2-D NMR COSY spectrum of Thiazolinyl 2-O-benzoyl-3,4,6-tri-O-benzyl-
1-thio-β-D-glucopyranoside  (2.8f) 
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                                                                                                                   2.13 
 
CDCl3 at 300 MHz 
 
Figure A-7:  
1
H NMR spectrum of Ethyl O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-
glucopyranosyl)-(16)-2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (2.13) 
 
  
CDCl3 at 75 MHz 
 
Figure A-8:  
1
H NMR spectrum of Ethyl O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-
glucopyranosyl)-(16)-2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (2.13) 
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CDCl3 at 300 MHz 
 
 
 
Figure A-9:  2-D NMR COSY spectrum of Ethyl O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-
D-glucopyranosyl)-(16)-2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (2.13) 
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Figure A-10:  
1
H NMR spectrum of Ethyl O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-
glucopyranosyl)-(16)-O-(2,3,4-tri-O-benzyl-D-glucopyranosyl)-(16)-2,3,4-tri-O-
benzoyl-1-thio-β-D-glucopyranoside (2.15) 
 
 
CDCl3 at 75 MHz 
 
Figure A-11:  
13
C NMR spectrum of Ethyl O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-
glucopyranosyl)-(16)-O-(2,3,4-tri-O-benzyl-D-glucopyranosyl)-(16)-2,3,4-tri-O-
benzoyl-1-thio-β-D-glucopyranoside (2.15)  
1.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Figure A-12:  
1
H NMR spectrum of Ethyl O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-
glucopyranosyl)-(16)-O-(2,3,4-tri-O-benzyl-D-glucopyranosyl)-(16)-2,3,4-tri-O-
benzoyl-1-thio-β-D-glucopyranoside (2.15) 
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Figure A-13:  
1
H NMR spectrum of Methyl O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-
glucopyranosyl)-(16)-O-(2,3,4-tri-O-benzyl-D-glucopyranosyl)-(16)-O-(2,3,4-tri-O-
benzoyl-β-D-glucopyranosyl)-(16)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.16). 
 
 
CDCl3 at 75 MHz 
 
Figure A-14:  
13
C NMR spectrum of Methyl O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-
glucopyranosyl)-(16)-O-(2,3,4-tri-O-benzyl-D-glucopyranosyl)-(16)-O-(2,3,4-tri-O-
benzoyl-β-D-glucopyranosyl)-(16)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (2.16). 
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Figure A-15:  2-D NMR COSY spectrum of Methyl O-(2-O-benzoyl-3,4,6-tri-O-benzyl-
β-D-glucopyranosyl)-(16)-O-(2,3,4-tri-O-benzyl-D-glucopyranosyl)-(16)-O-(2,3,4-
tri-O-benzoyl-β-D-glucopyranosyl)-(16)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
(2.16). 
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Figure A-16:  
1
H NMR spectrum of Phenyl 3-O-tert-butyldimethylsilyl-4,6-O-
benzylidene-1-thio-β-D-glucopyranoside (A) 
 
CDCl3 at 300 MHz 
 
Figure A-17:  2-D NMR COSY spectrum of Phenyl 3-O-tert-butyldimethylsilyl-4,6-O-
benzylidene-1-thio-β-D-glucopyranoside (A) 
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Figure A-18:  
1
H NMR spectrum of Phenyl 2-O-benzoyl-3-O-tert-butyldimethylsilyl-4,6-
O-benzylidene-1-thio-β-D-glucopyranoside (B) 
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Figure A-19:  2-D NMR COSY spectrum of Phenyl 2-O-Benzoyl-3-O-tert-
butyldimethylsilyl-1-thio-β-D-glucopyranoside (C). 
Premathilake, Hemali D., UMSL, p.209 
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Figure A-20:  
1
H NMR spectrum of Phenyl 2-O-Benzoyl-6-O-Benzyl-3-O-tert-
butyldimethylsilyl-1-thio-β-D-glucopyranoside (D) 
 
 
CDCl3 at 300 MHz 
 
Figure A-21:  2-D NMR COSY spectrum of Phenyl 2-O-Benzoyl-6-O-Benzyl-3,-O-tert-
butyldimethylsilyl-1-thio-β-D-glucopyranoside (D) 
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Figure A-22:  
1
H NMR spectrum of Phenyl 2-O-benzoyl-3,4,6-tri-O-tert-
butyldimethylsilyl-1-thio-β-D-glucopyranoside (3.1c) 
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Figure A-23: 
13
C NMR spectrum of Phenyl 2-O-Benzoyl-3,4,6-tri-O-tert-
butyldimethylsilyl-1-thio-β-D-glucopyranoside (3.1c) 
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Figure A-24: 2-D NMR COSY spectrum of Phenyl 2-O-benzoyl-3,4,6-tri-O-tert-
butyldimethylsilyl-1-thio-β-D-glucopyranoside (3.1c) 
  
Premathilake, Hemali D., UMSL, p.212 
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Figure A-25: 
1
H NMR spectrum of Phenyl 2-O-Benzoyl-3,4,6-tri-O-tert-
butyldimethylsilyl-1-thio-β-D-glucopyranoside (3.1c) 
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Figure A-26: 
1
H NMR spectrum of Phenyl 2-O-benzoyl-6-O-benzyl-3,4,-di-O-tert-
butyldimethylsilyl-1-thio-β-D-glucopyranoside (3.1d) 
Premathilake, Hemali D., UMSL, p.213 
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 Figure A-27: 2-D NMR COSY spectrum of Phenyl 2-O-benzoyl-6-O-benzyl-3,4,-di-O-
tert-butyldimethylsilyl-1-thio-β-D-glucopyranoside (3.1d) 
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Figure A-28: 
1
H NMR spectrum of Methyl 6-O-(2-O-benzoyl-6-O-benzyl-3,4,-di-O-tert-
butyldimethylsilyl-β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (3.3d). 
 
 
 
CDCl3 at 75 MHz 25 
0
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Figure A-29: 
13
C NMR spectrum of Methyl 6-O-(2-O-benzoyl-6-O-benzyl-3,4,-di-O-tert-
butyldimethylsilyl-β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (3.3d). 
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Figure A-30: 2-D NMR COSY spectrum of Methyl 6-O-(2-O-benzoyl-6-O-benzyl-3,4,-
di-O-tert-butyldimethylsilyl-β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-
glucopyranoside (3.3d). 
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Figure A-31: 
1
H NMR spectrum of Methyl 6-O-(6-O-benzyl-2,3,4,-tri-O-tert-
butyldimethylsilyl-α/β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
(3.3a).  
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Figure A-32: 2-D NMR COSY spectrum of Methyl 6-O-(6-O-benzyl-2,3,4,-tri-O-tert-
butyldimethylsilyl-α/β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
(3.3a).  
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Figure A-33:  
1
H NMR spectrum of Methyl (p-methylphenyl 5-acetamido-4,7,8,9-tetra-
O-acetyl-5-N-benzoyl-3,5-dideoxy-2-thio-D-glycero-β-D-galacto-non-2-
ulopyranoside)onate (4.18).  
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Figure A-34:  
13
C NMR spectrum of Methyl (p-methylphenyl 5-acetamido-4,7,8,9-tetra-
O-acetyl-5-N-benzoyl-3,5-dideoxy-2-thio-D-glycero-β-D-galacto-non-2-
ulopyranoside)onate (4.18). 
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Figure A-35:  2-D NMR COSY spectrum of Methyl (p-methylphenyl 5-acetamido-
4,7,8,9-tetra-O-acetyl-5-N-benzoyl-3,5-dideoxy-2-thio-D-glycero-β-D-galacto-non-2-
ulopyranoside)onate (4.18). 
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Figure A-36:  
1
H NMR spectrum of Methyl (methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-
5-N-benzoyl-3,5-dideoxy-2-thio-D-glycero-β-D-galacto-non-2-ulopyranoside)onate 
(4.19). 
 
 
 
CDCl3 at 75 MHz 
 
Figure A-37:  
13
C NMR spectrum of Methyl (methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-
5-N-benzoyl-3,5-dideoxy-2-thio-D-glycero-β-D-galacto-non-2-ulopyranoside)onate 
(4.19). 
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Figure A-38:  
1
H NMR spectrum of Methyl (methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-
5-N-benzoyl-3,5-dideoxy-2-thio-D-glycero-β-D-galacto-non-2-ulopyranoside)onate 
(4.19). 
 
  
ppm
2.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
Premathilake, Hemali D., UMSL, p.222 
 
 
 
 
DMSO at 300 MHz at 80 
o
C 
 
Figure A-39:  
1
H NMR spectrum of Methyl (phenyl 5-acetamido-4,7,8,9-tetra-O-acetyl-
5-N-benzoyl-3,5-dideoxy-2-thio-D-glycero-β-D-galacto-non-2-ulopyranoside)onate 
(4.20). 
 
 CDCl3 at 75 MHz 
 
Figure A-40:  
13
C NMR spectrum of Methyl (phenyl 5-acetamido-4,7,8,9-tetra-O-acetyl-
5-N-benzoyl-3,5-dideoxy-2-thio-D-glycero-β-D-galacto-non-2-ulopyranoside)onate 
(4.20). 
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Figure A-41:  
1
H NMR spectrum of Methyl (phenyl 5-acetamido-4,7,8,9-tetra-O-acetyl-
5-N-benzoyl-3,5-dideoxy-2-thio-D-glycero-β-D-galacto-non-2-ulopyranoside)onate 
(4.20). 
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DMSO at 300 MHz at 80 
o
C 
 
Figure A-42:  
1
H NMR spectrum of O-(Methyl  5-acetamido-4,7,8,9-tetra-O-acetyl-5-N-
benzoyl-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonate)-(26)-1,2:3,4-di-
O-isopropylidene-α-D-galactopyranose (4.22b). 
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Figure A-43:  
13
C NMR spectrum of O-(Methyl  5-acetamido-4,7,8,9-tetra-O-acetyl-5-N-
benzoyl-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonate)-(26)-1,2:3,4-di-
O-isopropylidene-α-D-galactopyranose (4.22b). 
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Figure A-44:  2D-NMR COSY spectrum of O-(Methyl  5-acetamido-4,7,8,9-tetra-O-
acetyl-5-N-benzoyl-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonate)-(26)-
1,2:3,4-di-O-isopropylidene-α-D-galactopyranose (4.22b). 
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Figure A-45:  
1
H NMR spectrum of Methyl O-(methyl  5-acetamido-4,7,8,9-tetra-O-
acetyl-5-N-benzoyl-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonate)-(26)-
2,3,4-tri-O-benzyl-α-D-galactopyranoside (4.23b). 
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Figure A-46:  
13
C NMR spectrum of Methyl O-(methyl  5-acetamido-4,7,8,9-tetra-O-
acetyl-5-N-benzoyl-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonate)-(26)-
2,3,4-tri-O-benzyl-α-D-galactopyranoside (4.23b). 
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Figure A-47: 
1
H NMR spectrum of Methyl O-(methyl  5-acetamido-4,7,8,9-tetra-O-
acetyl-5-N-benzoyl-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonate)-(26)-
2,3,4-tri-O-benzyl-α-D-galactopyranoside (4.23b). 
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Figure A-50:  
1
H NMR spectrum of   2-Allylphenyl 2,3,4,6-tetra-O-acetyl-β-D-
glucopyranoside (B) 
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Figure A-51:  
13
C NMR spectrum of   2-Allylphenyl 2,3,4,6-tetra-O-acetyl-β-D-
glucopyranoside (B) 
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Figure A-52:  2-D NMR COSY spectrum of   2-Allylphenyl 2,3,4,6-tetra-O-acetyl-β-D-
glucopyranoside (B) 
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Figure A-53:  
1
H NMR spectrum of   2-Allylphenyl 2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranoside (5.1b). 
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Figure A-54:  
13
C NMR spectrum of   2-Allylphenyl 2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranoside (5.1b). 
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Figure A-55:  2-D NMR COSY spectrum of   2-Allylphenyl 2,3,4,6-tetra-O-benzoyl-β-D-
glucopyranoside (5.1b). 
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Figure A-56:  
1
H NMR spectrum of 2-Allylphenyl 2,3,4,6-tetra-O-benzyl-β-D-
glucopyranoside (5.1a).   
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Figure A-57:  
13
C NMR spectrum of 2-Allylphenyl 2,3,4,6-tetra-O-benzyl-β-D-
glucopyranoside (5.1a).   
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Figure A-58:  2-D NMR COSY spectrum of 2-Allylphenyl 2,3,4,6-tetra-O-benzyl-β-D-
glucopyranoside (5.1a).   
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Figure A-59:  
1
H NMR spectrum of 2-Allylphenyl 2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-
glucopyranoside (5.1c). 
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Figure A-60:  
13
C NMR spectrum of 2-Allylphenyl 2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-
glucopyranoside (5.1c). 
  
Premathilake, Hemali D., UMSL, p.235 
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Figure A-61:  
1
H NMR spectrum of 2-Allylphenyl 2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-
glucopyranoside (5.1c). 
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Figure A-62:  
1
H NMR spectrum of 2-Allylphenyl 2,3,4-tri-O-benzoyl-β-D-
glucopyranoside (5.13).   
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Figure A-63:  
13
C NMR spectrum of 2-Allylphenyl 2,3,4-tri-O-benzoyl-β-D-
glucopyranoside (5.13).   
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Figure A-64:  2-D NMR COSY spectrum of 2-Allylphenyl 2,3,4-tri-O-benzoyl-β-D-
glucopyranoside (5.13).   
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Figure A-65:  
1
H NMR spectrum of 2-Allylphenyl 2,3,4-tri-O-benzyl-β-D-
glucopyranoside (5.24).   
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Figure A-66:  2-D NMR COSY spectrum of 2-Allylphenyl 2,3,4-tri-O-benzyl-β-D-
glucopyranoside (5.24).   
  
Premathilake, Hemali D., UMSL, p.239 
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Figure A-67:  
1
H NMR spectrum of Phenyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-D-
glucopyranosyl)-2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (5.20). 
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Figure A-68:  2-D NMR COSY spectrum of Phenyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-D-
glucopyranosyl)-2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (5.20). 
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Figure A-69:  
1
H NMR spectrum of 2-Allylphenyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-D-
glucopyranosyl)-2,3,4-tri-O-benzyl-β-D-glucopyranoside (5.25). 
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Figure A-70:  
13
C NMR spectrum of 2-Allylphenyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-D-
glucopyranosyl)-2,3,4-tri-O-benzyl-β-D-glucopyranoside (5.25). 
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Figure A-71:  2-D NMR COSY spectrum of 2-Allylphenyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-
D-glucopyranosyl)-2,3,4-tri-O-benzyl-β-D-glucopyranoside (5.25). 
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Figure A-72:  
1
H NMR spectrum of 2-Allylphenyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-D-
glucopyranosyl)-2,3,4-tri-O-benzoyl-β-D-glucopyranoside (5.14). 
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Figure A-73:  
13
C NMR spectrum of 2-Allylphenyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-D-
glucopyranosyl)-2,3,4-tri-O-benzoyl-β-D-glucopyranoside (5.14). 
  
Premathilake, Hemali D., UMSL, p.243 
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Figure A-74:  2-D NMR COSY spectrum of 2-Allylphenyl 6-O-(2,3,4,6-tri-O-benzyl-α/β-
D-glucopyranosyl)-2,3,4-tri-O-benzoyl-β-D-glucopyranoside (5.14). 
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Figure A-75:  1H NMR spectrum of 2-Allylphenyl O-(2,3,4,6-tetra-O-benzyl-α/β-D-
glucopyranosyl)-(16)-O-(2,3,4-tri-O-benzyl-α/β-D-glucopyranosyl)-(16)-2,3,4-tri-O-
benzoyl-β-D-glucopyranoside (5.32). 
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Figure A-76:  
13
C NMR spectrum of 2-Allylphenyl O-(2,3,4,6-tetra-O-benzyl-α/β-D-
glucopyranosyl)-(16)-O-(2,3,4-tri-O-benzyl-α/β-D-glucopyranosyl)-(16)-2,3,4-tri-O-
benzoyl-β-D-glucopyranoside (5.32). 
  
Premathilake, Hemali D., UMSL, p.245 
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Figure A-77:  2-D NMR COSY spectrum of 2-Allylphenyl O-(2,3,4,6-tetra-O-benzyl-
α/β-D-glucopyranosyl)-(16)-O-(2,3,4-tri-O-benzyl-α/β-D-glucopyranosyl)-(16)-
2,3,4-tri-O-benzoyl-β-D-glucopyranoside (5.32). 
